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Abstract 
A critical phase of placental development 1s the differentiation of 
cytotrophoblasts into invasive extravillous trophoblasts. Alterations of this process 
can lead to serious pregnancy pathologies such as preeclampsia and intrauterine 
growth restriction. Unfortunately it is poorly understood which physiological and 
molecul ar mechanisms are involved in the regulation of trophoblast differentiation. 
lntegrin-Linked Kinase (ILK) is a ubiquitous protein able to regulate outside-
inside signaling by binding to integrins. Since ILK is overexpressed in tumors that 
become invasive, it was hypothesized that ILK is expressed in human placenta and 
that it is necessary for the differentiation of trophoblasts into invasive cells. To test 
the hypothesis, spatial and temporal patterns of ILK expression were studied in 
n01mal human and mouse placentas by immunohistochemistry, immunofluorescence 
analysis, and immunoblot analysis. In human placenta, ILK was present in 
cytotrophoblast and extravillous trophoblast in the first trimester (n= 17), early second 
trimester (n=6) and at tem1 (n= IO). By comparison, ILK was present in the three 
layers of the mouse placenta: labyrinth, junctional zone, and trophoblast giant cells. 
HTR8-SVneo cells were also used to determine the role of ILK in migration 
and invasion . When ILK function was impaired in HTR8-SVneo cell s with a 
dominant negative form of ILK, migration and invasion were inhibited. Furthermore, 
HTR8-SVneo and human chorionic villous explant cultures were utilized to study the 
effect of the oxygen environment on ILK expression and activity. Exposure of HTR 8-
SVneo cells to a low oxygen environment produced a transient increase in the 
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expression of ILK mRNA, but did not affect the level of protein expression nor its 
kinase activity. In contrast to these results, placental explants showed lower 
expression of ILK under 3 % 0 2 environment compared to placental ex plants exposed 
to 8 % and 20 % 0 2 . Placentas from preeclamptic patients also showed lower 
detection of ILK in the fetal capillaries compared to age-matched controls. 
In total these novel results showed that ILK is present in human and mouse 
placenta in cells that invade the maternal uterus during pregnancy and that it plays a 
critical role in the migration and invasion of trophoblasts. 
The results contribute to a better understanding of the mechanisms involved in 
the control of placental invasion and could assist in the production of future tools to 
improve the early diagnosis and treatment of gestational trophoblastic diseases such 
as preeclampsia. 
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CHAPTER! 
INTRODUCTION 
1. 1 Human Placenta 
The placenta is a remarkable transient organ present only in female mammals 
during gestation. It has several particular characteristics that make it unique. First, it 
is an organ fom1ed by cells originating from two separate organisms in close 
relationship, the fetus and the mother who collaborate in a dynamic equ ilibrium to 
maintain the homeostasis of both. Throughout pregnancy, particularly at the 
begi1ming, cells derived from the trophectoderm of the implanting blastocyst in 
concert with cells from the maternal decidua combine to form the definitive placenta 
(Benirschke and Kaufmann 2000). During this process, fetal-derived cells invade the 
maternal uterus in a fine ly regulated manner. This characteristic in particular, makes 
the placenta an important model for identifying pathways and/or therapeutic strategies 
to treat cancer, a disease marked by uncontrolled invasiveness (King et al. 2000; Lala 
et al. 2002; Ferretti et al 2007). Also, in spi te of the placenta being what 
immunologists consider a semi-allograft organ, it does not trigger a host-allograft 
rejection from the mother to the baby, confim1ing that the placenta has distinctive 
features (Creasy and Resnik 2000). The main functi ons of the placenta are to supply 
nutrients and oxygen to the fetus and to remove waste in the opposite direction. It also 
provides immune protection, endocrine and metabolic support to the developing fetus. 
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Thus, normal and adequate placental development is crucial for the well-being of 
both the baby and the mother. Abnormal formation of the placenta leads to serious 
pathologies such as preeclampsia and intrauterine growth restriction (IUGR) stressing 
the importance of the regulation of this process (Zhou et al. 1993; Kaufmann et al. 
2003). A recent review of the literature showed that pretem1 birth in the USA 
increased from 9.5 % in 1981 to 12.7 % in 2005 (Goldenberg et al. 2008) . 
Interestingly while the percentage of spontaneous preterm births have remained 
constant through the years and preterm birth due to premature rupture of the 
membranes have declined as time passes, much of the increase in the singleton 
pretem1 birth rate is explained by rising numbers of preterm birth initiated by the 
physician to prevent serious complications such as eclampsia (Goldenberg et al. 
2008). Coincidently, the only treatment at the moment for preeclampsia is to deliver 
the baby when the symptoms appear, which makes preeclampsia one of the major 
reasons for that increase in prescribed preterrn birth. A better understanding of the 
mechanisms involved in the control of placental invasion might improve the 
prevention of preeclampsia or provide tools for an early diagnosis or a better 
treatment. It might also help to understand the high numbers of miscarriages that at 
the moment have no identified explanation, and last but not least, it might also 
provide clues for mechanisms regulating cell invasion that could then lead to new 
cancer treatments and/or diagnosis. 
1.1.1 Macroscopic Structure of the Placenta 
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The word placenta comes from the Latin for cake, from Greek 
plakoentalplakounta, "flat, slab-like" (Liddell and Scott 2009), referring to its round, 
flat appearance in humans. Macroscopically, a delivered normal term placenta can be 
described as a disk-shaped, round, or ovoid structure. The blood cord is normally 
inserted near the center of the disk and the membranes are attached at the periphery. 
There is an enom1ous variability in placental size and shape but usually the normal 
placenta weighs between 400 g and 500 g at term and measures around 18 to 20 em in 
diameter and approximately 2 em thick (Benirschke and Kaufmann 2000). Some 
variations can be explained by racial differences, altitude, pathologic circumstances at 
implantation, diseases or matemal habits such as smoking. Absolute growth, as 
detem1ined by DNA, RNA, and protein content, occurs in the placenta from 
fecundation until the 36th week of gestation. Thereafter, proliferation does not 
nmmally occur and the placenta undergoes only maturational changes until the end of 
the gestation which in humans can be between 38 to 42 weeks long (Benirschke and 
Kaufmann 2000) . 
The fetal surface, facing the amniotic cavity, has a glossy appearance because 
of the intact ep ithelial surface of the amnion. The maternal uterine face of the 
placenta is opaque and has a rough texture, as it is a surface orig inating from laminar 
degenerative processes within the junctional zone that lead to the separation of the 
organ during labour. It is composed of a heterogeneous mixture of trophoblastic and 
decidual cells embedded into prevailing amounts of extracellular debris, fibrinoid and 
blood clot (Bemischke and Kaufman 2000). The matemal surface of the placenta is 
divided into lobes (or cotyledons) by an incomplete system of grooves which 
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intemally correspond to septa that trace the lobules' borders (Benirschke and 
Kaufmmm 2000). When placentas are injected with a radiopaque medium they show 
that each lobe is occupied by one to three villous trees (Benirschke and Kaufmann 
2000) which are the structural and functional units of the placenta as will be 
explained in detail in the next section. 
1.1.2 Microscopic Structure of the Placenta 
The placenta only forms after an ovum has been fertilized and the embryo has 
been implanted in the mammalian uterus. Fertilization occurs in the fallopian tube 
within 24 to 48 h after ovulation and the initial steps of development, from fertilized 
ovum to a morula stage of 12 to 16 cells, occur as the embryo passes through the 
fallopian tube. After arriving to the uterine cavity and before implantation, a fluid-
filled inner cavity appears within the mass of cells and marks the transition from 
morula to blastocyst (Theiler 1989; Enders et al. 1990; Sadler 2006). This is 
accompanied by cellular differentiation : the surface cells become trophectoderm 
while an inner cell mass is formed and becomes the precursor of the embryo proper 
(Johnson and Ziomek 198 1 ). Within 72 h after entering the uterine cavity, the embryo 
hatches from a non-adhesive coating called the zona pellucida and exposes the 
trophectoderm (Red-Horse et al. 2004). Implantation is then dependent on a set of 
complex interactions between the hormonally primed uterus and the mature blastocyst 
(Enders 2000). Some molecules that are involved in endometrial receptivity include 
Leukemia Inhibiting Factor (LIF) (Cullinan et al 1996; Norwitz et al 2001), adhesion 
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molecules, such as integrins (Lessey and Castelbaum 2002), and proteins called 
mucms that have high sugar content and cause an increase in the expression of 
oligosaccharide receptors on the surface of endometrial epithelial cells (Lagow et al. 
1999). Embryos at/or near the implantation stage express Epidermal Growth Factor 
Receptors (EGFR) and heparan sulfate proteoglycans, both of which interact with 
epidem1al growth factor-like ligands. Proper implantation also depends on the 
differentiation of the trophectodem1 into the different trophoblast lineages that will 
form the placenta. The tem1 "trophoblast" was introduced by A.A.W. Hubrecht, a 
Dutch scholar, at the end of the 19111 century (Hubrecht 1899, cited by Boyd and 
Hamilton 1966) to designate those cells derived from the blastocyst that do not 
contribute to the embryo but are essential for its nourishment (Norwitz et al. 200 1; 
Red-Horse et al. 2004; Gude et al. 2004). Immediately after implantation, 
trophoblasts derived from the trophectodenn differentiate and invade the maternal 
uterine wall. By the 10111 day after conception, the blastocyst is completely embedded 
in the stromal tissue of the uterus, the uterine epithelium has regrown to cover the site 
of implantation, and the trophectodenn has differentiated into an outer layer of 
syncytiotrophoblast underlied by a mononuclear layer of cytotrophoblasts (CT) 
fom1ing a primitive placenta with primary vi lli (Pijnenborg et al. 1981 ; Pijnenborg 
1988; Benirschke and Kaufmann 2000). The primary villi are then infiltrated by 
mesenchyme to form secondary vil li. The definitive villi (tertiary vi lli), which are the 
structural and functional units of the fetomaternal interface, become apparent as early 
as 21 days of pregnancy (Benirschke and Kaufmann, 2000). The trophoblasts, 
coordinated with the mesenchyme and capillaries, proliferate and differentiate to 
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organize themselves into floating villi and anchoring villi (Fig 1.1 ). These tree-like 
arranged placental villi arise from the chorionic plate and protrude into the 
intervillous space that is filled with maternal blood. The surface of the floating villi is 
composed of an outer continuous layer of villous syncytiotrophoblast beneath which 
there is a layer of villous cytotrophoblasts (vCT). The stroma of the villi is composed 
of the fetal vessels which are embedded in a mixture of, macrophages, connective 
tissue cells and c01mective tissue fibers and it is separated from the vCT by a 
basement membrane (BM). The ramifications of the villous tree can be subdivided 
into segments that differ mainly in caliber, stromal structure, vessel structure and 
relative position within the villous tree and these characteristics define five villous 
types (Benirschke and KaufmaJm, 2000). Although the description of each type of 
villi is beyond the scope of this thesis, it is important to note that as a consequence of 
presenting different types of villi , human placentas studied under the microscope may 
show heterogenous groups of villi with differences in number and structure of fetal 
blood vessels and diameter. 
1.1.3 Overview of Trophoblast Differentiation 
During early placentation, two fundamental pathways of trophoblast 
differentiation take place: the fusion and invasion pathways. In the fusion pathway, 
polarized stem vCT m floating villi proliferate and fuse with existing 
syncytiotrophoblast to maintain the multi-nucleated layer (Huppertz et a!. 2002; 
Baczyk eta!. 2006; Huppertz and Gauster 201 1). The vCT in the floating villi 
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Figure 1.1 Schematic drawing of the human placenta. The arrows point at the 
main structures forming the floating and anchoring vi lli. EVT: extravillous 
trophoblast (adapted from Gray's Anatomy of the Human Body. Gray H, 20111 Ed). 
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represent the proliferating stem cells for the syncytiotrophoblast. The 
syncytiotrophoblast main functions are the exchange of gas and nutrients as well as 
the synthesis of essential hormones. 
In the invasion pathway, polarized stem CT cells in anchoring villi tips migrate 
off the villous basement membrane, penetrate through the syncytiotrophoblast to form 
columns of non-polarized extravillous trophoblast (EVT) cells which connect the 
embryo to the uterine wall (Castellucci et al. 2000; Georgiades et al. 2002; Pollheimer 
and Knofler 2005). These anchoring villi attach the placenta firmly to the uterus and 
give rise to both the EVT that invade the decidua (interstitial EVT), and those that 
remodel the maternal arterioles, endovascular EVT. The formation of anchoring villi 
is accompanied by changes in the synthesis, degradation, and spatial distribution of 
extracellular matrix (ECM) proteins, and the specific spatial/temporal expression of 
adhesion molecules (Damsky et al. 1992; Damsky et al. 1994; Aplin et al. 2006; 
Aplin et al. 2009). Proximal cell columns of EVT cells in the villous tip are 
proliferative, rounded, cohesive cells that are marked by the high expression of a6~4 
integrin, E-cadherin and laminin (Damsky et al. 1992). The more distal cells that are 
interstitial and endovascular EVT cells have differentiated into isolated, highly 
invasive, pleomorphic cells that express a5~1 and a1~1 integrins, fibronectin and 
type IV collagen (Damsky and Werb 1992). 
The transforn1ation of the arterioles produces dilated uterine arterioles that 
are unresponsive to maternal vasomotor control (Gude et al. 2004) ensuring that 
enough blood supply reaches the intervillous space for the proper exchange with the 
fetus. In the non-pregnant state, the uterine vessels carry < 1 % of the maternal 
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cardiac output as it only has to maintain a uterus that weighs only around 50 g. At 
term, these same vessels must support a uterus, placenta and fetus that can weigh up 
to 5000 g altogether (Kliman 2000). To adapt to this demand, instead of increasing 
the amount of vessels which would increase linearly the amount of blood flow, the 
maternal arteries are transformed into wider vessels that do not respond to vasoactive 
compounds increasing the blood flow exponentially thus ensuring that the fetus will 
receive enough blood (Kliman 2000). Another specialization for the optimization of 
exchange is the presence of microvilli at the surface of the syncytiotrophoblast that 
increase the effective surface area for nutrients and gas exchange (Benirschke and 
Kaufmann 2000). The factors that regulate trophoblast differentiation will be 
discussed in detail in Section 1.1.5. 
1.1.4 Human Placental Functions 
The main functions of the placenta are transport, immune protection and endocrine 
support of the fetus. 
1.1.4.1 Transport of Gases and Nutrients 
1.1.4.1.1 Transport of Gases. The lungs are not functional during fetal life 
so gas exchange occurs through the placenta by simple diffusion. The direction of 
oxygen movement from the mother to the fetus is facilitated by the higher 
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concentration and affinity for oxygen of fetal hemoglobin when compared to matemal 
hemoglobin (Bauer and Rathschlag-Schaefer 1968; Tyuma and Shimizu 1969; Bunn 
1981 ) . Interestingly, in pregnant women who smoke the carbon monoxide in the 
cigarette competes with oxygen for the hemoglobin and transforms the fetal 
hemoglobin into carboxyhemoglobin which has very low affinity for oxygen 
exposing the fetus to a transient hypoxia (Soothill 1996). This contributes partially to 
the fetal growth restriction in fetuses born from women that smoke and that is highly 
prevalent in these patients. 
1.1.4.1.2 Transport of Nutrients. The nutrient transfer capacity of the 
placenta, which is dependent on adequate placental development, plays a critical role 
in fetal growth (Barry et al. 2008). Most of the nutrients use active transporters and 
the passage through the placenta is essential for the viability of the fetus . For 
example, glucose is the main carbohydrate transported across the placenta from the 
mother to the fetus. As the fetal gluconeogenesis metabolic enzymes are not well 
developed, the glucose must be derived from the matemal circulation. Transport of 
glucose across the placenta is via protein-mediated facilitated diffusion and a number 
of glucose transporters (GLUT) are involved, such as GLUT 1 and GLUT 3 
(Baumann et al. 2002). Intrauterine growth restriction (IUGR), usually a consequence 
of placental malfunction, is associated with altered glucose metabolism with an 
mcrease of GLUTl expression at the placental interface (Langdown and Sugden 
2001). 
Transport of ammo acids to the fetus during pregnancy occurs VIa the 
microvilli and basal membranes of the syncytiotrophoblast and IS mediated by 
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specific active transporters. Using functional criteria such as substrate specificity and 
sodium dependence, approximately 15 different transport systems have been 
identified in the human placenta (Jansson 200 I ; Jansson et al. 2009). Furthermore, 
the actual absolute placental amino acid transport is reduced in cases of fetal growth 
restriction (Regnault et al. 2005). 
Lipids include free fatty acids, triacylglycerols, phospholipids, glycolipids, 
sphingolipids, cholesterol esters and fat soluble vitamins among others. Both free 
fatty acids and triacylglycerols can readily cross the membranes of the 
syncytiotrophoblast by simple diffusion. Once they reach the cytoplasm of the 
placental trophoblast, they can bind to cytoplasmic proteins, they can be transported 
out of the trophoblast, or alternatively they can be oxidized or esterified. Cholesterol 
is derived from maternal blood via an interaction of circulating low density 
lipoprotein (LDL) with LDL receptors on the microvillous membrane of the 
syncytiotrophoblast followed by internalization of LDLs by receptor-mediated 
endocytosis (Gude et al. 2004). 
1.1.4.2 Immune Function of the Placenta 
The placenta is considered a semiallograft as it contains half of the genes from 
the father in direct contact with the mother. interestingly, there is no immune 
response triggered by these "foreign" molecules. In 1953 Medawar was the first to 
suggest that the semi-allogeneic fetus is able to survive because either there was an 
anatomical separation between the mother and the fetus or that there was a functional 
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suppression of maternal lymphocytes (Medawar 1953; Veenstra van N ieuwenhoven 
et al. 2003). It is now known that there is no physical separation between the mother 
and the fetus as various cells such as syncytiotrophoblast and EVTs are in direct 
contact with maternal blood thus with maternal immune cells. There is, however, a 
lack of antigen stimulation of maternal lymphocytes (Veenstra van Nieuwenhoven et 
a!. 2003), since the syncytiotrophoblast lacks both class I and II major 
histocompatibility complex (MHC) molecules and the fetal EVT do not express major 
MHC Ia antigens, which are responsible for the rejection of allografts in humans 
(Veenstra van Nieuwenhoven et al. 2003). The EVT only express human leukocyte 
antigen (HLA) G and E which are non-polymorphic members of the class I 
histcompatibility complex. HLA G and E are thought to be involved in the resistance 
of EVT cells to lysis by uterine natural killer (uNK) cells via direct binding with 
killer inhibitory receptor (KIR) on the uNK (Pazmany et al. 1996; Munz et al. 1997; 
Rieger et a!. 2002). As for the immune suppresion in Medawar's theory, there is not a 
general suppression but a change in lymphocyte function. There is a shift away from 
type 1 cytokine production with a decrease in the type 1/type 2 cytokine ratio wh ich 
is beneficial for nom1al pregnancy. Type I cytokines such as interferon-y (IFN-y) and 
tumor necrosis factor-a (TNFa) are harmful for pregnancy because they inhibit 
embryonic and fetal development (Chaouat et a!. 1990) and tern1inate pregnancy 
when injected in pregnant mice. The decreased ratio of type 1/type 2 cytokine 
production may be explained in different ways. First, hormones such as progesterone 
and estrogen may directly affect lymphocyte production towards type 2 cytokines 
(Piccinni et al. 1995). Also, syncytiotrophoblasts express indolamine dioxygenase an 
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enzyme which functions in the catabolism of tryptophan and indirectly suppresses 
maternal T -cell activity by tryptophan deprivation (Schrocksnadel et al. 1996; Mmm 
et al. 1998; Kudo et al. 2001 ). 
There are other mechanisms that the trophoblast may use to escape the 
maternal immune system. One way is by the expression of apoptosis-inducing ligands 
(Veenstra van Nieuwenhoven et al. 2003). The expression of Fas Ligand (FasL) was 
observed in syncytiotrophoblast, in vCT and EVT, as well as the expression of the 
receptor Fas was found on decidual leukocytes suggesting that FasL expression on 
trophoblasts might be a mechanism protecting the trophoblasts against activated 
leukocytes (Runic et al. 1996; Uckan et al. 1997; Kauma et al. 1999, Veenstra van 
Nieuwenhoven et al. 2003). Another apoptosis-inducing pathway such as binding of 
the TNF-related apoptosis-inducing ligand (TRAIL) to its receptor (TRAIL-R) may 
play a role in immunomodulation during pregnancy as TRAIL is expressed on 
trophoblasts (Phillips et al. 1999; Phillips et al. 2001). With these ligands, 
trophoblasts cells can induce apoptosis of activated immune cells if necessary and 
protect the placenta and the fetus from a harmful immune response (Veenstra van 
Nieuwen.hoven et al. 2003). Furthermore, the trophoblasts express CD46, a 
complement receptor that binds C3b and C4b, preventing complement mediated 
damage to the trophoblast and villous mesenchyme (Holmes and Simpson 1992). 
Trophoblasts also express cytotoxic T lymphocyte associated antigen 4 (CTLA-4) 
which binds and inactivates activated lymphocytes by binding to CD80 and CD86 
(Heikkinen et al. 2004). In summary, the placenta does not present antigens to the 
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immune system and in case an immune response is triggered, the trophoblasts have all 
the machinery required to stop the response in situ so there is no damage to the fetus. 
1.1.4.3 Endocrine Functions of the Placenta 
Endocrine, paracrine and growth factors produced by the placenta include: 
estrogens (produced in conjunction with the fetal adrenal gland and possibly feta l 
liver), progesterone, human chorionic gonadotropin (hCG), human chorionic 
somatomammotropin (CSH 1, originally called placental lactogen), human placental 
growth hormone (hPGH), growth factors such as epidennal growth factor (EGF), 
insulin-like growth factors 1 and II (IGF-1 and lGF-II), and platelet-derived growth 
factor (PDGF), as well as cytokines, chemokines, eicosanoids and related compounds, 
vasoactive autocoids, and many others like corticotropin-releasing hormone. 
Discussion of all of these factors is beyond the scope of this thesis; however, a short 
description of hCG and the steroids estrogen and progesterone is warranted. 
1.1.4.3.1 Human Chorionic Gonadotropin: hCG is one of the 
earliest pregnancy-associated peptides secreted by the cells of the placenta. After 
implantation, hCG is produced principally by the syncytiotrophoblast. It can be 
detected in the serum or urine as early as 7 to 8 days before expected menses and 
reaches a peak of 100,000 mU/ml by the 9th or lOth week of gestation (Creasy and 
Resnik 2000). The major biological role of hCG during early pregnancy is to maintain 
the corpus luteum until the placenta starts synthesizing progesterone (Creasy and 
Resnik 2000). During this phase of pregnancy if progesterone actions are blocked by 
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a competitive antagonist, such as mifepristone, or the corpus luteum is removed 
before 9-10 weeks, pregnancy cmmot be maintained unless progesterone 
supplementation is provided. After the 1oth week of gestation the corpus luteum 
disappears and the major source of progesterone is the placenta (Creasy and Resnik 
2000). Levels of hCG in serum drop down to 5,000-10,000 mU/ml and remain 
constant until the end of the pregnancy (Cole 1997). 
1.1.4.3.2 Progesterone and Estrogens: Progesterone is synthesized 
within the syncytiotrophoblast mainly from maternal cholesterol (Fig 1.2). Ninety 
percent of the progesterone is secreted into the maternal compartment and the rest is 
secreted into the feta l compartment where it is converted into fetal adrenal steroids, 
cortisol and dehydroepiandrosterone (DHEA). In contrast to other steroidogenic 
organs, the placenta does not express cytochrome P450 17-a-hydroxylase-17:20 lyase 
(P450c17) and cmmot transform progesterone into androgens. Therefore placental 
estrogen depends on androgen precursors (DHEA) produced by the maternal adrenal 
gland and by the expanded zone of the fetal adrenal gland. The biosynthesis of 
estrogens demonstrates the interdependence of the fetus , the placenta and the mother 
(Fig 1.2). During pregnancy a woman produces more estrogen than a normal woman 
could produce in more than 150 years (Tulchinsky et al. 1972). The major estrogens 
fon11ed in the placenta are estriol, estradiol, estrone and estero!. The major androgenic 
precursor to placental estrogen fon11ation is DHEA sulfate (DHEA-S), which is the 
major androgen produced by the fetal adrenal cortex. DHEA-S transported to the 
placenta is cleaved by sulfatase to fon11 free unconjugated DHEA and is then 
aromatized by placental aromatase cytochrome P450 to estrone and 1 7 ~-estradiol. 
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Figure 1.2 Progesterone and estrogens synthesis during pregnancy. Progesterone 
and estrogens are produced by the placenta with precursors derived from the maternal 
and fetal circulation. P450scc, P450 cholesterol side-chain; p450cl 7, P450 17a-
hydroxylase/17- 20 lyase enzyme, 3~-HSD, 3 beta hydroxysteroid dehydrogenase; 
17~-HSD, 17 beta hydroxysteroid oxidoreductase; DHEA, dehydroepiandrosterone; 
DHEA-S, dehydroepiandrosterone sulfate. 
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1.1.4.3.3 Role of Estrogens and Progestins: Even before implantation a 
normal level of these h01mones is important as progesterones and estrogens induce 
the formation of a receptive uterus which is critical for implantation. Studies with 
transgenic approaches showed that uterine expression of progesterone receptor (PR) 
A and estrogen receptor (ER) a, but not PR B or ER p, are required for implantation 
(C01meely et a!. 2002; Hewitt and Korach 2002). ln mice, a very nanow range of 
estrogen concentrations determines the duration of the window of receptivity, i.e., the 
period of time during which the uterus is able to support implantation (Ma et a!. 
2003). Estrogen also has effects on the blastocyst, as its 4-hydroxy catechol 
metabolite mediates blastocyst activation, a requisite step in implantation (Paria et al. 
1998). Once implantation has occurred progesterones are important in maintaining 
the uterine quiescence during pregnancy by actions on uterine smooth muscle. It is 
proposed that progesterone may be acting by limiting the production of stimulatory 
prostaglandins and inhibiting the expression of contraction-associated protein (CAP) 
genes (ion chatmels, oxytocin and prostaglandin receptors and gap junctions) within 
the myometrium (Norwitz et a!. 1999; Challis et al. 2000) . Administration of 
exogenous progesterone at term not only blocks the expression of CAP genes, but 
also blocks the onset of labor (Lye and Porter 1978). Even in humans, where there is 
no evidence of a fall in maternal plasma or uterine progesterone, administration of the 
PR antagonist RU486 leads to increased uterine activity and induction of labor 
(A vrech et al. 1991 ). Progesterone also inhibits prostaglandin production presumably 
contributing to uterine quiescence and delaying cervical ripening (Andersson et al. 
2008). Progesterone also plays an important protective role by inhibiting T-
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lymphocyte mediated reactions protecting the baby from an immune response 
(Grossman 1985). It also plays a role in homing ofuNK cells and up-regulates HLA-
G gene expression, the ligand for various NK inhibitory receptors. At high 
concentrations, progesterone is a potent inducer of Th2-type cytokines as well as of 
LIF and monocyte-colony stimulating factor (M-CSF) production by T cells (Mori et 
al 1977; Arck et al. 2007). All these functions point at progesterone as one of the 
critical hormones during pregnancy not only to prevent labour but alos to protect the 
fetus from an immunological rejection . 
Estrogens have a broad variety of functions in the physiology of pregnancy as 
they stimulate the ripening of the cervix (Andersson et al. 2008) and stimulate the 
increase in prostaglandins necessary for initiation of labour (Challis 1971 ; Challis et 
al. 2000). Apart from the important role that estrogens play during labor, they 
increase uterine blood flow and prepare the breast for lactation (Pepe and Albrecht 
1995).In 1967, Pinto et al. (1967a; 1967b) examined the role of estrogens in human 
parturition by administrating a large amount of 17~-estradiol (200 mg intravenously 
in I h) to non-laboring pregnant women at term. They found that estradiol treatment 
increased uterine contractility within 4- 6 h and accelerated the time to delivery. They 
also showed that the administration of progesterone rapidly induced a block in the 
estrogen effect (Pinto et al. 1967 b). Studies in rats and sheep also demonstrated that 
treatment with estradiol at mid-gestation induces pretem1 labor (Dawe et al. 1982; 
Wu et al. 2004). In humans (and higher primates) circulating estrogens increase at 
around mid-gestation and continue to rise gradually until birth, in contrast with most 
of the non-primates that show a sharp increase in estrogen concentration before labor 
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onset (Tulchinsky et a!. 1972; Boroditsky et a!. 1978; Mesiano 2007). This has led to 
the concept that estrogen activation in human parturition, as with progesterone 
withdrawal, is mediated at the functional level, by an increase in myometrial estrogen 
responsiveness. Thus, for most of pregnancy, the human myometrium appears to be 
refractory to estrogens at least in tenns of CAP gene expression. This lack of 
response of the myometrium to estrogens is likely due to very low levels of ER a and 
ER p. Importantly, ER a expression is low in non-laboring term myometrium and 
increases in association with labour onset, suggesting that functional estrogen 
activation is mediated by increased ER a expression (Mesiano et a!. 2002) during 
parturition. 
1.1.5 Placental Development Regulation 
During placental formation cells derived from the trophectoderm invade the 
decidua. This is a finely regulated mechanism of invasion as it is ultimately restricted 
to the inner third of the myometrium in humans and only to the decidua in rodents 
(Pijnenborg et a!. 1980; Georgiades et a!. 2002). Abnormally shallow invasion leads 
to serious pathologies such as preeclampsia and IUGR stressing the importance of the 
regulation of this process (Zhou et a!. 1993; Kaufmann et a!. 2003). Excessive 
invasion can lead to deficient development of the decidua with abnormally firm 
attachment of the placenta directly onto the myometrium (placenta increta), or to 
invasion through the myometrium to the uterine serosa and even into adjacent organs 
(placenta percreta) (Norwitz et a!. 2001 ). It is not completely understood which 
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physiological and molecular mechanisms are involved in the regulation and control of 
trophoblast differentiation, but the local oxygen environment (Genbacev et al. 1997; 
Caniggia et al. 2000a), paracrine signals secreted by decidual cells, autocrine control 
from trophoblast-derived growth factors and interaction with different ECM 
components are likely to be involved (Damsky et al. 1992; Kilbum et al. 2000; Leach 
et al. 2004; Pollheimer and Knofler 2005). The action of the main regulators will be 
discussed below. 
1.1.5.1 Oxygen as a Regulator of Trophoblast Differentiation 
Due to the nature of the tissue, most of what is known about the 
morphological aspects of early placental fonnation has been extrapolated from animal 
models (Kliman 2000). Examination of monkey implantation sites has revealed that 
trophoblasts begin migrating down into the matemal arteries as early as l 0 days after 
fertilization and at 14 days many of the spiral arteries, but not the veins, are occluded 
(Blakenship et al. 1993). Studies in humans using histochemical and ultrasonographic 
approaches suggested that there is in fact trophoblast plugging of the matemal spiral 
arteries until 12 weeks of gestation (Pjinenborg et al. 1982). More evidence came 
from studies that perfused hysterectomy specimens from pregnancies at week 8, 9 and 
13 weeks of gestation with barium sulfate and examined them roentgraphically (x-ray 
photography). Spatial reconstruction of the uteroplacental network clearly showed a 
continuous trophoblastic shell at the level of the uterine-intervillous interface and no 
direct entry of the contrast medium inside the intervillous space at weeks 8 and 9. 
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These findings showed that a very limited amount of maternal blood reaches the 
intervillous space during the first trimester of gestation (Bustin and Schaaps 1987; 
Jaffe et al. 1997). Although the evidence was very strong, the concep t that the 
placenta had low regional oxygen tension in the first trimester was further confirmed 
by elegant experiments done by Rodesch et al. (1992) and Jauniaux et al. (1999, 
2001). By directly measuring placental oxygen partial pressure with an oxygen 
sensing probe they showed a significant increase in oxygen tension from about 25 
mm Hg to 54 mm Hg at around week 10 of gestation. These experiments 
demonstrated that maternal blood flow into the intervillous space is only established 
at around the end of the first trimester (weeks 10 -1 2). Interestingly this is the time 
when the placenta develops enhanced mechanisms for protection against oxidative 
stress (Watson et al. 1998). So it is critical that maternal blood flow to the embryo be 
limited very early in gestation to protect the conceptus from excessively elevated 
oxygen levels that would lead to an increased production of harmful reactive oxygen 
species (Rodesch et al. 1992). 
Virtually every cell type is capable of sensing a lack of oxygen and eliciting 
an adaptive response. A well recognized transcription factor associated with 
physiological responses to hypoxia is hypoxia-inducible factor I (HIF-1) identified as 
a mediator of oxygen tension effects in many mammalian systems (Semenza 1998). 
HIF-1 regulates changes in gene expression, including the transcription of specific 
genes that will help sustain the supply of oxygen to tissue cells during oxygen 
deprivation (De Marco and Caniggia 2002) . Some examples of proteins expressed in 
response to low oxygen are vascular endothelial growth factor (VEGF) that is 
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involved in angiogenesis (Shweiki et al. 1992), erythropoietin that induces 
hemoglobin synthesis (Goldberg et al. 1988) or endothelin that is a vasoactive 
compound (Minchenko and Caro 2000). The adaptive response to low oxygen also 
includes the metabolism of glucose (Shetty et al. 1993; Semenza 2000) with increased 
expression of GLUT! , a glucose transporter. 
There are extensive studies showing that trophoblast cells become highly 
proliferative in low oxygen tensions and as soon as they are cultured in 8 % or 20 % 
oxygen they differentiate into invasive trophoblast cells able to migrate and invade 
Matrigel while expressing HLA-G and matrix metalloproteinase (MMP) 9, markers 
of the invasive phenotype (Genbacev et al. 1996; Genbacev et al. 1997; Caniggia et 
al. 2000a). Early studies on the effect of oxygen on trophoblast differentiation showed 
that when anchoring villi from early gestation (6 to 8 weeks) were explanted onto an 
ECM substrate under standard conditions (20 % 0 2 or 98 mm Hg) the cell columns 
were visible and kept the normal architecture, but did not incorporate 5-bromo-29-
deoxyuridine (BrdU), a thymidine analog. The anchoring villi that were maintained in 
a hypoxic atmosphere (2% 0 2 or 14 mm Hg) showed prominent cell columns and the 
nuclei of many of the CT in these columns incorporated BrdU (Genbacev et al. 1997). 
These results suggested that at low concentrations of oxygen the trophoblast cells 
proliferate while at 20 % oxygen (high levels) the cells do not proliferate but instead 
invade the artificial matrix . Concomitant with these results, when villous explants 
were subjected to antisense-induced inhibition of HIF-1 a to simulate the effect of an 
increase in oxygen tension, the expression of transfonning growth factor p (TGFP)-3 
was inhibited and EVT outgrowth and invasion were stimulated as indicated by the 
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expression of invasive markers such as MMP2 and MMP9, switching of the 
expressiOn of integrins on the surface of the trophoblasts and downregulation of 
proliferation markers such as Ki67 (Rodesch et al. 1992; Caniggia et al. 2000b ). 
These elegant experiments suggest that oxygen per se is an important factor 
regulating the differentiation of trophoblasts, inhibiting the proliferative phenotype of 
these cells and stimulating the invasive transfom1ation of EVT necessary for normal 
placental development. 
1.1.5.2 Autocrine and Paracrine Control of Trophoblast Invasion 
During nom1al human pregnancies interstitial or endovascular invasion does 
not occur beyond the decidua and the first third of the underlying myometrium so the 
extent of trophoblast invasiveness must be precisely controlled by trophoblast-derived 
as well as maternal factors in a time- and distance-dependent manner (Graham and 
Lala 1992; Lala and Hamilton 1996; Bischof et al. 2000; Knofler 2010). Those 
observations are confirmed by histologic evaluation of ectopic pregnancies (Paterson 
and Grant 1975), in which trophoblasts are dramatically more invasive and 
destructive, suggesting once more that local factors in the decidua or endometrium 
inhibit trophoblast invasion (Creasy and Resnik 2000). Growth factors and the 
different components of the ECM affect trophoblast behaviour either promoting or 
inhibiting their proliferation, migration, invasion and survival. Numerous growth 
factors have been identified at the fetal-maternal interface controlling the proliferative 
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Table 1.1 Growth factors that regulate trophoblast proliferation. 
EVT, extravillous trophoblast; vCT, villous cytotrophoblast; "+" stimulates;"-", 
inhibits. 
GROWTH FACTOR CELL ORIGIN EFFECT REFERENCE 
EGF EVT + Maruo et al 1995 
TGFa EVT + Lysiak et al 1993 
Amphiregulin EVT + Lysiak et al 1995 
CSF-1 Decidua, vCT and EVT + Hamilton et al 1998 
Angiotensin II EVT + Ino et al 2003 
VEGF EVT + Cha et al 200 1 
PlGF EVT + Athanassiades and 
Lala 1998 
TGFP Decidua Graham and Lala 
1992 
EGF, epidem1al growth facto; TGFa, transforming growth factor alpha; CSF-1 , colony 
stimulating factor-1 ; YEGF, vascular endothelial growth factor; PlGF, placental growth 
factor; TGFp, transfom1ing growth factor beta. 
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Table 1.2 Growth factors that regulate trophoblast migration or invasion. 
EVT, extravillous trophoblast, "+", stimulates; "-", inhibits. 
GROWTH FACTOR CELL EFFECT REFERENCE 
IGF-Il Decidua + Irving and Lala 1995 
Endothelin EVTand + Chakraborty et al 2003 
decidua 
EGF EVT + Bass et al 1994, Qiu et al 
2004 
HGF Decidua + Cartwright et al 2002 
HB-EGF Decidua cell, + Leach et al 2004 
EVT 
Activin A Decidua cell + Cannigia et al 1997 
TGF~ Decidua cell Graham and Lala 1992, 
Cannigia et al 1999 
Endostatin Decidua cell Pollheimer et a! 2011 
Kisspeptin I 0 Decidua cell Bilban et al 2004; Pollheimer 
and Knofler 2005 
sFtl-1 endothelium Clark et al 1998 
sEng endothelium Venkatesha et al 2006 
IGF-ll, insulin-like growth factor II; EGF, epidermal growth factor; HGF, hepatocyte 
growth factor; HB-EGF, heparin-binding epidermal growth factor; TGF~, transforming 
growth factor; sflt-1, soluble fms-related tyrosine 1-VEGF receptor; sEng, soluble endoglin. 
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as well as invasive capacity of trophoblasts (Lala and Hamilton 1996; Bischof et al. 
2000) (Tables 1.1 and 1.2). Different decidual cell types which are in close contact to 
interstitial EVT (i.e. decidual stromal cells, uNK cells and macrophages) are thought 
to regulate these processes in a paracrine manner. In addition, EVT express multiple 
ligands and hormones as well as their receptors indicating autocrine control (Bischof 
et al. 2000; Lala and Chakraborty 2003). Throughout gestation, growth factors such 
as EGF (Maruo et al. 1995), transforming growth factor-a (TGF-a), amphiregulin 
(Lysiak et al. 1993; Lysiak et al. 1995), colony stimulating factor-! (CSF-1) 
(Hamilton et al. 1998), VEGF and placental growth honnone (PlGF) (Athanassiades 
and Lala 1998) are abundantly secreted from diverse cell types of the feta l-maternal 
interface including EVTs and were shown to promote proliferation of trophoblasts. In 
addition, in choriocarcinoma cells lines, angiotensin II and VEGF modulated cell 
proliferation through extracellular signal regulated kinase (ERK)-dependent 
signalling (Chaetal. 2001; lno et al. 2003). 
Other growth factors also promote migration and/or invasion. For example, 
JGF-ll produced by trophoblasts (Irving and Lala 1995) promoted migration via 
inhibition of adenyl-cyclase and stimulation of mitogen-activated protein kinase 
(MAPK) in EVT (Hamilton et al. 1998; McKinnon eta!. 2001). Furthennore, insulin 
growth factor binding protein (IGF-BP) produced by decidual cells, bind to RGD-
binding sites of aS~ 1 integrin on EVT stimulating focal adhesion kinase (F AK) and 
MAPK which induced attachment to the ECM (Gleeson et al. 2001). Treatment of the 
cells with a specific MAPK/ERK kinase kinase (MEK) inhibitor reduced basal 
trophoblast migration and abolished the effects of IGF-Il and IGFBP-1 on ERKl/2 
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phosphorylation, inhibiting the migration of the trophoblasts (Gleeson et al. 2001; 
McKinnon et al. 2001 ). Similarly, endothelin, produced by trophoblasts and decidua 
cells (Chakraborty et al. 2003) and EGF promoted HTR8-SVneo cell migration which 
was accompanied by activation/phosphorylation of ERK1 and ERK2 (Chakraborty et 
al. 2003; Qiu et al. 2004). Hepatocyte growth factor (HGF) promotes migration of 
SGHPL-4 cells, a trophoblast-derived cell line, via phosphoinositide 3 kinase (Pl3K) 
(Cartwright et al. 2002). Another growth factor promoting migration of isolated first 
trimester trophoblasts is EGF (Bass et al. 1994). Qiu et al. (2004) showed that EGF 
induced both ERK and protein kinase B (PKB)/ AKT8 virus oncogene cellular 
homolog (AKT) phosphorylation whereas EGF-activated cell migration could be 
blocked by inhibiting either MAPK or Pl3K. In addition rapamycin, which 
specifically blocks mammalian target of rapamycin (mTOR), decreased 
phosphorylation of the 70 kDa S6 kinase and migration of the cells. HGF (Cartwright 
et al. 2002) and heparin binding-epidermal growth factor (HB-EGF) (Leach et al. 
2004) also induce differentiation of trophoblasts into the invasive phenotype. 
Decidual cells also produce a variety of inhibitory proteins such as TGF~ fam ily 
members, IFN-y, endostatin, kisspeptin-10 or TNF-a to fine-tune and limit the extent 
of trophoblast invasion (Bauer et al. 2004; Bilban et al. 2004; Pollheimer and Knofler 
2005; Lash et al. 2006). Signalling proteins of the small body size/ mothers against 
decapentaplegic (Smad) family are the downstream effectors of the TGF~ 
superfamily (TGF~, activins, nodal, bone morphogenetic proteins) (Schiller et al. 
2004). TGF~ factors were amongst the first identified regulators of invasive 
trophoblast differentiation since they inhibited proliferation of first trimester 
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trophoblasts (Graham and Lala 1992). Furthermore, TGF~ exerts anti -invasive effects 
on trophoblasts by increasing tissue inhibitors of metalloproteinases (TIMPs ), that 
inhibit metalloproteinase activity, and by upregulating plasminogen activator 
inhibitor 1 (PAI-l) which inhibits urokinase-type plasminogen activator (uP A) 
activity (Graham 1997). Conversely, antisense oligonucleotide-mediated inhibition of 
TGF~-3 expression in explant cultures promoted trophoblast outgrowth (Caniggia et 
al. 1999). Contrary to TGF~, activin promoted outgrowth and differentiation of 
villous explant cultures which was accompanied by expression of the EVT markers 
HLA-G and MMP-2 (Caniggia et al. 1997). 
Besides classical growth factors , many different cytokines and chemokines are 
secreted from EVTs and decidual cell types, predominantly from macrophages and 
fibroblasts (Table 1.3) (Jokbi et al. 1997; Hanna et al. 2006; Hannan and Salamonsen 
2007). Many of their respective receptors were identified on EVTs (Drake et al. 
2004). Chemokines such as chemokine (C-X3-C motif) ligand 1 (CX3CL1), 
chemokine (C-C motif) ligand 14 (CCL14), chemokine (C-C motif) ligand 4 (CCL4) 
(Hannan and Salamonsen 2007), chemokine (C-X3-C motif) ligand 16 (CXCL16) 
(Huang et al. 2006) or chemokine (C-C motif) ligand 21 (CCL21 ) (Red-Horse et al. 
200 I ), increased trophoblast migration or invasion in vitro. Similarly, the interleukins 
IL- l , IL-6, IL-8 or IL-1 1 secreted from uNK cells were shown to promote gelatinase 
activity and/or trophoblast invasion (Librach et al. 1994; Meisser et al. 1999; Paiva et 
al. 2007). Moreover, regulatory binding proteins such as IGF-BPs (Irving and Lala 
1995; Chakraborty et al 2003), soluble TNF receptors (Knofler et al 1998b ), soluble 
fms-related tyrosine kinase 1-VEGF receptor (sFlt-1) (Clark et al. 1998) a 
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Table 1.3 Cytokines that regulate trophoblast migration and/or invasion. 
EVT, extravillous trophoblast; uNK, uterine natural killer; "+", stimulates,;"-", 
inhibits 
CYTOKINE CELL EFFECT REFERENCE 
CX3CL1 macrophages, fibroblasts + Hannan and Salamonsen 
2007 
CCL14 macrophages, decidua, EVT + Hannan and Salamonsen 
2007 
CCL4 decidua, macrophages + Hannan and Salamonsen 
2007 
CXCL16 macrophages + Huang et al 2006 
CCL21 macrophages + Red-Horse et al 200 1 
TN Fa decidua, macrophages Bauer et al 2004 
lFNy uNK cells Lash et al 2006 
IL- l uNK cells + Librach et al 1994 
IL-6 uNK cells + Meisser et al 1999 
IL-8 uNK cells + Paiva et al 2007 
IL-11 uNK cells + Paiva et al 2007 
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VEGF/PlGF antagonist, or soluble endoglin (sEng), a secreted TGF~ co-receptor 
(Venkatesha et al. 2006), have been identified at the fetal-maternal interface adding 
further complexity to the growth factor network regulating trophoblast invasion. 
Physiological levels of soluble fms-related tyrosine kinase-1 (sFlt-1) and soluble 
endoglin (sEng) appear to be critical for normal progression of pregnancy since serum 
levels of these factors are elevated in patients with preeclampsia (Tjoa et al. 2007). 
1.1.5.3 Interaction with the Extracellular Matrix (ECM) 
In order to properly invade the uterus a subpopulation of trophoblasts 
differentiates from epithelial-like cells to invasive cells (Kaufmam1 and Castellucci 
1997). Multiple growth factors regulate trophoblast differentiation but this regulation 
is coordinated with the effect of the ECM that also interacts with the cells and 
controls the main cellular processes such as proliferation, survival, migration and 
invasion. The major cell surface receptors that cells use to assemble and recognize a 
functional ECM are integrins. Integrins are heterodimeric transmembrane proteins 
composed of a and ~ subunits (Hynes 2002). Eighteen a subunits and eight ~ 
subunits can assemble in 24 different combinations (Hynes 2002; Legate et al. 2009). 
The type of integrins expressed by a cell determines the ECM components that the 
cell can bind. It is widely recognized that activation of integrins is achieved by 
separating the a and ~ cytoplasmic tails as a consequence of talin binding to ~­
integrin membrane proximal sequences facilitated by kindlins (Wegener 2007; 
Wegener and Campbell 2008). Many proteins bind directly to integrins, yet only talin 
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and kindlins can regulate integrin affinity (Moser et al. 2009). Integrin activation 
increases the affinity of individual integrins for ECM ligands, but for a cell to bind 
strongly to ECM an increased avidity of the interaction is required by clustering 
integrins so that hundreds, or thousands, of weak interactions sum into a tightly 
bound adhesive unit. Ligand-bound integrins then recruit adaptor protein and kinases 
fonning structures called nascent adhesions (Choi et al. 2008). A subset of nascent 
adhesions progresses to more stable dot-like focal complexes, which can mature into 
larger focal adhesions (FAs) and finally into streak-like fibrillar adhesions (Geiger 
2001 ). Once integrins are activated and clustered they are able to transmit the vast 
anay of intracellular changes collectively refened to as "outside-in" signalling 
(Legate and Fassler 2009). As integrin tails have no catalytic activity of their own, 
they must bind accessory molecules that help in cytoskeletal organization. Cells, 
therefore need to integrate the infonnation coming from separate signals such as the 
ECM or many different growth factors , cytokines and honnones, and respond 
deciding whether to live or die, to divide or not, to migrate or invade, among other 
possibilities. One strategy that cells use to achieve specificity involves scaffold 
proteins which organize groups of interacting signalling proteins, both temporally and 
spatially, into signalling complexes. Database mining combined with an extensive 
literature search recently identified 156 signalling, structural, and adaptor molecules 
that comprise the " integrin adhesome" (Zaidel-Bar 2007; Legate et al. 2009). FA 
proteins involved in establishing and maintaining the integrin- cytoskeleton linkage 
can roughly be divided into four classes: (1) integrin-bound proteins that directly bind 
actin, such as talin (Jiang et al. 2003), a -actinin (Brown et al. 2006), and filamin 
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(Samuelsson et a!. 2011 ); (2) integrin bound proteins that indirectly associate with 
and regulate the cytoskeleton such as kindlin, integrin-linked kinase (ILK) (Hannigan 
et al. 1996), paxillin (Laukaitis et al. 2001 ), and F AK (Schaller et al. 1995); (3) non-
integrin-bound actin binding proteins, such as vinculin (Ziegler et al. 2008; Critchley 
and Gingras 2008); and ( 4) adaptor and signalling molecules that regulate the 
interactions of the proteins from the above-mentioned groups, such as actin-related 
proteins (Arp) 2/3, Wiskott-Aldrich syndrome protein (WASP) (Kiselar et al. 2007), 
and diaphanous-related formin (DRF) (Riveline et al. 2001) that control actin 
polymerization (Butler et al. 2006) and signalling molecules like Rho GTPases which 
control the spatial and temporal regulation of the actin assembly (Jaffe and Hall 
2005). The most important GTPases for the regulation of actin dynamics at the FA 
are Ras-related C3 botulinum toxin substrate 1 (Racl), Cell Division Cycle protein 42 
homolog (Cdc42) and Ras homolog gene family, member A (RhoA) (Jaffe and Hall 
2005, Legate and Fassler 2009). Experiments utilizing novel imaging technologies 
such as total internal reflection fluorescence (TIRF) microscopy and fluorescent 
speckle microscopy, in combination with structural, biochemical, and in vivo data, 
point to talin, vinculin, a-actinin, and ILK as the crucial structural elements of the 
integrin- actin linkage, as well as the main components regulating FA growth (Legate 
and Fassler 2009). 
During human placental development the EVT cells undergo a "switch" in 
expression of adhesion molecules, particularly integrin receptor proteins which bind 
to specific ECM ligands, as they differentiate (Aplin 1993 ; Damsky et al. 1994; 
Vicovac and Aplin 1996) (Fig 1.3). Proximal cell columns of EVT cells, in the tip of 
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Figure 1.3 lntegrin switching. Trophoblast cells switch the expression of integrins 
on their surface as they differentiate. This schematic drawing highlights, in different 
colours, the expression of different integrin receptors along the extravillous 
differentiation pathway: uncoloured represents a6~4, red represents aS~ I, purple 
represents al~ I, and green represents av~3 positive EVT. FV, floating villi ; AV, 
anchoring villi ; EVT, Extravillous trophoblast. 
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Decidua 
the anchoring villi are proliferative, rounded, cohesive cells marked by the high 
expression of a6~4 integrin (Damsky et al. 1992). More distally from the base of the 
column, the interstitial EVT cells have differentiated into isolated, highly invasive, 
pleomorphic cells that highly express a5~ 1 and a 1 ~ 1 integrins which are receptors for 
fibronectin and type IV collagen (Kam et al 1999; Damsky and Ilic 2002). The 
importance of the integrin-ECM interaction to trophoblast differentiation is stressed 
by the fact that patients with preeclampsia show abnormal integrin expression at the 
surface of EVT cells (Zhou et al. 1993). It is also possible to recapitulate trophoblast 
differentiation in vitro as well as the integrin switching by exposing trophoblasts to 
collagen or Matrigel (Aplin 1993; Damsky et al. 1994; Vicovac et al. 1995). These 
results suggest that the adoption of an invasive trophoblast phenotype is mediated by 
integrin-regulated signalling. 
1.2. Integrin-Linked Kinase 
1.2.1 ILK Structure 
ILK is a 55 kDa cytoplasmic protein recently described as a serine/threonine 
pseudokinase due to the unusual conformation of the kinase domain (Wickstrom et al. 
201 0). A detailed explanation of the kinase domain is included in Section 1.2. 1.1. 
Ubiquitously expressed in mammalian tissues (Hannigan et al. 1996; Su et al. 2004), 
the gene encoding ILK is localized to human chromosome ll p 15.5-11pl 5.4 
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(Hannigan and Dedhar 1997). A single isoform has been identified to date in all 
studied species (Legate et al. 2006). The protein (accession number Q13418, Uniprot 
database) contains 452 amino acids with three distinctive structural and functional 
domains: the kinase domain, the pleckstrin-homology (PH) domain and the ankyrin 
(ANK) domain (Fig 1.4). 
1.2.1.1 The Kinase Domain: The C-terminal region of the protein contains 
a readily identifiable protein kinase catalytic domain divided into XI subdomains 
spanning from amino acids 193 to 446 (Melchior et al. 2002). Although there are a 
number of amino acids missing that are typically highly conserved in Ser/Thr protein 
kinases, ILK subdomains align with other representative protein kinases such as 
protein kinase A (PKA) and insulin receptor kinase (IRK) (Dedhar et al. 1999). Also 
the invariant lysine residue in subdomain II that is required for A TP binding is 
present in the ILK amino acid sequence. The GXGXXG sequence found in 
subdomain I in most kinases is replaced in ILK by the sequence NENHSG which puts 
ILK in the category of atypical kinases; however, there are other active protein 
kinases that lack all three glycine residues in the GXGXXG consensus like mitosis 
inhibitor kinase 1 (Mik1) and vacuolar protein sorting 15p (Vps 15p) (Hanks et al. 
1988). Mutational studies of catalytic domains of different proteins have confirmed 
that three highly conserved amino acid triplets, Histidine-Arginine-Aspartic acid 
(HRD), Aspartic acid-Phenylalanine-Glycine (DFG) and Alanine-Proline-Glutamic 
acid (APE) in subdomains VI, VII and VIII respectively, are crucial for kinase 
activity (Hanks et al. 1988). Ofthese three, only APE is present in ILK (Hannigan et 
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Figure 1.4 ILK protein domains. ILK contains a N -terminal ankyrin domain 
(yellow), a pleckstrin homology domain (PH) (green) and a C-terminal kinase domain 
(blue). The 5 ankyrin repeats are shown with numbers (1-5) and the II subdomains of 
the kinase domain are shown with roman numerals (I-XI). 
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al. 1996; Hannigan et al. 2005). In fact, many mammalian kinases lack some or even 
the three conserved residues and are categorized as atypical kinases or pseudokinases. 
Some examples are members of the PI3K like family, ataxia-telangiectasia mutated 
protein (ATM), ATM and Rad3-related protein (ATR) and DNA-dependent protein 
kinase that lack the APE and have the HRD motif modified to Aspartic acid-
Arginine-Histidine (DRH) (Walker et al. 1999). Importantly, mutations that replace 
the invariant glutamic acid (E) for a lysine (K) in position 359 of the APE sequence 
result in an inactive form of ILK (ILK-E359K) that functions as a dominant-negative 
(Delcommenne et al. 1998; Dedhar et al. 1999) impairing the binding to parvins. 
Altogether these comparisons confinn that ILK does not present a typical kinase 
domain it still has similar structure to other functional and important kinases 
(Boudeau et al. 2006). It is important to notice that the catalytic domain of ILK 
contains an integrin binding region that binds to ~ 1 and ~3 tails (Hannigan et al. 
1996) and also mediates interactions of ILK with the actin binding adaptor proteins 
a -parvin, ~-parvin and paxillin (Nikolopoulos and Turner 2000; Yamaji et al. 2001; 
Nikolopoulos and Turner 2001 ; Zhang et al. 2004; Chiswell et al. 2008; McDonald et 
al. 2008). These interactions are fundamental for the normal function of ILK as a 
regulator of cytoskeletal organization (Stanchi et al. 2009). 
The unusual conformation of the kinase domain led to recent studies that 
concluded that ILK might be a pseudokinase (Wickstrom et al. 201 0) and that it 
might regulate the phosphorylation of different substrates by acting as an adaptor 
protein, either to recruit a distinct S473 kinase activity or to inhibit a S473 specific 
phosphatase activity (Lynch et al. 1999). Knock-in mice carrying mutations in the 
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putative PH domain (R211A) or in the autophosphorylation site (S343A or S343D) 
are completely nom1al and do not show changes in AKT or glycogen synthase kinase 
3 beta (GSK3p) phosphorylation or actin organization downstream of integrins 
(Lange et a!. 2009). In accordance with this statement, Fukuda et a!. (20 li) studied 
the structure of the ILK kinase domain bound to its cytoskeietal regulator, the C-
tem1inal calponin homology domain of a-parvin with crystallography. While 
maintaining a canonical kinase fold, the ILK kinase domain displayed a pseudoactive 
site conformation. They suggested that rather than performing the kinase function, 
this conformation specifically recognizes a-parvin to promote effective assembly of 
ILK into FA. The a-parvin-bound ILK kinase domain can simultaneously engage PI 
and P3 integrin cytoplasmic tails. They also found that ILK is able to bind A TP but 
under their experimental conditions ILK was unable to hydrolyze the bound ATP. 
These results define ILK as a distinct pseudokinase that mechanically couples 
integrins and a-parvin to mediate cell adhesion (Fukuda et al. 2009). There are still 
controversies as it could be that a-parvin is inhibiting the ATP hydrolysis (Hannigan 
et a!. 20 II). Dete1mination of the mechanisms and regulation of enzyme catalysis by 
the ILK kinase domain has not been completed yet due to the poor solubility and 
stability of ILK in solution so crystallography of pure protein has not been possible. 
Recently Maydan et a!. (20 I 0) was able to express full length-ILK in insect and 
mammalian cells and this should provide tools to better understand the biochemistry 
of ILK reactions (Maydan eta!. 201 0; Hannigan et al. 2011). 
1.2.1.2 The Pleckstrin Homology Domain: The putative PH domain is 
located between amino acids 180 and 212. This motif is involved in the binding of 
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phosphatidylinositol phosphates. Phosphatydylinositol (3,4,5)-triphosphate (PIP3) is 
the secondary messenger product of PI3K and stimulates the kinase activity of 
purified recombinant ILK (Maydan et a!. 201 0; Boppart et a!. 2011 ). Interestingly, 
integrin and growth factor-dependent stimulation of ILK activity is inhibited by 
inhibitors of Pl3K and expression of constitutively active forms of PI3K also results 
in constitutively increased ILK activity, suggesting that ILK is a PIP3-dependent 
kinase (Dedhar et al. 1999). In order to study the role of the PIP3 binding motif in the 
regulation of PKB/ AKT phosphorylation, Persad et al. (200 1) mutated arginine 21 1 
(R2 11) within the PIP3 binding motif. R211 is in the WKGRW motif (Tryptophan-
Lysine-Glycine-Arginine-Tryptophan) that is imp011ant in binding phosphoinositide 
phospholipids in PH domains (Taker and Cantley 1997). When the PH domain of 
ILK was mutated in DU 145 prostate cancer cells, AKT phosphorylation was reduced 
significantly and was not stimulated by addition of serum . These results strongly 
suggested that the PH domain is important for the activation of ILK, indicated in this 
case by the phosphorylation of AKT (Persad et a!. 2001 ). 
1.2.1.3 The Ankyrin Repeat Domain: the ANK repeat is one of the most 
common protein-protein interaction motifs in nature (Mosavi et a!. 2002). In silica 
studies predicted four ANK repeats in the N-terrninus but recently a crystallography 
study revealed a fifth ANK repeat when ILK is fo lded (Chi swell et al. 20 10). The 
ILK consensus ANK repeat motif is a 33-amino acid repeat that fo lds into a hairpin-
helix-tum-helix structure. Two anti-parallel helices from each repeat pack against one 
other, and the hairpin that links each pair of helices is oriented perpendicular to the 
helices to form a characteristic cross-sectional "L" shape (Sedgwick and Smerdon 
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1999; Mosavi et a!. 2002). Within ANK repeat domains, adjacent repeats stack on top 
of one another such that the helices form helical bundles. The stacked repeats form a 
curved left-handed superhelical spiral. The interior surface of the spiral is concave 
and fom1s the "ankyrin groove", a feature that has been described as a cupped hand, 
with the helices as the palm and the hairpins as fingers. This concave surface provides 
an ideal recognition site for intem1olecular interactions (Chiswell et a!. 2008). 
Experiments designed to identify potential interactors of the ILK ANK repeat domain 
have identified the Linl-1 , Isl-1 and Mec-3 (LIM)-domain protein (Way and Chalfie 
1988) named Particularly Interesting New Cysteine-Histidine-rich protein (PINCH) 
as a candidate (Tu eta!. 1999). In addition to binding ILK through LIM! , PINCH also 
binds indirectly to activated EGF receptor and PDGF receptor via non-catalytic 
region of tyrosine kinase adaptor protein 2 (Nck-2) forming a signalling complex 
coupling integrins and growth factors. This indirect cmmection between integrins, 
ILK and growth factor receptors is important for the coordination of the different 
signalling pathways regulated by the outside-inside signals (Dedhar et al. 1999). ILK 
ANK domain also binds to integrin-linked kinase-associated serine/threonine 
phosphatase 2C (ILK-AP) an ILK specific inhibitor (Leung-Hagesteijn et al. 2001; 
Kumar eta!. 2004). 
1.2.1.4 Other ILK Binding Partners: In a recent study, the Dedhar group 
identified new proteins associated with ILK utilizing "stable isotope labeling with 
amino acids in cell culture" (SILAC) and mass spectrometry techniques. Some 
examples of the newly described ILK-associated proteins include rapamycin-
insensitive companion of mTOR (Rictor), a and p tubulin, RuvB-likel and 2, HSl-
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associating protein (HAX-1), T-complex protein 1 subunit and Ras-GTPase-
activating-like protein 1 (IQ-GAP1) (Dobreva et a!. 2008). Detailed analysis with 
immunoprecipitation, western blotting and colocalization analyses showed that when 
ILK is found in a complex with RuvB-1 and a-tubulin, a-parvin and PINCH are not 
present, suggesting that ILK forms distinct protein complexes throughout the cell 
(Dobreva et a!. 2008). On a different set of studies, ILK, PINCH and parvins formed 
a ternary complex termed tlPP that localizes to F As. These studies showed that their 
interaction is essential for the recruitment of this complex to the plasma membrane in 
response to outside-inside signalling and for coordination of cytoskeletal organization 
(Boulter and Van Obberghen-Schilling 2006; Legate eta!. 2006; Stanchi eta!. 2009) . 
It also suggests that ILK function is likely regulated by interactions with different 
proteins in response to the need of the cell. 
1.2.2 ILK Functions 
ILK is an atypical serine/ threonine kinase that binds to integrins directly and 
to tyrosine kinase receptors indirectly to coordinate outside-inside signals that control 
cell survival, proliferation and differentiation (Hannigan et a!. 1996; Wu and Dedhar 
2001 ). Several laboratories have demonstrated that ILK has direct targets for its 
kinase activities, phosphorylating AKT, GSK3 ~' myosin light chain and ~-parvin 
(Lynch et a!. 1999; Zhang et a!. 2004; Legate et a!. 2006; Boulter et al. 2006). There 
is still a lot of controversy and apparently the results from these communications 
might only be the consequence of partially purified ILK, as Fukuda et a!. (20 11) 
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working with highly purified recombinant ILK protein were unable to repeat the 
former results. In addition to its function as a kinase, ILK appears to be a key 
mediator of protein-protein interactions, an area where there is more consensus 
(Hannigan et al 2005; Legate et al. 2006; Fukuda et al. 2009). Deletion of ILK in C. 
elegans, Drosophila, or Danio (zebrafish) leads to muscle disconnection from the 
body wall due to the detachment of actin from the plasma membrane (Zervas et al 
2001; Mackinnon et al. 2002; Postel et al 2008; Legate and Fassler 2009). In ILK-
deficient mice, muscle detachment occurs at the level of the integrin- ECM interaction 
(Wang eta!. 2008) suggesting that ILK regulates adhesion strength by reinforcing the 
integrin-actin connection and thus stabilizing the clustered state of integrins (Legate 
and Fassler 2009). Furthermore, ILK can undergo phosphorylation-dependent 
shuttling to the nucleus (Acconcia et al. 2007) where it appears to be important for 
maintenance of nuclear integrity, suggesting that ILK can be involved in a wide range 
of signal ling pathways. In a recent publication, Butler et al. (2009) showed that ILK 
also plays an important role to promote syncytialization and hormonal differentiation 
of human trophoblast-derived BeWo cells, showing that ILK is ab le to coordinate 
signalling pathways that lead to differentiation of trophoblast cel ls. 
Loss-of-function studies have stressed the importance of ILK in development 
and normal physiology. Embryonic lethality was observed in Xenopus laevis 
(Yasunaga et al. 2005) and in mice (Sakai et a!. 2003) when ILK knockouts were 
developed. The lethality of the knockout model has made the delineation of ILK 
tissue-specific functions challenging. Fortunately, Cre-lox and RNA interference 
technologies have led to the design of different experimental strategies that have 
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allowed the study of the different tissue-specific roles ofiLK (McDonald eta!. 2008). 
The different studies with conditional knockouts have led to the conclusion that ILK 
is a multifunctional protein that can regulate several key cellular processes. ILK 
functions in bone, skin and central nervous system are related to cell adhesion, 
proliferation and migration (Terpstra eta!. 2003; Belvindrah eta!. 2006; Lorenz eta!. 
2007) while cells of the immune system rely on the adaptor and kinase capacities of 
ILK to maintain cell survival and normal tissue function. The regulation of each 
function seems to be tissue-specific as the mutation of ILK in chondrocytes (Terpstra 
et a!. 2003), central nervous system (Graus-Porta et a!. 2001 ; Belvindrah eta!. 2006) 
and endothelial cells (Vouret-Craviari et a!. 2004) reduces proliferation while in 
keratinocytes the conditional knockdown of ILK has the opposite effect and 
proliferation is increased (Lorenz eta!. 2007). To date, only one study was conducted 
on the importance of ILK in trophoblast differentiation (Butler eta! 2009). 
1.2.3 ILK Signalling Pathways 
As discussed previously, ILK is able to bind directly to integrins and 
indirectly to growth factors receptors creating a coordinating dock for several 
signalling pathways that control essential functions in living cells. The kinase activity 
of ILK is stimulated by integrins binding to extracellular proteins and soluble 
mediators including growth factors and chemokines (Delcommenne et al. 1998; Li et 
a!. 2003 ; Xie et a!. 2004; Rosano et a!. 2006) in a PI3K-dependent manner 
(Delcommenne et al. 1998) while it is antagonized by phosphatases such as ILK-AP 
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(Leung-Hagesteijn et al. 2001) and phosphatase and tensin homolog deleted on 
chromosome 10 (PTEN) (Persad et al. 2001). Following activation, ILK exerts 
control over a diverse set of downstream effectors that modulate crucial cellular 
functions. In particular, ILK regulates the phosphorylation of AKT at Ser 473 and of 
GSK3P at Ser 9 in various cell types (Delcommenne et al. 1998). By promoting 
phosphorylation of AKT, ILK stimulates signalling pathways that regulate cell 
survival, including those that involve the inhibition of caspase activation and the 
stimulation of nuclear factor (NF)-KB (Troussard et al. 1999; Persad et al. 2000; 
Hannigan et al. 2005; Acconcia et al. 2007). The phosphorylation of GSK3P by ILK 
regulates pathways that lead to the activation of activator protein l (AP-1) and P-
catenin-LEF transcription factors, which in turn stimulate MMP9 and cyclin D 1, 
respectively (Delcommenne et al. 1998; Novak and Dedhar 1999; Troussard et al. 
2003) stimulating invasion or proliferation. ILK also phosphorylates nascent 
polypeptide-associated complex a (aNA C), a transcriptional coactivator of AP-1 
(Quelo et al. 2004). Finally, ILK can modulate cell spreading, migration and 
cytoskeletal organization in mammary epithelial cells by activating p21 activated 
kinase (PAK)-interactive exchange factor a-PIX , a guanine-nucleotide exchange 
factor (GEF) for Rae 1 and Cdc42 (Fi lipenko et al. 2005) and by activating cofilin 
through an interaction with phosphorylated Src as studied in rat intestinal epithelial 
cells (Kim et al. 2008). High levels of ILK expression reduced the expression of E-
cadherin by stimulating the expression of its repressor, Snail through the stimulation 
of poly(ADP-ribose) polymerase 1 (PARP-1 ), thereby promoting epithelial-to-
mesenchymal transition (EMT) and leading to invasion and metastasis in Spc2, a 
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mouse mammary epithelial cell line (McPhee et al. 2008). During placental 
fom1ation, the stimulation of Snail expression in trophoblasts cells may be an integral 
component of ILK-induced downregulation of E-cadherin to facilitate the fusion of 
trophoblasts into syncytiotrophoblast (Butler et al. 2009). Fig 1.5 summarizes the 
most relevant ILK signalling pathways. 
1.2.4 ILK in Cancer 
ILK has been extensively studied in cancer cells where it appears to be 
upregulated in highly invasive tumors (Hannigan et a!. 2005; Legate et al. 2006; 
Dillon et al. 2007). The expression of ILK is usually elevated in human malignancies 
and its expression is correlated with tumor stage and grade, for example, high levels 
of ILK expression correlates with poor patient survival in prostate cancer and 
melanoma (Graff et al. 2001; Dai et al. 2003) . ILK expression is increased in human 
colon carcinomas, with greater expression in invasive regions of the tumors 
correlating with increased phosphorylation of GSK3~ and nuclear translocation of~­
catenin (Marotta et al. 2003; Hannigan et al. 2005) . ln patients with adenomatous 
polyposis ILK is consistently increased in the colonic polyps (Marotta et al. 2003), 
indicating that the alterations in ILK expression might regulate progression from 
benign disease to the different stages of cancer (Hannigan et al. 2005). It might also 
indicate that the lack of regulation of ILK could be a consequence of cell cycle 
control disruption. ln ovarian cancers, ILK expression is increased relative to benign 
tumors and is not detectable in the normal ovarian surface epithelium. In this type of 
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Figure 1.5 ILK signalling pathways. Multiple signalling pathways are controlled by 
ILK directly or indirectly to regulate cell migration, angiogenesis, survival, invasion, 
proliferation and epithelial-mesenchymal transition (EMT). ECM, extracellular 
matrix; GF, growth factors; GFR, growth factor receptor; PI3K, Phosphoinositide 3 
kinase; PTEN, Phosphatase and Tensin homolog deleted on Chromosome 10; PIP3, 
Phospatidylinositol 3,4,5-triphosphate; PINCH, Particularly Interesting New 
Cysteine-Histidine rich protein; ~parv, ~-parvin; a PIX, a-PAK-interactive exchange 
factor; GSK3~, Glycogen synthase kinase ~; AP-1, Activator protein 1; aNAC, a-
Nascent polypeptide-Associated Complex; NF-KB, Nuclear Factor-KB; COX2, 
cyclooxygenase 2; ILK-AP, Integrin-Linked Kinase-Associated serine/threonine 
Phosphatase 2C; HIF-la, Hypoxia Inducible Factor-1a; VEGF, Vascular Endothelial 
Growth Factor; Rictor , Rapamycin-insensitive companion of mTOR, PDK1 , 3-
phosphoinositide-dependent kinase 1; Nck-2, Non-catalytic region of tyrosine kinase 
adaptor protein-2; mTOR, Mammalian target of rapamycin; AKT, AKT8 virus 
oncogene cellular homolog; MMP9, matrix metalloproteinase 9; Racl , Ras-related 
C3 botulinum toxin substrate 1; Cdc42, Cell division cycle protein 42 GTP homolog 
(Adapted from McDonald et al. 2008 with permission). 
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cancer the levels increase with tumor progression (Ahmed et al. 2003). Interestingly 
this research group found that the serum levels of ILK are significantly increased in 
patients with invasive ovarian carcinomas postulating ILK as a novel marker for 
ovarian carcinoma (Ahmed eta!. 2004). 
Recent studies in thyroid tumors showed that ILK is strongly expressed in 
tumor tissue but not in normal thyroid tissue as evaluated with a tissue microarray 
assay (Younes et a!. 2005). Very recently a study of patients with primary non-small-
cell lung cancer (NSCLC) tumours showed that out of 138 tumours, 88 (64%) 
presented an ILK immunoreactivity, which varied significantly between various 
histological subtypes as it ranged from 46% positive in squamous cell carcinoma 
(SCC) to 79% positive in adenocarcinoma. The 5-year cancer-related survival and the 
recurrence-free survival (RFS) of ILK-positive SCC patients was significantly shorter 
than the patients with ILK-negative tumors (Watzka et a!. 201 1) postulating ILK 
serum level as a candidate marker for cancer progression. 
1.2.5 ILK in Development 
The development of multicellular orgamsms reqmres integrin-mediated 
interactions between cell s and the ir extracellular sunoundings (Montanez et a!. 2008). 
lntegrin binding to extracellular matrix regulates the assembly of multiprotein 
complexes, which transduce signals that regulate many aspects of cellular physiology 
such as survival, proliferation, shape, polarity, gene expression and differentiation 
(Hynes 2002; Lange et a!. 2009). During the peri-implantation period of mammalian 
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development, the primitive endoderm forms on the surface of the inner cell mass 
(ICM) of the blastocyst and deposits a basement membrane (BM). The BM is 
required for the adjacent ICM cells to polarize and establish the columnar epiblast 
(primitive ectodenn) and for the remaining ICM cells to undergo apoptosis, resulting 
in the establishment of the proamniotic cavity (Coucouvanis and Martin 1995). In the 
absence of ILK, the primitive endodenn differentiates and produces a BM; however, 
there is a severe impediment to subsequent cavitation and polarization of ICM cells to 
form columnar epiblast cells (Sakai et al. 2003). This defect varies from the one 
observed in ~ 1-integrin deficient mice, which die of an inability of the primitive 
endoderm to produce laminin-a.l and hence a BM (Fassler and Meyer 1995; 
Aumaillet et al. 2000; Li et al. 2002; Li et al. 2003). If one overcomes the defect by 
exogenous addition of laminin, the ~ 1-null Embryoid Bodies can lay down a BM, 
differentiate and polarize an epiblast, and form cavities (Li et al. 2003). These data 
indicate that there are ~ 1-integrin functions independent of ILK, but also is evidence 
that ILK functions independently of ~1-integrin during the peri-implantation period. 
Mice lacking ILK failed to polarize epiblast cells and consequently, died during the 
peri-implantation period at embryonic day (E) 5.5 (Sakai et al. 2003). Embryonic 
lethality was also observed in ILK-deficient X. laevis (Yasunaga et al. 2005). 
Studies of the expression of ILK during mouse development showed that ILK 
is highly expressed in the heart and somites atE 8.5 and El 0.5 (Sakai et al. 2003) but 
the necessity of ILK for mouse trophoblast lineage development per se was not 
examined and remains unknown. 
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1.3 Abnormalities in Placental Development: Preeclampsia 
Preeclampsia is a pregnancy-specific syndrome that affects 3-5 % of pregnant 
women worldwide (ACOG 2002; WHO 2005; Redman and Sargent 2011) and is one 
of the most frequently encountered medical complications of pregnancy (Young et al. 
201 0). Gestational hypertension in pregnant women is defined as 140 mmHg or 
higher and/or diastolic blood pressure of 90 mm Hg that occurs at 20 weeks of 
gestation or later in a woman with previously normal blood pressure (ACOG 2002). 
One quarter of the women with gestational hypertension develops proteinuria and that 
is the time when the condition is called preeclampsia (PE). PE may also be associated 
with edema, visual disturbance, headache and epigastric pain. Laboratory 
abnormalities may include hemolysis, elevated liver enzymes and low platelet count 
(HELLP Syndrome) which occurs in 20 % of women with severe PE (Creasy and 
Resnik 2000). Early onset PE refers to syndromes that start before week 34 of 
gestation while late onset refers to development after 34 weeks of gestation (von 
Dadelszen et al. 2003). 1f untreated, the syndrome can develop into seizures 
threatening the life of the mother and the fetus , a syndrome known as eclampsia 
(ACOG 2002; Young et al. 201 0). The only available treatment at the moment for PE 
is the delivery of the baby at the time of diagnosis. For that particular reason PE is 
one of the most common reasons for induced preterm delivery. In developing 
countries it is still one of the leading causes of maternal mortality and morbidity. In 
Newfoundland a recent study showed that the PE incidence ranges from 4.2 % to 11 
% depending on the geographical area. The same study showed that there is higher 
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risk in women with sisters that had preeclampsia suggesting that genetic and/or 
environmental factors may be affecting the incidence of the disease (Parfrey et al. 
2002; Dawson et al. 2002). 
Although there has been a wide range of studies on PE, the pathogenesis of 
the syndrome is still unknown. Nonnally by week 22 of gestation the remodelling of 
the maternal arterioles is complete rendering non-resistant vessels that allow 
sufficient blood to reach the placenta (Kaufmatm et al. 2003). In PE invasive 
trophoblasts fail to fully remodel the maternal arterioles of the decidua and the inner 
third of the myometrium (Pijnenborg et al. 1982; Kaufmatm et a!. 2003) so the 
placenta shows a higher resistance to blood flow . It is well known that PE originates 
in the placenta and appears to progress in two stages: a preclinical one with poor 
placentation and, as a consequence, low placental blood supply. At this stage the 
patients do not show any signs or symptoms. There is a second clinical phase 
(Redman and Sargent 2011) when the patient develops the characteristic stgns: 
hypertension and proteinuria. It is believed that the dysfunctional placenta during the 
preclinical stage releases factors into the maternal circulation that cause the clinical 
features of this condition. One of the first studies on the pathogenesis of PE 
associated the syndrome with abnormal expression of adhesion molecules by 
cytotrophoblasts (Zhou et al. 1993) and with altered regulation of TGF~-3 (Caniggia 
et al. 1999). Interestingly, a recent study showed that the mechanisms of oxygen 
sensing were altered in PE as shown by lower levels of HIF 1-a in ex plants exposed to 
hypoxia from patients with early onset of PE when compared with normal 
pregnancies (Rolfo et al. 201 0). The production of placental anti-angiogenic factors, 
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specifically sFltl, a soluble fonn of the VEGF receptor and sEng, are also 
upregulated in PE (Karumanchi and Stillman 2006; Yinon et al. 2008). Apparently 
these soluble factors compete for VEGF with the non-soluble VEGF receptor on the 
endothelial cells resulting in endothelial dysfunction. This group not only detected an 
increase in serum levels of these two solubles markers in PE patients but also were 
able to develop for the first time a rat model of preeclampsia by injecting adenovirus 
expressing sFltl through the tail vein of Sprague-Dawley rats at days 8- 9 of 
pregnancy (Karumanchi and Stillman 2006). Although there has been an extensive 
a1Tay of studies on PE, the molecular basis for placental dysregulation of these 
pathogenic factors remain unknown so a better understanding of the mechanisms 
involved in the control of invasion may improve the prevention of PE or provide tools 
for an early diagnosis or a better treatment (ACOG 2002) . 
1.4 Experimental Models used for the Study of Trophoblast 
Differentiation 
1.4.1 Trophoblast Cell Lines 
Several investigators have established trophoblast cell lines derived from first 
trimester human placentas which are commonly used to study trophoblast invasion. 
HTR8-SVneo cells were generated by transformation of HTR8 cells, obtained after 
plating first trimester human chorionic villi onto Matrigel, with the gene encoding 
simian virus 40 large T antigen and display an unlimited life-span in culture (Graham 
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et al. 1993). These cells share features with invasive trophoblasts such as expression 
of cytokeratin 18 and some EVT-specific integrins such as a S integrin (ITGA5) 
(Graham et al. 1993). The cells are non-tumorigenic in nude mice and respond to 
TGF~-3 growth inhibition in a dose dependent manner (Graham et al. 1993). 
However, one al so has to be aware of the disadvantages of working with cell lines in 
vitro. The growth factors and cytokines that are produced by the surrounding cells in 
the decidua in vivo might be lacking in the in vitro model. So the behaviour of the 
studied trophoblast cell lines might not be refl ecting the response to nonnal control 
mechanisms during pregnancy. Cell lines still prove to be useful because they are 
easy to manipulate and to study providing very valuable preliminary data before 
planning the experiments in vivo (Aplin et al. 2006). 
Another useful model for in vitro studies of placental development is the 
villous explant culture. The system consists of culturing small pieces of chorionic 
villi on artificial ECM called Matrigel that allows the study of trophoblast column 
formation and EVT migration/invasion in a time- and distance-dependent manner 
(Genbacev et al 1993b ). This system has the advantage that after plating villous tissue 
pieces on ECM-coated di shes, EVT develop and it is possible to study the express ion 
of cell-specific markers such as HLA-G and integrins a5p1 and a1P1 (Vicovac et al. 
1995; Bauer et al. 2004) under different experimental conditions. Explant cultures 
con·ectly mimic the EVT differentiation program (Miller et al. 2005), however, the 
different processes, i.e. , adhesion, proliferation and migration/invasion, cannot be 
studied separately. 
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1.4.2 Mouse as a Model for Placentation 
The mouse has become an important model system for studying the function 
of genes in mammals because of the ability to modify gene functions through 
transgenic and gene knockout approaches (Natale 2006). They also have the 
advantage of short reproductive times and large litters. Small mammals, compared to 
primates or the sheep model, also require less space making housing costs lower. A 
major benefit of mice compared to other rodents lies in the availability of embryonic 
stem cells which facilitates gene targeting and the development of transgenic lines 
(Carter 2007). 
Structurally and functionally there are many valuable analogies between the 
mouse and human placenta. They are both chorio-allantoic as the tissue separating 
circulating maternal and fetal blood consists of chorionic trophoblasts, allantoic 
mesenchyme and vasculature (Georgiades et al. 2002). They are also both considered 
hemochorial because the trophoblasts are in direct contact with the maternal blood 
(Pijnenborg et al. 1981 ). Placentation in both mice and humans involves the 
development of three physiologicall y and anatomically distinct regions (Fig 1.6): 1) 
labyrinth, analogous to the fetal placenta in humans, 2) the junctional zone or 
spongiotrophoblast, analogous to the basal plate in the human placenta and 3) the 
decidua in mouse and the placental bed in humans, although they do not present many 
analogies they are both located at the boundaries of the placenta. 
The labyrinth in the mouse can be considered analogous to the fetal placenta 
because this is where feta l and maternal blood circulates in close association for 
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Figure 1.6 Comparison of the human and mouse placenta main structures. These 
two diagrams show the analogous structures of the human and mouse placenta in the 
same colour. EVT, extravillous trophoblast. Note that the interstitial extravillous 
trophoblasts invade the myometrium in the human placenta but not in the mouse 
placenta (Adapted from Cross eta!. 2003b). 
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physiological exchange. The two structures have different branching patterns off the 
main projections of the chorionic plate. The human placenta maintains a tree-like 
structure with innumerable branches all having blunted-ended extremities. On the 
other hand, the branches off the main projections in the mouse are interconnected and 
form a maze like pattern (Georgiades et al. 2002). In mice, the ultrastructure has a 
slightly different organization than the human analogue. The trophoblastic portion of 
the mouse placenta consists of three layers. The layer lining the maternal blood 
spaces consists of a mononuclear trophoblast layer, in contrast with humans that have 
the syncytium in direct contact with maternal blood. Surrounding the mouse 
cytotrophoblast there are two layers of syncytiotrophoblast resting on a basement 
membrane shared with the fetal endothelia. Similar to human placental development, 
the cytotrophoblasts give rise to the syncytiotrophoblast by fusion, but the mouse 
cytotrophoblasts are the main hormone production source in the placenta unlike 
human cytotrophoblast (Benirschke and Kaufmann 2000; Georgiades et al. 2002). A 
recent study attempted to assess the molecular similarities or differences of mouse 
and human placenta by collecting protein and mRNA expression data through shot-
gun proteomics and microarray expression analysis of this highly vascular exchange 
region, microdissected from the human and mouse near-term placenta (Watson and 
Cross 2005). Over 7000 orthologous genes were detected with 70% co-expressed in 
both species in the labyrinth and human fetal placenta suggesting that the analogies 
are also present at the genomic level. More than 80% of the genes known to cause 
placental phenotypes when disrupted in mice are expressed in human placenta 
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making these genes good candidates to study if they are involved in human placental 
pathologies, such as PE and IUGR (Watson and Cross 2005). 
The mouse junctional zone, also called spongiotrophoblast layer, and the 
sunounding secondary trophoblast giant cells could be considered as the analogue of 
the basal plate (Georgiades et al. 2002). In both species this zone contains zygote-
derived cytotrophoblasts but neither syncytiotrophoblast nor fetal blood vessels. The 
area is traversed by trophoblast-lined maternal arterial and venous channels. IJ1 mice 
there are two types of cytotrophoblasts present, spongiotrophoblasts and trophoblast 
glycogen cells (GlyC) which are derived from the spongiotrophoblasts (Coan et al. 
2006). The Gly C are the only zygote-derived trophoblasts that express uPA, a 
secreted proteolytic enzyme involved in cell migration (Teesalu et al. 1998) that is 
also expressed in EVT. Also, Gly C are the only trophoblast cells to invade the 
decidua after E 13 (Coan et al. 2006). The localization pattern and the fact that they 
give rise to the invasive cells of the placenta suggest that the spongiotrophoblasts can 
be considered comparable to the cell columns of the human placenta while the Gly C 
can be analogous to the interstitial EVT (Cross et al 2003 a). Interestingly, Mash 2 is 
expressed in the spongiotrophoblasts and its human orthologue (MASH2 or HASH2) 
is detected in cytotrophoblasts cell columns (Alders et al. 1997; Janatpour et al. 1999; 
Hemberger and Cross 2001) and in both organisms this gene is downregulated during 
trophoblast differentiation into invasive trophoblasts, which are the Gly C in mouse 
and interstitial EVT in humans. The maternal arteries in the mouse decidua are lined 
by endovascular trophoblast giant cells (TGC) that can be considered the analogues of 
the endovascular EVT. The secondary endovascular TGC are large polyploid cells 
62 
that form through the process of endoreduplication. They are invasive and phagocytic 
and first mediate the invasion of the implanted conceptus into the maternal decidua 
(Zybina et al. 2000; Simmons et al. 2007). In addition they produce paracrine and 
endocrine factors including angiogenic factors (Lee et al. 1988; Carney et al. 1993; 
Voss et al. 2000), vasodilators (Yotsumoto et al. 1998; Gagioti et al. 2000), 
prolactin/placental lactogen 1 (Pll/CSHl) (Wiemers et al. 2003), placental lactogen 2 
(Pl2/CSH2) and proliferin (Plf) (Lee et al. 1988; Yamaguchi et al. 1992; Carney et al. 
1993; Hamlin et al. 1994 ). It is important to note that the TGC are a heterogenous 
group of cells that are found lining the maternal blood spaces in the labyrinth, the 
maternal canal and the spiral arteries. The expression of genes from the prolactin and 
cathepsin families define subsets of TGC: those in the spiral arteries express Plf only, 
the ones lining the maternal canal are Plf and Pl2 positive while the ones present in 
the labyrinth express Pl2 and cathepsin (Simmons et al. 2007). The parietal TGC are 
easily identified by their location in the boundaries with the maternal decidua and 
their large nuclei that are significantly larger than the nuclei of all the other cells that 
form the mouse placenta (Simmons et al. 2007). At the molecular level, interstitial 
EVT cells, in humans, and parietal TGC in rodents, share expression of the matrix-
degrading enzyme MMP9 (Librach et al. 1994) and the adhesion molecule al~1 
integrin (Sutherland et al. 1993; Damsky et al. 1994). 
The third layer is the maternal uterine tissue bordering the maternal side of the 
murine TGC zone which could be considered analogous to the human placental bed. 
This area becomes progressively invaded by zygote-derived trophoblasts in both 
species (Bischof et al. 2002). Trophoblast invasion in human placentas normally 
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extends up to, but not beyond, the inner third of the myometrium (Bros ens et a!. 1967; 
Pijnenborg et al. 1982). In contrast, in murine placentas, trophoblast invasion is 
evident throughout the decidua basalis but not the myometrium (Redline and Lu 
1989). Thus, the murine decidua basalis and the human placental bed could be 
considered as analogous regions as far as their relative location but the extent of 
trophoblast invasion is different (Georgiades et a!. 2002). Caution should still be 
taken when extrapolating conclusions based on analysis of the matemal structure in 
this layer as the mouse myometrial arteries are only slightly modified with loss of the 
smooth muscle layer but no replacement of the endothelial cell has been detected as 
in human myometrial arteries (Pijnenborg 1988; Georgiades et a!. 2002; Adamson et 
al. 2002). 
1.5 Rationale 
Placental dysfunction is likely the major cause of two of the most common 
and serious complications of human pregnancy, matemal PE and IUGR (ACOG 
2002; Redman and Sargent 2011 ). Each disorder affects around 5% of all pregnancies 
and is associated with serious morbidity and mortality, and the only known treatment 
to date is premature delivery, which places the baby at high risk of prematurity-
related complications (Roberts and Gammill 2005; Mari and Hanif 2007). Even 
though PE and IUGR have been intensely studied for decades, the molecular 
pathways, etiology and pathogenesis of these diseases remain poorly understood (Cox 
et al. 2009). Despite the fact that cancer cells and trophoblasts share many common 
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characteristics (Lala et al. 2002; Fenetti et al. 2007), the invasion by trophoblasts is 
confined to specific areas of the pregnant uterus and little is known about the 
mechanism(s) that regulate the fine tuning of this process. MacPhee et al. (2001) 
discovered that F AK is involved in invasive trophoblast differentiation and described 
that it is only expressed until weeks 10-12 of gestation so there must be other FA 
proteins that are regulating the organization of FA and the differentiation of the 
trophoblast cells. One candidate is ILK because it is involved in many of the 
signalling pathways also known to control trophoblast differentiation, especially the 
outside-inside signalling pathway involving integrins and crosstalk between integrins 
and growth factor receptors (Legate and Fassler 2009). Thus, I hypothesize that ILK 
plays a crucial role in the differentiation of trophoblasts into invasive cells. This work 
will contribute to the overall understanding of trophoblast differentiation and help to 
elucidate some of the mechanisms that might lead to pregnancy-related pathologies. 
1.6 Objectives 
1) To determine the temporal and spatial expression of ILK in the human 
placenta: After written consent, human placentas from 1 st and 2nd trimester elective 
terminations and deliveries at term were studied by immunofluorescence and 
immunoblot analysis to describe the temporal and spatial pattern of ILK expression in 
human placenta. 
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2) To study the role of ILK in trophoblast migration and invasion. Human 
placental explant derived trophoblasts named HTR8-SVneo were transiently 
transfected with different ILK constructs and used to study if ILK was necessary for 
migration and invasion of this cell line. 
3) To determine the contribution of the oxygen environment on the regulation of 
ILK expression in the placenta. Human placental explants and HTR8-SVneo cells 
were exposed to different oxygen tensions in order to study the effect of oxygen in 
ILK expression and/or activity. 
4) To compare ILK expression in PE vs normal placentas of human patients. 
Placentas were studied by immunofluorescence in an attempt to determine if the 
levels of ILK were altered in placentas from pregnancies complicated by 
preeclampsia in comparison to placentas obtained from normal pregnancies. 
5) To analyze ILK expression in the mouse placenta and determine the feasibility 
of a trophoblast lineage specific knockout of ILK in mice. To date there are no 
data on ILK expression in mouse placenta and since the mouse is a good experimental 
model the spatiotemporal pattern of ILK expressiOn was studied by 
immunofluorescence and immunohistochemistry. 
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CHAPTER2 
MATERIALS AND METHODS 
2.1 Human Placenta Tissue Collection 
Ethics approval for this study (protocol # 03.44) was obtained from the 
Human Investigation Committee of Memorial University of Newfoundland and the 
Health Care Corporation of St. John ' s Research Proposals Approval Committee. All 
study participants with confirmed ultrasound-dated pregnancy provided written 
consent. 
Placental tissues were collected from first and second trimester elective 
terminations by the attending obstetrician utilizing dilatation and curettage. Samples 
were collected at the following weeks of gestation: 6-8 (n= 16), 9-12 (n=27) 
representing the first trimester, 13-15 (n=6) for the second trimester and 37-42 (i.e. , 
term; n=25). Placental tissues were collected in sterile phosphate buffered saline 
(PBS) and transported on ice to the laboratory within I 0 min of the procedure. After 
washing and dissecting of tissue in cold PBS, samples were fixed in 4% 
paraformaldehyde (PF A) in PBS or Zinc-buffered fixative (ZBF) overnight with 
agitation or snap frozen in liquid nitrogen and stored at -80 oc. 
Placental tissues from tern1 pregnancies were collected at the case room 
(Janeway Children ' s Hospital, St. John 's, NL) immediately after delivery. Term 
placentas were dissected and 3 pieces each from the central fetal side, peripheral fetal 
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side, central maternal side and peripheral maternal side were placed in cold PBS for 
extensive washing and subsequently fixed in either 4% PF A or ZBF or snap frozen in 
liquid nitrogen and stored at -80 oc. 
2.2 Mouse Breeding and Mouse Placenta Collection 
Experimental procedures were approved by the Animal Care Committee of 
Memorial University of Newfoundland (Protocols # 07-03-DM to 08-03-DM) and 
conducted in accordance with the guidelines established by the Canadian Council on 
Animal Care. C57BL/6J mice were purchased from the Jackson Laboratory (Bar 
Harbor, Maine, USA) and housed in microisolator cages with exposure to a 12 h dark 
and 12 h light cycle. Mice were mated and the day a vaginal plug was evident was 
designated as E0.5. Mice were anesthetised with C02 and euthanized by cervical 
dislocation. Mouse placentas were collected from pregnant mice between E7 .5 and 
E 17.5. Implantation sites, including the uterine wall, were collected in 
diethylpyrocarbonate (DEPC)-treated cold PBS and fixed in 4% PF A with rotation 
overnight at RT. The following day they were washed in RNase free PBS for 24 h 
and refrigerated until they were processed for paraffin embedding. 
2.3 Tissue Processing and Paraffin Embedding 
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The mouse and human placental tissues were processed and paraffin 
embedded by the Histology Unit in the Faculty of Medicine at Memorial University 
of Newfoundland. Tissues were dehydrated in an ethanol series (70 %, 80 %, 2 X 95 
%, 2 X 100 %) for 1 hat RT followed by xylene penetration (2 X 100% for 1 h) and 
paraffin infiltration (3 X 1 h) at 60 oc and a final paraffin infiltration for 1.5 h at the 
same temperature. Sections of paraffin-embedded tissues (5 )lin thick) were prepared 
and utilized for immunofluorescence (IF) and immunohistochemistry (lHC). Some 
sections were stained with hematoxylin and eosin to examine tissue morphology. 
Periodic Acid-Schiff staining was also utilized to identify the GlyC in the mouse 
placenta (Natale 2006). 
2.4 Immunofluorescence Analysis 
For IF, following deparaffinization and rehydration, epitope retrieval was 
conducted by incubation of tissue sections with 0.1 % Trypsin/PBS for I 0 min at RT 
followed by a wash in PBS. Sections were blocked in 5 % normal goat serum/1 % 
horse serum/1 % fetal bovine serum in PBS for 30 min at RT with gentle agitation. 
Samples were then incubated for I hat RT in primary antisera or affinity-purified lgG 
of the appropriate species at the same concentration as the primary antisera, to serve 
as a negative control. All the antisera used for experiments are listed in Table 2.1. 
After three washes in PBS, the tissue sections were incubated with appropriate 
Rhodamine-Red-X (RRX) or Fluorescein isothiocyanate (FITC)-conjugated 
secondary antisera. The sections were then washed with PBS containing 0.02 % 
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Table 2.1 Antisera utilized for immunofluorescence (IF) and immunohistochemistry 
(IHC) experiments. N/A, not applicable, the dilution depends on the primary antiserum 
used (see Chapter 2, Materials and Method, section 2.12) 
Antisera Method Dilution Supplier Catalogue 
# 
Mouse anti-ILK clone IHC I :200 Abeam, Ltd, Cambridge, AB49979 
65. I IF MA, USA 
Rabbit anti-ITGA5 IF 1:250 Chemicon International, AB1 928 
Temecula, CA 
Mouse anti-ITGAV IF 1:100 BD Biosciences, Palo Alto, 6 11 012 
CA 
Mouse anti-pAKT I (S lF 1: I 00 Cell Signaling Technology 405I 
473), clone 587F ll 
Mouse anti- IF 1:100 Chemicon International MAB3554 
Cytokeratin 7 
Rabbit anti-VWF IF 1:200 Chemicon International AB7356 
Rabbit anti-CSH 1 IF 1:150 Chemicon International AB954 
Rabbit anti-Cx26 IF 1:150 Chemicon International AB81 43 
Rabbit anti- IF 1:50 Abeam, Ltd, Cambridge, AB59925 
Cx3 1/GJB3 MA, USA 
Rabbit anti-laminin lF 1: I 00 Abeam, Ltd, Cambridge, AB 11575 
MA, USA 
Rabbit-anti-EGFP IF I : I OO Clontech Laboratories, Inc 632377 
FITC-Sheep anti- lF I :250 Sigma, St. Louis, MO, F75 12 
Rabbit IgG USA, 
ChromPure Rabbit IF N/A* Jackson lmmunoResearch 011-000-
IgG Labs, West Grove, USA 003 
ChromPure Mouse IF N/A* Jackson ImmunoResearch 015-000-
IgG Labs, West Grove, USA 003 
HRP-Goat anti- IHC 1:250 Promega Corporation, W402B 
Mouse IgG (H+L) Madison, WI, USA 
RRX-Donkey anti - IF 1:150 Jackson ImmunoResearch 715-295-
Mouse lgG Labs Inc, West Grove, 150 
USA 
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Tween 20 (PBST) and mounted in Vectashield (Cat # H-1000; Vector Laboratories 
Inc., Burlington, Ontario, Canada). If double immunofluorescence experiments were 
used, incubations in additional primary and secondary antisera were employed as 
described above, following washes in PBST and blocking of tissue sections for 30 
min. All slides were observed using a Leica DM-IRE2 inverted microscope (Leica 
Microsystems, Richmond Hill, Ontario, Canada) attached to a Retiga EXi CCD 
camera (Qimaging, Burnaby, B.C, Canada) and equipped for epifluorescence 
illumination. Openlab Image Analysis software (Version 5.5; Improvision, Inc., 
Lexington, MA, USA.) was used for image capture and analysis. Analysis of mouse 
placenta was perfmmed on at least three placentas from at least three different 
animals per gestational age collected. 
2.5 Immunohistochemical Analysis 
For IHC, after deparaffinization and rehydration, sections of mouse placenta 
were first subjected to antigen retrieval as described above and then treated with 3% 
H20 2 to block endogenous peroxidases. Following addition of primary antisera raised 
against ILK or lgG control and horseradish peroxidase (HRP)-conjugated secondary 
antisera (Table 2.1 ), colour development was conducted using the Vector Peroxidase 
Kit (Vector Laboratories, Inc, Cat # SK-4100). Tissue sections were then 
counterstained with Hematoxylin QS (Vector Laboratories Inc, Cat # H -3404), 
dehydrated and mounted in Penn ount (ThennoFisher Scientific). 
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2.6 Cell Culture 
The HTR8-SVneo cell line was a kind gift from Dr. Charles Graham (Queen's 
University, Kingston, Ontario). This cell line, originally derived from primary human 
villous explants, has been extensively characterized and has become an accepted cell 
line model of EVT. It is invasive and non-tumorigenic and these cells have been used 
in the past for assessing trophoblast invasion (Graham et al. 1993; Leach et al. 2004; 
Kotani et al. 2009). Cells were maintained in RPMI 1640 media (Cat # 11875; 
invitrogen Ltd) supplemented with 10 % fetal bovine serum (FBS) (Cat # CS-C08-
500-U; Cansera lntemational, Inc), 0.5% Penicillin (100 U) and 0.5% Streptomycin 
(100 IJ.g) (Cat # 15140-122; Invitrogen). Cells were cultured at 37 oc in a humidified 
tissue culture incubator containing 5% C02 in air. For those experiments requiring 
serum starvation, cells were cultured in RPMI 1640 media with 0.5 % FBS according 
to Graham et al. (1993). 
A low oxygen environment was created in some experimental settings to study the 
effect of oxygen tension on ILK expression and/or activity. For culture in low oxygen 
tension, the cells were placed in a C-chamber system attached to a ProOx 110 oxygen 
controller (Biospherix Ltd, USA) and cmmected to a 3% 0 2/97 % N2 tank and a probe 
that constantly monitored the level of 0 2. 
Hypoxic conditions were also mimicked by the addition of cobalt chloride 
(CoC}z) to the culture media. Cobalt can substitute for ferrous iron and become 
incorporated into newly synthesized heme moieties. Unlike iron, cobalt binds 0 2 with 
much lower affinity and thus locks the respective heme containing protein in a deoxy 
72 
conformation (Daghman et al. 1999). Desferrioxamine (DFX) was also added to the 
cell culture system to mimic hypoxia. Iron chelators such as desferrioxamine interfere 
with the binding of oxygen to ferrous heme also maintaining a deoxy status 
(Goldberg et al. 1988). In all experiments, the level of HIF -1 a was assessed by 
immunoblot analysis to confirm that cells were indeed exposed to a low oxygen 
environment or in a hypoxia mimic situation. 
2. 7 Preparation of pEGFP Plasmids 
2. 7.1 Preparation of Plasmid DNA 
To confi1m the identities of plasmids that were obtained for experiments a 
small volume of each plasmid was cultivated and purified for subsequent restriction 
endonuclease digestion. 
2.7.1.1 Mini Preparation of Plasmid DNA 
The expression vectors pEGFP-C3 (enhanced green fluorescent protein), 
pEGFP-C3-lLK-WT, -E359K, -S343D and pcDNA3.1-lLK were obtained spotted 
onto Whatman paper from Dr. Greg Hatmigan (Monash University, Australia). The 
spot on the paper was excised and eluted m 50 f.ll of Tris-EDT A 
(ethylendiaminetretraacetic acid) buffer (TE; lOmM Tris pH 8, lmM EDTA) by 
incubating at 55 oc for 5 min, followed by centrifugation and storage at - 20 oc until 
use. 
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DH5a Escherichia coli competent cells (Invitrogen, Library efficiency® 
DH5a™ Cat.#. 18263-012) were thawed on wet ice, gently mixed and aliquoted into 
100 ~-tl volumes in chilled polypropylene tubes. Approximately 1 11g of plasmid DNA 
was added to the competent cells and incubated on ice for 30 min followed by a heat-
shock for 45 sec at 42 oc in a water bath and an incubation on ice for 2 min. YT 
media (0.9 ml consisting of 1.6 % Bacto tryptone, 1 % yeast extract, 0.5 % NaCl, pH 
7) was added to the mixture and incubated for l h at 37 oc with agitation. Then 25 or 
50 ~-tl of the inoculated medium were each spread on agar culture plates containing 
ampicillin or kanamycin (depending on the plasmid) and incubated overnight at 37 
oc. The following day, four sterile tubes ofYT medium with ampicillin (50 ~-tg/ml) or 
kanamycin (30 1-lg/ml) were each inoculated with one colony from the appropriate 
culture plates and incubated at 37 oc on a shaker ovemight. Each 3 ml mini-culture 
was pelleted by centrifugation at 3000 rpm for 10 min at 4 °C, re-suspended in 100 ~-tl 
of ice-cold glucose-TRIS-EDTA buffer (Solution I) and vortexed vigorously to 
remove any cell clumps and incubated for 5 min at RT. Two hundred microlitres of 
fresh 1 % SDS, 0 .2 N NaOH (Solution 11) was added to each mixture and mixed by 
inversion. The lysate was then incubated on ice for 5 min. One hundred fifty 
microlitres of 5 M potassium acetate (Solution III) was added to each tube, gently 
vo11exed and incubated on ice for I 0 min . The samples were then centrifuged at full 
speed for 15 min and the supernatant was transferred to a fresh tube and extracted 
with one volume of phenol/chloroform (I: I). After vortexing, the tubes were 
centrifuged for 5 min and the aqueous phase transferred to new tubes. One volume of 
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chloroform was added to each sample and the tubes vortexed and centrifuged for 5 
min. The top aqueous phase was then transferred to new tubes. 
The DNA was then precipitated with two volumes of ice-cold 95 % ethanol at 
-70 oc for I h. Following centrifugation at full speed for 5 min and discarding of the 
supernatant, the pellets were washed with two volumes of ice-cold 70 % ethanol, 
centrifuged and air dried. The DNA was resuspended in 50 Ill of ultra pure water and 
quantified. Quantification of DNA was performed by UV absorbance spectroscopy (1 
A260 O.D. Unit for dsDNA =50 1-lg/mL). The plasmids were then stored at - 20 °C. 
2.7.1.2 Restriction Enzyme Assay 
Every time a new vector was obtained and purified, the presence of the eDNA 
of interest was confirmed by restriction enzyme digestion assays. pEGFP-C3-ILK 
expression plasmids (pEGFP-C3-ILK-WT, -E359K, -S343D) were digested with 
Hindlll (New England BioLabs; Cat # R0104S) and Xhol (New England Biolabs; Cat 
# R0146S) restriction enzymes whi le pcDNA3.1 -lLK was digested with Xhol using a 
standard protocol. The following represented a 20 Ill reaction mixture: 2 Ill reaction 
buffer 2 (50 mM NaCl, 10 mM Tris-HCl, I 0 mM MgCh, 1 mM dithiothreitol, pH 7.9 
New England Biolabs Cat # B7002S), 2 ul of I mg/ml bovine serum albumin (BSA), I 
!lg DNA, 20 U each of Hind Ill and Xhol, and dH20 to complete 20 Ill. A control 
without enzyme and a control without plasmid DNA were included for each vector 
tested. The tubes were incubated for I hat 37 oc and after complete digestion of the 
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DNA, electrophoresis was conducted on 1 % agarose gels in IX Tris-acetic acid-
EDTA (T AE) buffer. Each digested DNA sample (20 J..!l) was mixed with 4 J..!l of 6X 
loading buffer and 15 J..!l of these prepared samples were loaded in each lane of the 
gel. 1n addition, 1 ).lg of 1 kb ladder (New England Biolabs, Cat # N3232L) was also 
run in a gel lane as a DNA standard marker. The gels were run at 80 V for 1 -1 Yz h. 
Pictures were taken with a KODAK Gel Logic 200 Imaging station (Mandel 
Scientific Company, lnc) . 
2.7.1.3 Midi Preparation of Plasmid DNA 
After confinning the identity of the appropriate plasmids, 50 ml 2X YT media 
containing appropriate antibiotics were each inoculated with appropriate mini-
cultures and grown overnight at 37 oc with agitation (midi-cultures). Plasmid DNA 
was subsequently isolated using a QlAGEN Midi -kit (Cat # 12 I43) according to the 
manufacturer's instructions. 
Briefly, cultures were pelleted by centrifugation at 6000 g for 15 min at 4 °C, 
re-suspended in 6 ml of Buffer PI and vortexed to remove any cell clumps. Six ml of 
buffer P2 were added; the mixture was shaken vigorously and incubated 5 min at RT 
to lyse the bacteria. Six ml of chilled buffer P3 was added to the lysate and mixed. 
Each lysate was poured into the barrel of a QIA filter cartridge and incubated at RT 
for I 0 min. To separate contaminating proteins, genomic DNA and detergent from the 
plasmid DNA, the mixture was fi ltered through a QIA filter on to an affinity QIA 
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high speed mini column that had been previously equilibrated. After several steps of 
washing, the DNA was eluted from the column with 5 ml of QF Buffer and collected 
in a Falcon tube where the DNA was subsequently precipitated by adding 3.5 ml of 
RT isopropanol and incubating for 5 min at RT. The precipitated DNA was attached 
to a QIA precipitator. DNA was washed again with 70 % ethanol and dried before it 
was finally eluted with dH20. 
Quantification was performed by UV absorbance spectroscopy (1 A260 O.D. 
Unit for dsDNA = 50 ug/mL). To assess DNA quality A260/A280 was measured and 
only plasmid DNA with ratios between 1.6 and 1.8 was used. All plasmids were 
stored at - 20 °C. 
2.8 Migration Assays 
HTR8-SVneo cells were initially seeded on 22 x 22 em glass coverslips (1 x 
105 cells/coverslip) placed in 35 mm tissue culture dishes and cultivated in RPMI 
1640 media, as described above, with the omission of antibiotics during transfection. 
When cells reached approximately 85% confluence, they were transiently transfected 
with empty pEGFP-C3 expression vector (BD Clontech, Cat # 6082-1 ), pEGFP-C3 
containing human ILK-WT or pEGFP-C3 containing human ILK-E359K using 
Lipofectamine 2000 (Cat.#. 11668- 027; Invitrogen Ltd.) according to the 
manufacturer's instructions. Transient transfections were conducted with 2 1-1g of 
DNA with a DNA:Lipofectamine ratio of 1 :4. Before starting the definitive 
77 
experiments, different ratios of DNA: Lipofectamine were tested to determine the 
ideal ratio that yielded the most efficient transfection with the lowest volumes of 
lipofectamine. 
Twenty-four hours after transfection, a wound was created in the confluent 
cell monolayers with a sterile pipette tip and cells were cultivated under serum 
starving conditions to study migration. The wounds were initially photographed 
(migration time=O h) using a lOX objective under phase contrast and epifluorescence 
illumination with a DM-IRE2 inverted microscope (Leica Microsystems) equipped 
with a Retiga EXi CCD camera (Qimaging). A second set of pictures was taken 24 h 
later (total of 48 h post-transfection) to assess cell migration into the wounds. The 
ratio of the number of transfected cells (i.e. , EGFP-ILK fusion protein-containing 
cells) to the total number of cells in the wound after 24 h was subsequently 
detem1ined from the captured images using Openlab Image Analysis software 
(lmprovision). Migration assays were completed in triplicate and the experiment was 
repeated four times. 
2.9 Invasion Assays 
Following transient transfection of HTR8-SVneo cells with pEGFP-ILK 
expression vectors (as described in section 2.7), 5 x l04 cells were plated on growth 
factor-reduced Matrigel-coated transwell inserts containing 8 )..lm polyethylene 
terephthalate (PET) membranes (Millipore Inc.; Cat # PIEP1 2R48) and cultured 
under standard tissue culture conditions in RPMI 1640 media containing 0.5% BSA. 
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The lower chamber of the trans well contained RPMI 1640 media 110% FBS as an 
attractant. Under these culture conditions, HTR8-SVneo cells demonstrated an 
invasive phenotype characteristic of EVT cells (Graham et al. 1993, Kilburn et al. 
2000). After 72 h of incubation, the transwells were washed with cold PBS and fixed 
with cold methanol for 3 min. The Matrigel was removed and each PET membrane 
was mounted on glass slides with Vectashield containing 4',6-diamidino-2-
phenylindole (DAPI, Vector Laboratories; Cat #H-1200). The total numbers of 
transfected (EGFP-fusion protein-expressing) cells were counted on the underside of 
the membrane with a Leica DM-IRE2 inverted microscope (Leica Microsystems, 
Richmond Hill, Ontario, Canada) attached to a Retiga Exi CCD camera (Qlmaging, 
Burnaby, B.C, Canada) and equipped for epifluorescence illumination. Microscopic 
images were captured and analyzed with Openlab Image Analysis software (Version 
5.5; lmprovision, Inc., Lexington, MA, USA.). All invasion assays were conducted in 
triplicate and repeated three times. 
2.10 MTT Assay 
HTR8-SVneo cells were seeded (1 x 104 cells/well) in 96-well plates and 
cultured in RPMI 1640 media as described above. After transient transfection with 
the different pEGFP-C3 vectors, the cells were cultured under serum-starving 
conditions for 48 h and the assay was conducted following the manufacturer's 
detailed instructions (MTT, 3-( 4,5-dimcthylthiazol-2-yl)-2,5-diphenyltetrazolium 
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bromide, Cell Proliferation Kit I, Cat. # 1 465 007; Roche Diagnostics, Laval, 
Quebec, Canada). Briefly, following 72 h of incubation, 10 fll of MIT labeling 
reagent (3-[ 4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) was added to 
each well of the plate for 4 h at 37 oc followed by the addition of a solubilisation 
solution and incubation overnight. The following day absorbance measurements (550 
nm) were completed with a POLARstar Optima Plate Reader (BMG Laboratories, 
Offenburg, Germany). Assays were done in triplicate and the experiments repeated 
twice. 
2.11 Immunoblot Analysis 
Frozen tissue samples were pulverized under liquid nitrogen using a mortar 
and pestle and then homogenized in 500 fll of modified radioimmunoprecipitation 
assay (RIPA) lysis buffer (50 mM Tris-HCl , pH7.5, 150 mM NaCl, 1% Triton X-1 00, 
1 % sodium deoxycholate, and 0.1 % SDS) containing 100 ~tM Na3 V04 and 
Complete TM mini EDT A free protease inhibitors (Cat # 1 836 153, Roche Molecular 
Biochemicals) 
For protein extraction of cell lines, cells were initially seeded at 2 x 105 
cells/well in 6-well plates and cells were lysed by the addition of 500 f.!llwell of 
modified RIP A lysis buffer containing inhibitors. Cells were harvested with a plastic 
cell scraper and homogenized with a 27G needle attached to a 1 ml syringe. Samples 
were cleared by centrifugation and supernatants retained for protein assays and 
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immunoblot analysis. Sample protein concentrations were determined by Bradford 
Assay (Bradford 1976) (Cat# 500-0001 , Bio-Rad Laboratories). Protein samples (40 
).lg/lane) and standards (Bio-Rad Cat # 161-0374) were separated in 10 % 
polyacrylamide gels under denaturing conditions (Laemmli 1970) and gels were 
electroblotted to 0.45 11m nitrocellulose membrane (Cat # 88018, Pierce). Blots were 
rinsed in Tris-buffer saline-Tween 20 (TBST; 20 mM Tris base, 137 mM NaCl, and 
0.1 % Tween 20, pH 7.6) and blocked in either 5 % BSA/TBST or 5 % skim 
milk/TBST. Appropriate primary antibodies (listed in Table 2.2) at specific dilution 
factors, according to the manufacturer's suggestion, were incubated on blots either at 
4 oc overnight or 1 h at RT, depending on the primary antibody, with constant 
agitation and then rinsed in TBST. lmmunoblots were incubated in HRP-conjugated 
secondary antibody for 1 hat RT with constant agitation and then washed with TBST. 
The enhanced chemiluminescent reaction was developed with the Pierce Supersignal 
West Pico chemiluminescent substrate detection system (Cat # 34080, Pierce; 
Thenno Fisher Scientific) and multiple exposures were generated to ensure the 
linearity of the film response. Densitometric analysis of the bands, to nom1alize and 
compare bands of different gestational weeks or experimental treatments, were 
perfonned on scanned film images utilizing Image J software (NIH, USA). 
2.12 Kinase Assays 
HTR8-SVneo cells were seeded in 35 mm culture dishes at 2.5 x 105 cells/dish and 
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Table 2.2 Antisera utilized for immunoblot analysis 
Antisera 
Rabbit anti-ILK 
Rabbit anti-ILK 
Rabbit anti-AKT 
Rabbit anti-pAKT1 (Ser 473) 
Mouse anti-GSK3a/p 
Rabbit anti-pGSK3~ 
Mouse anti-HIF-1a 
Mouse anti-ACTB 
Dilution Supplier Catalogue 
# 
1:2000 Upstate, Waltham, MA 05-575 
1:4000 
1:1000 
1:1000 
1:1000 
1:1000 
1:250 
1:5000 
Cell Signaling 3862 
Technology, MA , USA 
Cell Signaling Technology 9272 
Cell Signaling Technology 9271 
Santa Cruz Biotechnology, sc-7291 
CA, USA 
Cell Signaling Technology 9336 
BD Biosciences, Palo 610958 
Alto, CA 
Sigma, St Louis, MO, A5316 
USA 
HRP-Goat anti rabbit-IgG (H+L) 1:10000 Pierce Rockford, IL, USA 31460 
HRP-Goat anti mouse IgG 1:10000 Pierce Rockford, IL, USA 31430 
(H+L) 
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cultured in either 20 % or 3 % oxygen conditions as described above for 24 h. Cells 
were lysed with Triton buffer (20 mM Tris pH 7.5, 150 mM NaCI, lmM EDTA, 1 
mM ethyleneglycoltetraacetic acid (EGTA), 1 % Triton , 2.5 mM sodium 
pyrophosphate, 1 mM ~-glycerophosphate, lmM Na3 V04, l )...l.g/ml Leupeptin 
containing CompleteTM Mini EDTA-free protease inhibitors). Protein concentrations 
were detetmined by the Bradford method (Bradford 1976). For immunoprecipitation, 
4.0 )...l.g of mouse monoclonal ILK antisera (Upstate Cat # 05-575) or non-specific lgG 
(Jackson lmmunoResearch Labs Inc, Cat # 0 15-000-003) was added to 400 J.lg of 
appropriate HTR8-SVneo cell lysate and incubated ovemight at 4 oc with gentle 
agitation. The following day, TrueBlot anti-mouse IP beads (50 J..tl) (Cat # 00-8811 ; 
eBiosciences, San Diego, CA, USA) were added to each sample and incubated for 2 h 
at 4 oc with gentle agitation. ILK antibody-bead complexes were centrifuged at 
13,000 x g for 1 min at 4 oc and subsequently washed three times with 500 J.ll of 
Triton lysis buffer followed by three washes with 500J.1l of kinase buffer (Cat # 9802; 
Cell Signaling). Complexes were resuspended in 50 J.ll of kinase buffer supplemented 
with 1.0 J.ll of 10 mM ATP (Cat # 9804; Cell Signaling) and 1 J.lg of GSK3~ fusion 
protein (Cat # 9237; Cell Signaling) and incubated for 30 min at 30 °C. The reaction 
was then terminated with 12 J.ll of 5 X sodium dodecyl sulfate-polyacrylamide gel 
(SDS-PAGE) loading buffer followed by vortexing and centrifugation for 30 sec at 
14,000 x g. All samples were heated to 95 oc for 5 min prior to loading on 10 % 
polyacrylamide gels according to Laemmli (1970) followed by electroblotting to 0.45 
J...lm pore nitrocellulose membrane (Cat # 88018, Pierce; Thermo Fisher Scientific). 
lmmunoblot analyses of phosphorylated GSK3~ (Ser-9) (Cell Signaling Cat # 9336), 
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total GSK3 alp (Santa Cruz Cat # 7291) and ILK proteins (Cell Signaling Cat # 
3862) (See Table 2.2) were then conducted 
2.13 Placental Explant Cultures 
Isolation and culture of placental explants were conducted at the Samuel 
Lunenfeld Research Institute through a collaboration with the laboratory of Dr. 
Isabella Caniggia. Placentas from patients that underwent elective terminations, 
following informed consent, were collected in cold PBS, pH 7.4, by a registered nurse 
at the medical center. All the tissues were manipulated with smooth ended forceps 
and dissected with ophthalmologic scissors under a dissecting microscope. 
The morning of chorionic villous dissections, Matrigel aliquots were taken 
from the -20 oc freezer and thawed at 4 oc. Prior to coating of transwell insert 
membranes, Matrigel was transported on ice to the laminar flow hood to prevent 
gelling. All Matrigel aliquoting and setup work with the Matrigel was done with cold 
PBS and transwell inserts and pipet tips were kept cold before use. For the 
preparation of the inserts, 120 )..Ll of Matrigel was poured on to the inserts utilizing 
1000 111 tips and the inserts incubated at 37 oc for 30 min to promote gelling. 
Villi fragments were cut in a tissue culture hood and placed in a drop of PBS 
on aluminum foil pieces to aid tissue weight determination. All chorionic villi 
samples utilized were between 20-40 mg in wet weight. The villi fragments were 
placed on millicell-CM culture dish inserts pre-coated with Matrigel. Using a long 
needle, the fragments were spread out on the Matrigel to maintain their tree-like 
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architecture, but without pushing the fragments into the artificial substrate. The 
tissues were incubated for 30-60 min, without culture media, on the Matrigel to 
facilitate settling on the substrate. Serum free media was then added to each insert. 
For these particular experiments, DMEM/F12 media without phenol red containing 1 
% Penicillin/Streptomycin and 0.25 1-lg/ml ascorbic acid, pH 7.4 was used. The wells 
of the tissue culture plate were also filled with DMEM/F 12 media containing 10 % 
FBS as a source of growth factors to act as attractant and the explants were divided 
into experimental groups: four samples (n=4) were incubated at 3 % oxygen, 8 % 
oxygen and 20 % oxygen. The media was changed every 48 h and the experiments 
were conducted for 4-6 days in triplicate. Ex plants were fixed in 4 % PF A/PBS for 4 
h at 4 °C, dehydrated with increasing concentrations of alcohol and then paraffin 
embedded. 
2.14 RNA Isolation 
RNeasy Mini Kit from Qiagen (Qiagen Cat # 74 104) was used for 
preparation of RNA samples obtained from HTR8-SVneo cells cultured under normal 
and low oxygen environments. This method was used when the RNA was then 
analyzed by quantitative real time polymerase chain reaction (qRT -PCR) since the 
A260/A280 ratios obtained for RNA isolated with the TRizol method were not 
adequate indicating the quality of the RNA was not good enough for qRT -PCR. 
Cells cultured in 6 well plates were first lysed and homogenized m the 
presence of a highly denaturing guanidine-thiocyanate containing buffer, which 
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immediately inactivated RNases to ensure purification of intact RNA. Ethanol was 
then added to each cell sample to provide appropriate binding conditions, and each 
sample was applied to an RNeasy Mini spin column to bind total RNA while allowing 
efficient removal of contaminants. Several additional washing steps with different 
washing buffers ensured that high-quality RNA was then eluted in 20 111 of RNase-
free water. 
RNA was then quantified by absorbance measurement at 260 nm and the 
quality and integrity of the RNA was assessed by the A260/ A280 ratio and 
electrophoresis on I % formaldehyde-agarose gels. RNA samples were then stored in 
the -80 oc freezer for future use. 
2.15 Real Time PCR 
2.15.1 DNase Treatment of the RNA 
The purified RNA was treated with deoxyribonuclease I (DNase 1, 
amplification grade, Invitrogen Cat # I 8068-015) to remove any genomic DNA. 
Briefly, in RNase-free tubes, I 11g of each RNA sample, 1 ~d of lOX DNase I reaction 
buffer, 1 111 of DNase I (1 U/ Ill) and DEPC-treated water to a final volume of 10 111 
were mixed and incubated for 15 min at RT. DNase I was inactivated by the addition 
of 1 111 of 25 mM EDTA pH 8 followed by an incubation for 10 min at 65 °C. 
Samples were then used for qRT-PCR or stored at -80 oc. 
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2.15.2 First Strand eDNA Synthesis 
Following DNase treatment, 8 J.!l of each RNA sample was mixed with 10 J.!l 
of 2X reverse transcriptase reaction mix containing oligo( dT), random hexamers, 
MgCh and deoxyribonucleotides (dNTPs) followed by 2 J.!l of 2X reverse 
transcriptase reaction enzyme mix (SuperScript Ill First-Strand synthesis SuperMix 
for qRT-PCR, Cat# 11752-050, Invitrogen). This mix included the Moloney Murine 
leukemia Virus (M-MLV) reverse transcriptase that has been engineered to reduce 
RNase H activity and provide increased thermal stability. The reaction mix also 
included RNaseOut recombinant ribonuclease inhibitor to protect against degradation 
of RNA due to ribonuclease contamination. The total volume of each reaction was 
adjusted to 20 J.!l with the addition of DEPC-treated water and the reactions incubated 
at 25 oc for J 0 min . Reaction tubes were then incubated at 50°C for 30 min and the 
reactions tem1inated by incubation at 85 oc for 5 min. Then 1 J.!l of E. coli RNase H 
was added to each tube and the mixtures incubated at 37 oc for 20 min. eDNA 
samples were either used for qRT-PCR or frozen at - 20 oc until use. 
2.15.3 Real Time PCR Analysis 
qRT-PCR analysis was performed with the two step qRT -PCR kit from 
Invitrogen (Cat # 11765- 100) using the SYBR® qPCR Supermix (Cat # 11 760- 100 
Invitrogen). The following primers were utilized: ILK forward (5'-AAG CTG CTA 
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GTT CCA AGG AAC CCT -3'), ILK reverse (5'-TCC ATA CGG CAT CAT CCA 
GTG TGT GAT -3'); 18S forward (5 ' -GCG AAA GCA TTT GCC AAG AA -3 '), 
18S reverse (5'-GGC ATC GTT TAT GGT CGG AAC -3 '). After an initial 
incubation of 50 oc for 2 min and 95 °C for I 0 min the reactions were cycled 40 
times. Each cycle consisted of denaturation at 95 °C for 15 s and primer annealing 
and extension at 60 oc for 30 s. Results were collected and analyzed with ABI 7000 
software. The data were controlled for quantity of mRNA input by measuring the 
reference gene, 18S. The amplification efficiencies of the target (ILK) and reference 
gene (1 8S) were simi lar as calculated by a calibration dilution curve for each gene. 
The relative amount of ILK mRNA was calculated with the 66Ct method. Melting 
curves were checked to confirm specificity of the primers. Dissociation (melting) 
curves were perfom1ed at the end of each run to confinn specificity of the 
amplification. Experiments were performed in triplicate and repeated three times. 
2.16 Statistical Analysis 
Data from immunoblot band density, migration assays, invasion assays and 
MTT assays were analyzed using GraphPad Prism version 5.02 (GraphPad Software 
Inc; www.graphpad.com). A one-way analysis of variance (AN OVA) was performed 
on the data followed by a Tukey-Kramer or Newman-Keuls post-test. Data were 
considered significantly different when P<O.OS . 
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CHAPTER3 
ILK IS EXPRESSED IN THE HUMAN PLACENTA AND 
REGULATES THE MIGRATION OF A TROPHOBLAST-
DERIVED CELL LINE 
3.1 ILK Expression in Human Placenta 
3.1.1 Experimental Rationale 
ILK is overexpressed when tumors become invasive (Ahmed et al. 2003; 
Marotta et al. 2003; Ahmed et al. 2004). Since trophoblasts have an invasive nature, it 
was hypothesized that ILK plays an active role in the regulation of trophoblast 
differentiation from proliferative to invasive cells. To test this hypothesis, it was 
necessary to explore if ILK was expressed in human placental cells as well as where 
and when ILK was expressed during pregnancy. For this purpose, ILK expression 
was examined in human placentas collected from elective terminations and tenn 
deliveries. 
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3.1.2 The Structure of the Normal Chorionic Villi is Preserved 
Following Sample Preparation 
To define the temporal and spatial pattern of ILK expression, human placentas 
from elective terminations were collected in a plastic trap after dilatation and 
curettage. As a consequence of this procedure the main organization of the organ was 
disrupted. A careful inspection of the tissue under a stereo-microscope ensured that 
only intact vi lli were collected in vials for fixation with 4 % PF A or for freezing in 
liquid nitrogen for storage. Following fixation and embedding, some paraffin sections 
were stained with hematoxylin and eosin to ensure that the different layers of the 
tissue were well preserved following sample collection (Fig 3.1). To properly identify 
the location of ILK in the human placenta, different markers were utilized such as 
cytokeratin 7 (CK7), human chorionic somatomammotropin (CSH 1 ), av-integrin 
(ITGAV), ITGA5 , and von Willebrand factor (vWF). CK7 was used as a specific 
marker for both vCT and EVT (King et al. 2000) while CSH 1, formerly known as 
human placental lactogen, was used as a marker for syncytiotrophoblast since it is 
secreted exclusively by the syncytiotrophoblast and exerts a metabolic effect on the 
mother to ensure that the nutritional demands of the fetus are met (Creasy and Resnik 
2000). ITGA V heterodimerizes with integrin ~5 and ~6 in the vCT and in the EVT 
cells that are at the base of the cell column. They form the receptor for vitronectin and 
fibronectin (Huang et a! 1998; van der Flier and Sonnenberg 2001 ). ITGA5 is a 
component of the receptor for fibronectin and is only expressed in those EVT that are 
becoming less proliferative and more invasive 
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Figure 3.1 A first trimester human placenta tissue section stained with 
Hematoxylin and Eosin. A representative photograph of week 9 placenta shows 
anchoring villi stained with Hematoxylin and Eosin. The syncytiotrophoblast, the 
cytotrophoblasts (CT) and the extravillous trophoblast (EVT) are indicated with 
arrows. The maternal blood occupies the intervillous (IVS) space during gestation but 
is lost after washes and fixation of the tissue. The stroma is composed of cmmective 
tissue and fetal blood vessels containing the nucleated fetal red blood cells (fRBC) 
that exchange gases and nutrients with the maternal blood. Scale bar, 50 ~-tm . 
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(Fisher and Damsky 1993; Damsky et al. 1994; Zhou et al. 1997; van der Flier and 
Sonnenberg 200 I). vWF is a specific marker of endothelial cells (Wagner et al. 1982; 
Warhol and Sweet 1984). 
3.1.3 ILK is Present in Floating and Anchoring Villi of Human Placenta 
Immunofluorescence analysis on the same placental sections corresponding to 
different weeks of gestation was used to identify those cells that expressed ILK. 
When ILK-specific antiserum and marker-specific antiserum were produced in the 
same species, adjacent serial sections were utilized for the study. The human 
placental samples were collected after informed written consent and ranged from 
week 6 to I2 in the first trimester (n=17), from week 13 to 15 (n=6) representing the 
early second trimester and from week 38 to 42 of gestation (n= 10) at term. The 
immunofluorescence analysis of the different samples showed that ILK was highly 
detectable in fl oating branches of chorionic villi. Specifically, ILK was localized to 
cells of the villous stroma and to cytoplasm and plasma membranes of vCT (Fig. 3.2). 
The localization of ILK to the vCT was confirmed by the localization of the 
cytotrophoblast marker CK7 to the same location in adjacent sections (Fig 3.3). 
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Figure 3.2 lmmunolocalization of ILK in floating branches of chorionic villi. 
Representative images of ILK expression in floating villi of human placenta from 
weeks (w) 6, 8, 10, 14, and 41 (term) of gestation. During the first and early second 
trimester, ILK was highly expressed in the villous cytotrophoblast layer but was also 
detectable in cells of the villous stroma and barely detectable in the 
syncytiotrophoblast layer. In term placenta, ILK was primarily localized to 
endothelial cells of fetal blood vessels. S: stroma; CT: villous cytotrophoblast; ST: 
syncytiotrophoblast; Control: non-specific mouse lgG control (w38). Scale bar, 50 
)..!111 . 
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Figure 3.3 Human chorionic somatomammotropin and cytokeratin 
immunostaining of human placental villi. The syncytiotrophoblast was identified 
by immunostaining with an antibody specific for human chorionic 
somatomammotropin (CSHl; green). The underlying layer was identified by 
immunostaining with an antibody against cytokeratin 7 (CK7), a marker of 
cytotrophoblast (red). Shown is a representative human placental tissue section from 
week (w) 8 of gestation. CT: villous cytotrophoblast; ST: syncytiotrophoblast. Scale 
bar, 50 ~-tm. 
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Compared to vCT, ILK was barely detectable m the overlying 
syncytiotrophoblast that was identified by immunostaining with a CSH ! -specific 
antibody (Fig 3.4). The immunostaining of the syncytiotrophoblast layer with ILK 
antibody showed consistently similar intensity to the non-specific mouse IgG 
controls. In some sections, ILK was also detected, at a low level, on the apical surface 
of the syncytiotrophoblast layer. This result may be artifactual because of the 
presence of microvilli in this layer. It is possible that some residual non-specifically 
bound primary antisera remained trapped in proximity of these structures despite 
washes during the experiments, although the presence of ILK in this region cannot be 
ruled out completely. 
In anchoring villi , ILK was primari ly localized to the plasma membranes of 
EVT cell columns (Fig 3.5). Specifically, in proximal EVT of the cell column, ILK 
expression co-localized with ITGA V expression (Fig 3.6), whereas ILK co-localized 
with ITGA5 in more distal regions of the cell columns (Fig 3.7). When compared 
among different gestational time points, there was no detectable variation observed in 
the level of ILK expression in situ. The spatial pattem of expression was also similar 
in the different weeks of gestation analyzed, thus ILK was detected in the cytoplasm 
and plasma membrane of the vCT, in the mesenchymal cells of the chorionic villi and 
in EVT. The detection of ILK seemed lower in the vCT at tenn but this might only be 
a consequence of a lower number ofvCT cells present in the floating villi . 
From 6 to 15 weeks of gestation, ILK was also readily detectable m 
developing blood vessels in chorionic vi lli, specifically located in endothelial cells, as 
confim1ed by co-immunolocalization of ILK with vWF (Fig 3.8). Similarly, in term 
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Figure 3.4 Immunolocalization of ILK and human chorionic 
somatomammotropin (CSHl) in human placenta. A representative tissue section 
of human placenta collected from week (w) 8 of gestation and immunostained with 
ILK and CSH 1-specific antibodies. ILK was inconsistently detected, at a low level, 
on the apical surface of overlying syncytiotrophoblast cells that expressed the 
syncytiotrophoblast marker CSH 1. CT, villous cytotrophoblast layer; ST, 
syncytiotrophoblast layer; S, stroma. Scale bar, 50 ~-tm. 
99 
100 
Figure 3.5 lmmunolocalization of ILK in anchoring branches of chorionic villi. 
Representative images of ILK expression in anchoring villi of human placenta from 
weeks (w) 6, 8, 11 , 15, and 37 (tem1) of gestation. During the first and early second 
trimester, ILK was highly expressed in the villous cytotrophoblast and extravillous 
trophoblast but was also detectable in cells of the villous stroma and barely detectable 
in the syncytiotrophoblast layer. At tenn ILK was only detected in a few cells of the 
basal plate. EVT, extravi llous cytotrophoblast; S, stroma; CT, vi llous cytotrophoblast; 
ST, syncytiotrophoblast; Control: non-specific mouse lgG control. Scale bar, 50 J.!m. 
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Figure 3.6 Expression of av-integrin (ITGA V) in human placenta. 
Representative human placental tissue sections from week (w) 14 of gestation are 
shown. Indirect immunofluorescence analysis with floating (upper panel) and 
anchoring (lower panel) villi showed that ITGA V is expressed in the cells that form 
the base of the anchoring villi and in villous cytotrophoblasts where it demonstrates a 
plasma membrane localization. There was also slight detection of ITGA V in the 
apical aspect of the syncytiotrophoblast. EVT, extravillous trophoblasts; ST, 
syncytiotrophoblast; vCT, villous cytotrophoblasst. Scale bar, 50 ).!m. 
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Figure 3.7 Immunolocalization of ILK and ITGAS in human placenta. 
Representative images from double immunofluorescence experiments with human 
placenta from week (w) 11 of gestation, illustrating that ILK co-localized (yellow) 
with ITGAS in the EVT cell column. CT, villous cytotrophoblast layer; EVT, 
extravillous trophoblast; ST, syncytiotrophoblast layer; S, stroma. Scale bar, 50 ~-tm. 
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Figure 3.8 Immunolocalization of ILK in blood vessels of chorionic villi. 
Representative images of chorionic villi from week (w) 14 and 40 of gestation 
illustrating the coimmunolocalization (arrowhead) of ILK with von Willebrand Factor 
(VWF) in blood vessel endothelial cells . BY, blood vessel ; CT, villous 
cytotrophoblast layer; ST, syncytiotrophoblast layer. Scale bar, 50 1-1m. 
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chorionic villi , ILK was still immunolocalized to endothelial cells of blood vessels, 
but markedly decreased in chorionic trophoblasts (Fig 3.8). 
To establish whether there were any changes in the temporal pattern of ILK 
expression in placental tissue during the first trimester, early second trimester and at 
term, protein extracts from human placentas were studied by immunoblot analysis. 
This analysis demonstrated that ILK was readily and comparably detected, at the 
expected molecular weight of approximately 55 k.Da at all gestational time points 
examined (Fig 3.9). 
3.1.4 ILK Substrate, AKT, is Present in the Same Areas as ILK in the 
Human Placenta 
AKT phosphorylation is regulated by ILK in many different cells such as PTEN 
null cancer cells (Wan and Helman 2003) and many reports showed that AKT 
phosphorylation on Ser-4 73 is dependent on ILK kinase activity (Persad et al. 2001; 
Nho et al. 2005). Thus, the temporal and spatial localization of Ser-473 
phosphorylated AKT (pAKT) in fi rst and early second trimester chorionic villi was 
studied to serve as an initial gauge of the activation state of ILK in this tissue. 
lmmunoblot analysis demonstrated that pAKT was detectable, at the expected 
molecular weight of 60 k.Da, in human chorionic villus tissue lysates at all gestational 
time points examined (Fig 3.10). 
A lower molecular weight band of unknown identity was consistently detected in 
all placenta ti ssue lysates, but this may also potentially represent an AKT degradation 
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Figure 3.9 ILK protein expression in human placental lysates. A) A 
representative immunoblot showing ILK protein expression in human placentas in 
first trimester, early second trimester and at term. Placentas from weeks (w) 8, 9, 10, 
12, 13 and 39 of gestation were studied by immunoblot analysis and showed 
comparable expression of ILK. ~-Actin (ACTB) was used as the loading control. B) 
Densitometric analysis of immunoblots . The ILK and ACTB bands were 
densitometrically analyzed with Image J (NIH). ACTB bands were used to normalize 
the level of expression of ILK. ANOVA analysis (P < 0.05) was used to compare 
statistically the relative amounts of ILK in different weeks of gestation. No 
significant differences were found among the groups. Three sets of gestational 
profiles were studied (n=3). 
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Figure 3.10 Expression of AKT and pAKT in human placentallysates. AKT and 
pAKT are expressed in the same weeks (w) of gestation as ILK. Human placentas 
(w8, 9, 10, 12, 13, 39, 40) were studied by immunoblot analysis. Jurkat celllysates of 
cells pre-treated (pAKT -) and untreated (pAKT +) with a PBK inhibitor (L Y294002) 
were included as negative and positive controls, respectively. ~-Actin (ACTB) was 
used as the loading control. Two complete sets of different gestational profiles were 
studied (n=2). 
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product. Similarly to ILK immunolocalization, from week 6 to week 15 of human 
gestation, pAKT was also detectable in the villous stromal cells and cytoplasm of the 
villous trophoblast cells as well as associated with plasma membranes of the vCT and 
EVT cells (Fig 3.11). pAKT was virtually undetectable in the syncytiotrophoblast 
layer of the chorionic villi . 
3.2 ILK Regulates Migration of the HTR8-SVneo Human 
Trophoblast Cell Line 
The observation that ILK was expressed in those cells of the chorionic EVT 
column that were becoming less proliferative and more migratory and invasive, 
suggested that ILK might be involved in trophoblast cell migration. The role of ILK 
in migration was studied using a trophoblast derived cell line named HTR8-SVneo. 
The expression of ILK was first studied by immunofluorescence to make sure that 
ILK was expressed in these cells under normal culture conditions (RPMI 1640 media, 
I 0 % FBS, I % Penicillin/Streptomycin, 5 % C02 in air) and low serum conditions 
(RPMI 1640 media supplemented with 0.5 % FBS). Under low serum conditions, the 
cells showed more intense staining at the plasma membrane compared to the rest of 
the cytoplasm (Fig 3. 12). The nucleus showed the same staining level as the controls 
suggesting that there was no detectable amount of ILK in the nucleus of HTR8-
SVneo cells but remarkably high levels of detection around the nucleus. 
To examine whether or not ILK expression was comparable in the trophoblast 
derived cell line to other invasive cells, the relative amount of ILK expression was 
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Figure 3.11 pAKT expression in human placenta. These representative pictures of 
week (w) 9 and w14 placentas show that pAKT is expressed in human placenta in the 
same areas where ILK is expressed, the villous cytotrophoblast layer (CT) in the 
floating villi and in the extravillous cytotrophoblasts (EVT). The detection of pAKT 
was much lower in the syncytiotrophoblast where lLK was almost undetectable. ST, 
syncytiotrophoblast; S, stroma; Control: non-specific mouse IgG control. Scale bar, 
50 )lm. 
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Figure 3.12 ILK expression in HTR8-SVneo cells under low serum conditions. 
Cells were grown on coverslips in RPMI 1640 media supplemented with 0.5 % FBS 
for 24 h, then they were fixed and stained with an antibody raised against ILK or a 
non-specific mouse IgG control. The cells showed positive immunostaining for ILK 
in the cytoplasm with a stronger signal on the plasma membrane and around the 
nuclear membrane. At the plasma membrane ILK immunostaining suggested that it 
could be associated with focal adhesions (white anows). Scale bar, 25 J.tm. 
11 7 
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invasive such as cancer cells. Comparable levels of ILK were detected in HTR8-
SVneo and 3T3 fibroblasts, mouse mammary epithelial (MME), cervical cancer 
(HeLa), and choriocarcinoma-derived cells lines, JEG-3 and JAR (Fig. 3.13). 
3.2.1 Migration Assay 
The literature indicates that ILK has a role in migration of different cells such 
as central nervous system cells (Belvindrah et al 2006), mammary epithelial cells 
(Filipenko et al 2005) and intestinal epithelial cells (Kim et al 2008) among others. 
Since in human placenta ILK was localized to those cells that express ITGAS and are 
migratory, the role of ILK in migration was studied by transiently transfecting 
trophoblast derived cells, HTR8-SVneo, with different ILK containing plasmids 
(pEGFP-ILK-WT, pEGFP-ILK-E359K) or an empty vector (pEGFP) and performing 
migration assays. EGFP-ILK-E359K is an EGFP-fusion protein that has a mutation 
that results in a dominant negative fonn of ILK (Delcommenne et al 1998; Dedhar et 
al 1999). 
First the expression of the plasmids in HTR8-SVneo cells was confim1ed by 
immunoblot analysis. Transient transfection of pEGFP-ILK-WT and pEGFP-ILK-
E359K for 48 h in HTR8-SVneo cells resulted in significant detection of the ILK-
EGFP fusion proteins on immunoblots at the expected molecular weight of 80 kDa, 
unlike HTR8-SVneo cells containing empty pEGFP vector, thus confinning the 
presence of the expression vectors in the cells (Fig 3.14). Furthermore, the 
immunoblot analysis demonstrated that detection levels ofEGFP-ILK-WT and 
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Fig 3.13 ILK protein expression in different invasive cell lines. A representative 
ILK immunoblot of the protein extracts of3T3, JEG 3, JAR, HTR8-SVneo, HeLa and 
MME cells is shown. Jurkat cell lysates of cells pre-treated (pAKT -) and untreated 
(pAKT +) with a PI3K inhibitor (LY294002) were included as negative and positive 
controls, respectively. ~-Actin (ACTB) was used as the loading control. The 
experiment was repeated twice (n=2). 
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Figure 3.14 Immunoblot of protein extracts from HTRS-SVneo cells transiently 
transfected with the different ILK plasmids. Immunoblots were probed with ILK-
specific antisera to detect endogenous ILK as well as EGFP-ILK fusion proteins. 
Transient expression of EGFP-ILK-WT and EGFP-ILK-E359K for 48 h in HTR8-
SVneo cells subsequently resulted in significant detection of these fus ion proteins on 
immunoblots at the expected molecular weight of 80 kDa. ~-Actin (ACTB) was used 
as the loading control. 
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EGFP-ILK-E359K fusion proteins in the respective cell lysates were similar and did 
not affect the expression of the endogenous ILK. Routinely transfection efficiencies 
of ~40-50% were observed microscopically. If the efficiency appeared to be markedly 
lower, the cells were discarded and a new experiment was performed. There were no 
significant differences observed in the transfection efficiency of the cells with the 
three plasmids. A representative flow cytometry analysis also verified that the 
efficiency of the transient transfection was ~40% (Fig 3 .15). The analysis was 
performed by Mrs. Kate Williams at the Electron Microscopy/Flow Cytometry Unit, 
Memorial University of Newfoundland. It is important to note that even though the 
transfection efficiency observed was similar in all experiments with the different ILK 
constructs, the intensity of the fluorescent signal was lower in the ILK-WT and the 
ILK-E359K-expressing cells when compared to the EGFP transfected cells. This may 
be a result of greater amounts of EGFP being produced in cells transfected with the 
empty vector compared to the production of larger EGFP-fusion proteins, which 
could be rate-limiting, upon transfection with the ILK-containing vectors. 
When the migration assays were performed over a 24 h period, transient 
expression of dominant negative pEGFP-lLK-E359K in HTR8-SYneo cells 
dramatically reduced the migration of these EGFP-labeled cells into wounds 
compared to cells expressing pEGFP-ILK-WT or pEGFP vector itself (Fig 3.16 and 
3.17; one-way ANOV A, P < 0.05). 
MTT viability assays demonstrated that the observed reduction in cell 
migration of HTR8-SVneo cells expressing pEGFP-ILK-E359K was attributable to 
the effects of dominant negative ILK expression, because these cells did not display 
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Figure 3.15 Flow cytometry of cells transiently transfected with pEGFP. a) 
Acquisition dot plot showing population of cells gated (region Rl). b) Acquisition 
histogram of the cells within Rl showing that 40 % of the cells were expressing 
EGFP. The number of cells is shown in the vertical axis and the intensity of the green 
fluorescence in the X-axis. This experiment confirmed that the efficiency for the 
transient transfection was 40 % (M 1 ). 
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Figure 3.16 Migration assay on uncoated surface. Transient overexpress10n of 
pEGFP-ILK-E359K in HTR8-SVneo cells dramatically inhibits cell migration. Phase 
contrast and corresponding fluorescent images of EGFP from wound assays with 
HTR8-SVneo cells transiently overexpressing the EGFP-ILK fusion proteins are 
shown. HTR8-SVneo cells were transiently transfected with either pEGFP (empty 
vector; EGFP) or pEGFP vector containing wild-type (WT) ILK or dominant 
negative (E359K) ILK. Following creation of a wound with a pipette tip, the wound 
area was photographed (0 h). Cells were grown for 24 h in low serum conditions. 
Wounds were then photographed (24 h) and the number of EGFP-positive cells in the 
wound area counted relative to total cells in the wound. Yellow bars indicate the 
position of the wound in the monolayer. Scale bar, 100 11111 . The experiment was 
repeated three times and conducted in triplicate (n=3). 
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Figure 3.17 Quantitative analysis of wound assays with HTRS-SVneo cells 
transiently overexpressing EGFP-ILK fusion proteins. The number of EGFP 
expressing cells were counted in each photographed wound area and expressed 
relative to the total number of cells present in that wound area. Transient 
overexpression of dominant negative ILK-E359K (E359K) dramatically inhibited cell 
migration into the wound (n=3; ANOVA, P < 0.05; Tukey-Kramer post-test) 
compared to cells overexpressing wild-type ILK (WT) or empty vector (EGFP). 
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any impaired viability as a result of pEGFP-ILK-E359K expression compared to 
pEGFP-ILK-WT or pEGFP- expressing cells (Fig. 3.18). 
It is well known that the proteins of the extracellular matrix (ECM) regulate 
the integrin signaling pathway (Hynes 1992; Assoian and Marcantonio 1997; Hynes 
2002). To test if the cells transfected with the dominant negative fonn of ILK were 
unable to migrate because there was no signal from the ECM, different matrices such 
as collagen, laminin and fibronectin were used to coat the slides on which the 
migration assays were performed. The experiments were performed in the same way 
as described above. Fewer ILK-E359K expressing cells were observed to migrate on 
the different matrices when compared with EGFP expressing cells (Fig 3.1 9-3.21). 
These results were consistent with the previous migration assay experiment on 
uncoated coverslips (Fig 3.16) indicating that the migration pattern of HTR8-SVneo 
cells transfected with dominant negative ILK was not due to the lack of ECM. 
Attempts to detem1ine if AKT phosphorylation was affected when the cells 
were transiently transfected with pEGFP-ILK-WT, pEGFP-ILK-E359K or pEGFP 
empty vector resulted in no evident effect of ILK fusion proteins on AKT 
phosphorylation (Fig 3.22). 
3.2.2 ILK and Actin Organization 
In order to determine what mechanisms might be involved in the regulation of 
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Figure 3.18 MTT assays. Transient overexpresswn of dominant negative ILK-
E359K (E359K) or wildtype ILK (WT) in HTR8-SVneo cells did not significantly 
decrease cell viability/proliferation relative to HTR8-SVneo cells overexpressing 
EGFP. Columns represent averages ± SEM (one way ANOVA, P < 0.05; Tukey-
Kramer post-test). 
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Figure 3.19 Migration assay on collagen. HTR8-SVneo cells were cultured on 
collagen-coated coverslips to confluency. HTR8-SVneo cells were transiently 
transfected with either pEGFP (empty vector; EGFP) or pEGFP vector containing 
dominant negative (E359K) ILK. Twenty four hours after creation of a wound with a 
pipette tip, the cells were photographed. Phase contrast and corresponding fluorescent 
images of EGFP from wound assays with HTR8-SVneo cells transiently 
overexpressing the EGFP or EGFP-ILK-E359K proteins are shown. Fewer HTR8-
SVneo cells migrated into the wound when they were transiently transfected with 
dominant negative pEGFP-ILK-E359K compared to cells transiently transfected with 
EGFP empty vector. Vertical bars indicate the position of the wound in the 
monolayer. The experiments were done in triplicate. Scale bars, 100 11m. 
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Figure 3.20 Migration assay on fibronectin. HTR8-SVneo cells were cultured on 
fibronectin coated coverslips to confluency. HTR8-SYneo cells were transiently 
transfected with either pEGFP (empty vector; EGFP) or pEGFP vector containing 
dominant negative (E359K) ILK. Twenty four hours after creation of a wound with a 
pipette tip, the cells were photographed.. Phase contrast and corresponding 
fluorescent images of EGFP from wound assays with HTR8-SVneo cells transiently 
overexpressing EGFP or EGFP-ILK-E395K proteins are shown. Fewer HTR8-SYneo 
cells migrated into the wound when they were transiently transfected with dominant 
negative pEGFP-ILK-E359K compared to cells transiently transfected with EGFP 
empty vector. Vertical bars indicate the position of the wound in the monolayer. The 
experiment was done in triplicate. Scale bar, 100 flm. 
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Figure 3.21 Migration assay on laminin. HTR8-SVneo cells were cultured on 
laminin-coated coverslips to confluency. HTR8-SVneo cells were transiently 
transfected with either pEGFP (empty vector; EGFP) or pEGFP vector containing 
dominant negative (E359K) ILK. Twenty four hours after creation of a wound with a 
pipette tip, the cells were photographed. Phase contrast and corresponding fluorescent 
images of EGFP from wound assays with HTR8-SVneo cells transiently 
overexpressing EGFP or EGFP-ILK-E359K proteins are shown. Fewer HTR8-SVneo 
cells migrated into the wound when they were transiently transfected with dominant 
negative pEGFP-ILK-E359K compared to cells transiently transfected with EGFP 
empty vector. Vertical bars indicate the position of the wound in the monolayer. The 
experiments were done in triplicate. Scale bars, 100 ).1m. 
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Figure 3.22 pAKT expression in HTR8-SVneo cells transiently transfected with 
ILK constructs. This representative blot shows that AKT is similarly phosphorylated 
in cells transfected with dominant negative pEGFP-ILK-E359K (ILK-E395K) when 
compared to wild type pEGFP-ILK-WT (ILK-WT) and pEGFP (EGFP) transfected 
cells. ILK expression is comparable in the three groups of cells. 
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migration by ILK, HTR8-SVneo cells were transiently transfected with dominant 
negative ILK-E359K, EGFP empty vector and ILK-WT and stained with anti-ILK 
and anti-EGFP antibodies to detem1ine if the EGFP-fusion proteins were localized to 
FAs. The cells transfected with ILK-WT fom1ed evident FAs with a high number of 
them colocalized with endogenous ILK at the plasma membrane (Fig 3.23 centre 
panels) while the cells transfected with the dominant negati ve JLK-E359K showed a 
homogeneous staining similar to the cells transfected with the pEGFP empty vector 
(Fig 3.23 top and lower panels). 
To further detennine if the organization of the cytoskeleton was affected by 
the disruption of ILK function, cells transiently transfected with the different ILK 
containing expression plasmids were stained with rhodamine phalloidin. Rhodamine 
phalloidin is a fluorescent derivative of a toxin produced by the mushroom Amanita 
phal/oides that binds to fibrillar actin in the cytoplasm of the cells by intercalating 
between the actin subunits (Wulf et al. 1979). The staining of the fibrillar actin in the 
cells transiently transfected with EGFP empty vector showed nice elongated actin 
filaments and so did the cells transfected with EGFP-ILK-WT (Fig 3.24). ln contrast, 
the expression of dominant negative ILK-E359K altered fibrillar actin structure. This 
was evident by the short and disorganized fibrillar actin in those cells that transiently 
expressed the dominant negative form of ILK (Fig 3.24). 
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Figure 3.23 ILK and focal adhesions. HTR8-SVneo cells were transiently 
transfected with EGFP-empty vector, dominant negative pEGFP-ILK-E359K, and 
pEGFP-ILK-WT. After 48 h post transfection the cells were fixed and double 
immunostained with antisera specific for ILK (red) and EGFP (green). In addition, 
the panels on the right show DAPI stained nuclei (blue). The EGFP-ILK-WT is able 
to localize to focal adhesions (white arrows) in contrast to the EGFP-ILK-E359K. 
Scale bar, 50 ~-tm . 
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Figure 3.24 ILK and actin organization. The staining of the fibrillar actin in HTR8-
SVneo cells transiently transfected with EGFP empty vector (a, b) showed nice 
elongated fibrillar actin (long arrows) and so did the cells transfected with EGFP-
ILK-WT ( c, d). In contrast, the cells transiently transfected with dominant negative 
ILK-E359K displayed short and disorganized fibrillar actin (arrowheads) (e, f). Scale 
bar, 25 J .. un. 
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CHAPTER4 
ILK IS EXPRESSED IN THE MOUSE PLACENTA AND 
REGULATES CELL INVASION IN VITRO. 
4.1 Experimental Rationale 
Mouse and human placenta have analogous structures that express 
homologous genes such as Mash2 (homolog to human HASH2) (Alders et al. 1997; 
Janatpour et al. 1999), Hand] (homolog to human HANDJ) (Knofler et al. 1998a), 
and Gem] (homolog to human GCMJ) (Janatpour et al. 1999; Nait-Oumesmar et a!. 
2000) but the expression of Ilk in mouse placenta has never been reported . Since the 
results (see Chapter 3) suggested that ILK protein is involved in regulation of 
trophoblast migration and the pattern of expression in human placenta showed that 
ILK is expressed in those cells that are becoming invasive, there is a need to explore 
ILK expression in the mouse placenta to determine if it is expressed in trophoblast 
lineages analogous to invasive human trophoblast. For that purpose mouse placentas 
were collected at different timepoints during gestation, fixed and studied for spatio-
temporal expression of ILK by immunohistochemistry. The long tenn goal is to test if 
it is feasible to create a conditional knockout for Ilk in the invasive mouse placental 
lineages. 
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4.2 ILK Expression in the Mouse Placenta 
The mouse placenta has a complex structure formed by three layers: the 
labyrinth consisting of chorionic villi and maternal capillaries, the spongiotrophoblast 
layer (also called the junctional zone) and the trophoblast giant cell layer surrounded 
by the maternal decidua (Fig 1.4). To identify the different cell types in each layer 
immunohistochemistry and immunofluorescence analyses uti lizing a combination of 
several trophoblast layer-specific markers were used. Antisera raised against 
Connexin (Cx) 26 was used to identify syncytiotrophoblast (Pauken and Lo 1995), Cx 
31 to confirm the identification of ectoplacental cone (Grummer et al. 1996), 
spongiotrophoblast and glycogen cells (GlyC) (Coan et al. 2006); and laminin as a 
marker of fetal capillaries in the labyrinth (Natale 2006). Periodic Acid-Schiff 
staining was also used to identify the GlyC in the mouse placenta (Natale 2006). 
4.2.1. Developmental Period between E7.5 - E10.5 
The precursors of the labyrinth and the spongiotrophoblast layers are found in 
the ectoplacental cone before E8.5 (Cross et al. 2003a) but the embryo is not 
completely implanted until E5.5 so samples were collected from E7.5 to E17.5. 
lLK was found in the ectoplacental cone at E7.5 (Fig 4. 1 ). This was confirmed 
by the co-localization with Cx3 1 (Grummer et al. 1996), a marker for ectoplacental 
cone at this stage of embryonic development. At E7.5 lLK staining was present 
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Figure 4.1 ILK is expressed in the ectoplacental cone at E7.5. Shown are 
representative photographs of ILK and Cx31 immunostaining demonstrating co-
localization in the ectoplacental cone (EPC). The figures on the left show a complete 
embryo with the ectoplacental cone surrounded by decidua. The right panels show a 
magnified area of the ectoplacental cone with clear ILK or Cx31 immunostaining in 
the membrane associated areas of the cells. Both the combined pictures also show the 
nuclei stained with DAPI in blue. Em, embryo; Dec, decidua; EPC, ectoplacental 
cone. Observed magnification: the panels on the left are at 200X (scale bar, 100 1-lm), 
the panels on the right are at 400X (scale bars, 50 ~tm). The smaller panels at the 
bottom of the figure are representative images of the lgG controls for mouse and 
rabbit secondary antibodies. 
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in the ectoplacental cone cells where it seemed to be highly expressed at membrane-
associated regions. Ectoplacental cone cells that express Cx31 are invasive (Grummer 
et al. 1996), suggesting that ILK, which is present in those cells, might play a role in 
invasion at this stage of development. 
From E8.5 to E 10.5 the different layers were identified by morphology and 
localization relative to the embryo. At E8.5 chorionic villi begin to form, immediately 
after choriallantoic attachment (Cross et al 2003a) and ILK was readily expressed in 
cells of the embryo as well as in cells of the ectoplacental cone that seemed to be 
differentiating into labyrinth (Fig 4.2). At E9.5 ILK was localized to the developing 
labyrinth (Fig 4.2) and also in the trophoblast giant cells (TGCs) that can be identified 
by their large nuclei at the periphery of the placenta. At E10.5, ILK immunostaining 
was clearly less intense in the labyrinth and spongiotrophoblast layers compared to 
the very prominent detection in the cytoplasm and nuclei of TGCs. Only a few cells 
expressed ILK in the decidua at E7.5. ln contrast, at E8.5 and onwards, ILK was 
expressed in the majority of the decidua cells. 
4.2.2 Developmental Period between E12.5- E17.5 
Unlike the human placenta, where the definitive structure of the placenta 
becomes apparent as early as day 21 of gestation, the mouse placenta does not 
achieve its definitive structure until halfway through gestation. By E 11.5 the labyrinth 
is completely fonned but GlyC do not appear within the spongiotrophoblast layer 
until about E12.5 (Hemberger and Cross 2001). 
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Figure 4.2 ILK is expressed early in gestation in the mouse placenta. Shown are 
representative pictures from embryonic day E7.5 to El0.5 demonstrating ILK 
immunostaining in the ectoplacental cone (EPC) at E7.5 and E8.5 and in the 
chorionic plate where the labyrinth starts to develop, at E9.5. At El0.5 the labyrinth, 
the spongiotrophoblast (Sp) and the trophoblast giant cells (TGC) also show 
expression of ILK. E, Embryo; EPC, ectoplacental cone; Dec, decidua; Lab, 
labyrinth. lgG control is shown in the panel insert. Scale bar, 100 ).till. 
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From El2.5 to El7.5, ILK was consistently localized to the labyrinth, 
junctional zone and TGCs (Fig 4.3 and 4.4). ILK was most highly detectable in 
TGCs, GlyC and labyrinthine trophoblast. ILK was also highly detectable in some 
spongiotrophoblast and TGC nuclei . In the following figures (Fig 4.5-4.7) each cell 
type is identified with the proper markers. During these developmental periods in the 
labyrinth, ILK was present in trophoblast cells and in endothelial cells lining the fetal 
capillaries of the labyrinth. To verify these initial observations, the expression of 
laminin, a marker of fetal capillary endothelial cell basement membranes (Coan et al. 
2006), and the gap junction protein Cx 26 that is expressed in syncytiotrophoblast 
(Pauken and Lo 1995) were studied at E l2.5 and El5 .5 by immunofluorescence 
analysis (Fig 4.5 and Fig 4.6). ILK was highly expressed in fetal capillary endothelial 
cells that expressed laminin in their basement membranes (Fig 4 .5). The fetal 
capillaries were also identified on occasion due to the presence of nucleated red blood 
cells in the lumen of the capillaries. In addition, ILK was expressed in the mouse 
syncytiotrophoblast layer that was identified by the expression of Cx 26 (Fig 4.6). At 
the junctional zone, between E l2.5 and El7.5 , ILK was expressed in the 
spongiotrophoblast and GlyC that are analogous to the EVT cells of the human 
placenta (Fig 4.4). To confirm in which cells of the junctional zone ILK was 
expressed, spongiotrophoblast and GlyC cell s were identified by comparing tissue 
sections immunostained for ILK with adjacent tissue sections stained with Periodi c 
Acid-Schiff which detects glycogen stored in the GlyC (Fig. 4 .7 top two panels). 
Furthennore, ILK localization to spongiotrophoblast and GlyC was confirmed by 
performing co-immunolocalization analysis ofiLK and Cx 31 , a marker of 
154 
Figure 4.3 ILK is expressed in the three layers of the mouse placenta from E12.5 
to E13.5. Immunohistochemical detection of ILK in mouse placenta showing that 
ILK is expressed in the labyrinth, the spongiotrophoblast layer and the trophoblast 
giant cells at all of the time points studied. Lab, labyrinth; Sp, spongiotrophoblast; 
GlyC, Glycogen cells; TGC, trophoblast giant cells, IgG, isotype matched lgG control 
from the same species as the primary antiserum used. IgG controls are shown in the 
panel inserts. Scale bars: 50 f.!m. 
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Figure 4.4 ILK is expressed in the three layers of the mouse placenta from El5.5 
to E17 .5. Immunohistochemical detection of ILK in mouse placenta showing that 
ILK is expressed in the labyrinth, the spongiotrophoblast layer and the trophoblast 
giant cells in all the time point studied. Lab, labyrinth; Sp, spongiotrophoblast; GlyC, 
glycogen cells; TGC, trophoblast giant cells (indicated by 31Towheads); IgG, isotype 
matched IgG control from the same species as the primary antiserum used. IgG 
controls are shown in the panel inserts. Scale bars, 50 )-lm. 
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Figure 4.5 ILK is expressed in the mouse placental labyrinth. In this 
representative image of an E 12.5 mouse placenta, ILK (in red) localized adjacent to 
laminin (in green) that was used here as a marker of the basement membrane of the 
mouse fetal capillary endothelial cells. Nuclei were stained with DAPI (in blue). The 
bottom right panel includes a cartoon showing that in the mouse placenta the 
syncytiotrophoblast is in contact with the fetal endothelial cells. FC, fetal capillary; 
MC, matemal capillary; IgG, isotype matched IgG control from the same species as 
the primary antiserum used. Scale bar, 50 J-lm. 
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Adapted from Physiology 20: 180-193, 2005 
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Figure 4.6 ILK is expressed in the syncytiotrophoblast. Representative image of 
El5 .5 mouse placenta showing that ILK (in red) is expressed in the 
syncytiotrophoblast cells. Cx26 (in green) is a marker for syncytiotrophoblast in the 
mouse placenta. Nuclei were stained with DAPI (in blue). Arrows are pointing to the 
areas where it is evident that ILK and Cx26 are in the same cells. Cx26, connexin 26; 
IgG control, isotype matched IgG control from the same species as the primary 
antiserum used; Scale bars, 50 !1m. 
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Figure 4.7 ILK is expressed in the Glycogen cells of the junctional zone. Top 
panels: Representative adjacent tissue sections from E 15.5 mouse placenta showing 
ILK expression and Periodic Acid-Schiff (PAS) staining. ILK is present in the same 
Glycogen cells that stain with PAS (dark purple). Lower panels: double 
immunofluorescence of ILK (red) and Cx31 (green) demonstrating that ILK is 
expressed in the glycogen cells. IgG control is shown in the panel insert. GlyC, 
glycogen cells; SpT, spongiotrophoblast layer; TGC, trophoblast giant cells. Scale 
bars, top panels 50 ).lm; lower panels 25 )liD. 
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spongiotrophoblast cells and GlyC during this period of pregnancy (Fig 4.7 three 
bottom panels) 
Throughout the gestation times studied, ILK was also found in secondary 
TGC (Fig. 4.4; right panels, top to bottom). The pattern of staining of the TGC was 
not equal in all the cells, some expressed ILK mainly in the cytoplasm while others 
displayed strong expression in the cell nuclei. The TGCs were easily identified by 
their location in the placenta and their readily visible large nuclei. 
4.3 ILK Regulates Trophoblast Invasion In Vitro 
Since ILK was expressed in human EVT (Fig 3.5), regulated trophoblast 
migration (Fig 3.16 and 3.17), and was detected in mouse invasive GlyC and TGCs 
(Fig 4.4), the role of ILK in the process of human trophoblast invasion was studied in 
vitro utilizing the HTR-SVneo trophoblast cell line originally derived from human 
EVT explants (Graham eta!. 1993). Human HTR8-SVneo cells become invasive on 
Matrigel after incubating them under low serum conditions (Graham et al. 1993, 
Kilburn et a!. 2000). HTR8-SVneo cells transiently expressing dominant negative 
pEGFP-ILK-E359K were markedly inhibited in their abil ity to invade through 
Matrigel (Fig 4.8; P<0.05) compared to control cells transfected with an empty 
pEGFP vector. When HTR8-SVneo cells transiently expressed a constitutively active 
form of ILK, pEGFP-ILK-S343D, invasion of these cells was significantly increased 
compared to the control group and pEGFP-ILK-E359K expressing cel ls (P<0.05). No 
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Figure 4.8 Quantitative analysis of the invasion assays with HTR8-SVneo cells 
transiently overexpressing EGFP-ILK fusion proteins. The number of EGFP-
expressing cells were counted on the underside of each membrane and expressed 
relative to the total number of transfected cells present in the control. Transient 
overexpression of pEGFP-ILK-E359K significantly inhibited cell invasion through 
the Matrigel (ANOVA, P < 0.05; Neuman-Keuls post-test) compared to cells 
overexpressing the control vector (pEGFP) or pEGFP-ILK-WT or pEGFP-ILK-
S343D. Transient overexpression ofpEGFP-ILK-S343D resulted in an increase in the 
numbers of cells that invaded the Matrigel compared to control cells (* denotes P < 
0.05; n=3). 
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significant difference in invasive capability was found in cells transfected with 
pEGFP-ILK-WT compared to pEGFP alone. 
In order to study if the proliferation of the cells was affected after the transient 
transfection with the different pEGFP-ILK plasmids (pEGFP, pEGFP-ILK-WT, 
pEGFPILK-E359K, pEGFP-ILK-S343D) MTT assays were performed. There were 
no significant differences in the proliferation of cells transfected with the pEGFP 
vector control when compared to cells transfected with pEGFP-ILK-WT and pEGFP-
ILK-S343D (Fig 4.9). In contrast, cells overexpressing dominant negative pEGFP-
ILK-E359K showed increased cell proliferation over a period of 72 h in low serum 
conditions compared to control cells. (P< 0.05 ; Neuman-Keuls post-test, n=3). 
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Figure 4.9 MTT proliferation assays. Transient overexpression of constitutively 
active pEGFP-ILK-S343D (ILK-S343D) or pEGFP-ILK-WT (ILK-WT) in HTR8-
SVneo cells did not significantly decrease cell viability/proliferation relative to 
control HTR8-SVneo cells overexpressing EGFP alone (EGFP) or non-transfected 
(NoT). In contrast, cells overexpressing dominant negative pEGFP-ILK-E359K (ILK-
E359K) showed increased cel l proliferation over a period of 72 h in low serum 
conditions compared to EGFP control cells. (ANOVA, P < 0.05 ; Neuman-Keuls post-
test). * denotes significant difference compared to control, P< 0.05 (n=3) 
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CHAPTERS 
EFFECT OF OXYGEN ON ILK EXPRESSION AND 
ACTIVITY 
5.1 Experimental Rationale 
Early human placental development takes place in a low oxygen environment 
(Rodesch et al. 1992). It is not until the end of the first trimester that there is a 
significant increase in oxygen tension from about 18 mmHg (3 %) to 60 mmHg (8 %) 
coinciding with the establishment of the maternal blood flow into the intervillous 
space (Rodesch et al. 1992). These changes in oxygen tension are critical for nom1al 
placental development as trophoblasts proliferate extensively under low oxygen and 
do not differentiate into invasive cells until the oxygen tension rises above 60 mmHg 
(Genbacev et al. 1997; Caniggia et al. 2000a). The previous results described in 
Chapters 3 and 4 indicated that ILK was playing a role in migration and invasion of 
trophoblast cells. Scandurro et al. (2001) showed, based on computer analysis of the 
published iLK gene sequence (GenBank no. AJ404847), that at least four potential 
consensus HIF binding sites (RCGTG) cal led hypoxia responsive elements (HRE) 
were identified in the ILK gene. The HREs found within ILK lie 5' to exon 1 as well 
as between exon 1 and 2 (nucleotides 1042-7, 1107-12, 3526-3 1, 3533-8). 
Fmihermore, when HepB3, human hepatocellular carcinoma cell s were cultured 
under I % oxygen tension, ILK expression was increased (Scandurro et al. 2001; 
Abboud et al. 2007). Considering these data and the previous results in Chapters 3 
171 
and 4, the effect of low oxygen tension on ILK protein and gene expression was 
studied in vitro with HTR8-SVneo trophoblast cells and chorionic villous explant 
cultures grown at different oxygen tensions. 
5.2 ILK mRNA Expression Increases Transiently upon Exposure to a 
Low Oxygen Environment. 
To analyze the effect of oxygen tension on ILK gene expressiOn m human 
trophoblast cells, HTR8-SVneo cells were cultured under low oxygen condi tions (3 % 
0 2) and under normal conditions (20 % 0 2) . ILK mRNA levels were studied by qRT-
PCR. First iLK mRNA levels at 3 % 0 2 were compared to 20 % 0 2 after 24 h of 
incubation of HTR8-SVneo cells in the respective 0 2 environment. The level of ILK 
expression was normalized to the expression of the I 8S ribosomal gene that was 
unaffected by oxygen tension. The amplification effici encies of the target (ILK) and 
reference gene (1 8S) were similar as calculated by a calibration dilution curve for each 
gene. There was no significant difference in the expression of ILK mRNA in HTR8-
SVneo cells grown under low oxygen compared to iLK mRNA expression in cells 
grown at normal oxygen tension over a period of 24 h (Fig 5. 1 ). ILK mRNA levels 
were further detem1ined at different time points of exposure to 3 % 0 2 and 20% 0 2 
tension (30 min, 3 h, 6 h, 12 h and 24 h). There was a transient but significant increase 
(Fig 5.2) in ILK expression in HTR8-SVneo cells cultured under 3% 0 2 at 6 h 
compared to 30 min . ILK expression then decreased so by 24 h of incubation the level 
of ILK mRNA was already lower than the corresponding level measured at 20 % 0 2. 
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Figure 5.1 ILK mRNA levels in HTR8-SVneo cells cultured at 3 % vs 20 % 02. 
Comparable levels of ILK mRNA are detected at 3 %and 20 % 0 2 tensions. Cells were 
cultured under the two oxygen conditions for 24 h and RNA extraction performed as 
described in Materials and Methods. ILK expression was studied by qRT-PCR 
utilizing 18S mRNA as a reference gene. The relative amount of ILK mRNA was 
calculated using the L}Ct method. ILK mRNA expression in HTR8-SVneo cells did 
not show a significant change at 3 % 0 2 when compared to cells cultured at 20% 0 2. 
(ANOVA, Neumann-Keuls post-test, P< 0.05; n=3). This graph shows the results of 
two experiments each with three replicates. 
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Figure 5.2 ILK mRNA expression in HTR8-SVneo cells increases transiently 
upon exposure to 3% 0 2 • Cells were cultured under 3 % 0 2 for 30 min, 3 h, 6 h, 12 
h and 24 h and compared with cells cultured for 24 h at 20 % 0 2. After each period of 
time cells were lysed, RNA extracted, and mRNA expression of ILK was studied by 
qRT-PCR. There was a transient but significant increase in ILK expression in HTR8-
SVneo cells cultured under 3% 0 2 at 6 h compared to 30 min. JBS rRNA was used as 
the reference gene and the relative amount of ILK mRNA was calcu lated using the 
~~Ct method.(*), significantly different form the cells cultured for 24 hat 20 % Oz 
(A OVA, Neumann-Keuls post-test, P<O.OS ; n=3). 
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5.3 ILK Protein Expression is Unaltered in Response to a Low 
Oxygen Environment 
The level of ILK protein was studied in HTR8-SVneo cells exposed to 
hypoxia mimic conditions and compared to nom1al cell culture conditions. 
Additionally, ILK protein was measured in cells directly exposed to low oxygen 
tension. To mimic hypoxic conditions, cobalt chloride (CoCh, 50 j..!M or 100 j..!M) or 
desferrioxamine (DFX, 5 j..!M or 10 j..!M) were added to the regular cell cultivation 
media. Cobalt can substitute for ferrous iron and becomes incorporated into newly 
synthesized heme moieties while DFX is an iron chelator (Keberle 1964). In both 
cases, the heme group is maintained in a deoxy state mimicking a low oxygen 
environment to the cell, even in the presence of oxygen (Gong et al. 1998; De Marco 
and Caniggia 2002). Immunoblot analysis was used to study the level of ILK protein 
in response to the hypoxic conditions. HIF-1 a degradation is inhibited in low oxygen 
tensions so it was used as a marker of exposure to hypoxia (Wang and Semenza 1995; 
Wang eta!. 1995). In normal cells, in the presence of oxygen, HIF -1 a is hydroxylated 
and degraded by the proteasome system so it is virtually undetectable (Salceda and 
Caro 1997; Ivan eta!. 2001) . When the HTR8-SVneo cells were exposed to different 
concentrations of CoCh (50 ~LM or 100 ~LM) or DFX (5 j..!M or 10 j..!M) HIF-1 a was 
detectable while it was not evident in control cells exposed neither to CoCh nor DFX. 
As shown in Fig 5.3 there was no significant difference in the level of 
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Figure 5.3 ILK protein expression does not change significantly in HTR8-SVneo 
cells grown under hypoxia mimic conditions. HTR8-SVneo cells were cultured in 
RPMI 1640 media, containing 10% FBS and 1% Pen /Strep, for 24 hat 37 °C in the 
presence of either cobalt chloride (CoCh, 50 or 100 J.lM) or desferrioxamine (DFX, 5 
or 10 J.lM) to create hypoxia mimic conditions. Cells were then lysed and analyzed for 
expression of ILK, HlFla, AKT and pAKT by immunoblot analysis. The 
immunoblots shown are representative of three experiments. 
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ILK protein in HTR8-SVneo cells grown under hypoxia mimic conditions compared 
to normal conditions (20 % 0 2). HIF -1 a was only detected in cells that had been 
cultivated in media containing CoCh or DFX. Total AKT and pAKT protein levels 
were analysed in order to test indirectly if ILK kinase activity was affected by the 
hypoxia mimic conditions, as AKT is a well-known ILK substrate (Delcommetm e et 
al. 1998; Persad et al. 2000) . pAKT was detectable in cells exposed to hypoxia mimic 
conditions but it was not detectable at 20 % 0 2 (Fig 5.3) with no significant changes 
in total AKT levels, suggesting that there was an increase in AKT phosphorylation in 
HTR8-SVneo cells in response to low 0 2. 
The effect of hypoxia on ILK protein levels was also studied by cultivating the 
cells in low 0 2 tension conditions instead of mimicking low 0 2 with CoCh or DFX. 
For thi s purpose the cells were placed in a hennetic culture chamber system, within a 
37 oc C02 tissue culture incubator as described in Materials and Methods. HTR8-
SYneo cells were also grown in 20 % 0 2 as a control to compare with cells cultivated 
in the 3 % 0 2 environment. The level of HIF -1 a was used as an indicator of cells 
exposed to hypoxic conditions. Cells were incubated in low 0 2 conditions (3 % 0 2) 
for 30 min, 3 h, 6 h, 12 h and 24 h and ILK expression was studied by immunoblot 
analysis. There was no significant change in the level of ILK at any time point of low 
0 2 exposure when compared to HTR8-SYneo cells cultured at 20 % 0 2 for 24 h (Fig 
5.4), despite a clear upregulation of HIF-1 a expression by 6 h of exposure to 3 % 0 2 
(Fig 5.4). 
As phosphorylation of AKT was increased under hypoxia mimic conditions 
(Fig 5.3), the importance of ILK signalling in this AKT phosphorylation under a low 
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Figure 5.4 ILK protein levels do not change in HTR8-SVneo cells in response to 
a low 0 2 environment. HTR8-SVneo cells were exposed to 3 % 02 for 30 min, 3, 6, 
12 and 24 h. A control group ofHTR8-SVneo cells were incubated at 20 % 0 2 for 24 
h. At the end of each period of time the cells were lysed and ILK protein expression 
was studied by immunoblot analysis. This representative blot of three experiments 
shows detection of ILK on immunoblots at around 55 kDa. HIF -1 a was used as a 
marker of the hypoxia exposure while ~-actin (ACTB) was used as the loading 
control. 
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oxygen environment was determined by transfecting HTR8-SVneo cells with pEGFP, 
pEGFP-ILK-E359K, or pEGFP-ILK-S343D plasmids. Cells were then incubated at 3 
% or at 20 % 0 2 for 24 h and the levels of pAKT were analyzed, by immunoblot 
analysis, in cell lysates collected from each of the conditions. There was no inhibi tion 
of AKT phosphorylation in cells transfected with the dominant negative pEGFP-lLK-
E359K, nor was there an increase in phosphorylation of AKT detected when cells 
were transfected with the constitutively active pEGFP-ILK-S343D (Fig 5.5). ILK 
showed comparable levels of expression in HTR8-SVneo cells cultivated in all the 
different environmental conditions. HlF -I a detection on immunoblots was included 
as a positive control for hypoxia exposure and was only present in those cells that 
were exposed to 3 % 0 2. 
5.4 ILK Kinase Activity In Vitro does not Change Significantly under 
Low Oxygen Environment 
The prevwus results showed that there was no detectable change in ILK 
protein expression levels when the cells were cultured under low 0 2 conditions. To 
study if ILK activity was affected by the 0 2 environment, HTR8-SVneo cells were 
cultured under nom1al and low 0 2 tensions in parallel for 24 h, lysed, and then ILK 
was immunoprecipitated for in vitro kinase assays. The first substrate that was tested 
for this assay was AKT (Cat # 14-279; Upstate). The problem encountered was that 
the substrate appeared to be undergoing phosphorylation in the IgG-matched control. 
Several trials to avoid the non-specific phosphorylation, such as adding a preclearing 
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Figure 5.5 pAKT levels in HTR8-SVneo trophoblast cells increase in 3 % 02. 
HTR8-SVneo cells were cultured in either 3 % or 20 % 0 2 for 24 h and after cell lysis 
the extracts were studied by immunoblot analysis with specific antibodies that 
recognize HIF-la, ILK, pAKT and AKT. Blots shown are representative of three 
experiments. No T, non- transfected HTR8-SVneo cells, E359K, HTR8-SVneo 
transiently transfected with the dominant negative pEGFP-lLK-E359K; S343D, 
HTR8-SVneo transiently transfected with the constitutively active pEGFP-ILK-
S343D; EGFP, HTR8-SVneo transiently transfected with pEGFP; 3 %, 3 % 0 2; 20 %, 
20 % 0 2. 
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step or increasing the number of washes between the incubations with antibodies 
failed so the substrate was changed to GSK3~, another well-known substrate of ILK 
(Delcommenne et al. 1998; Novak and Dedhar 1999; Troussard et al. 1999). As 
shown in Fig 5.6 there was no significant difference in the activity of ILK in hypoxic 
conditions compared to 20 % 0 2 (Fig 5.6) as suggested by the comparable detection 
of pGSK3 ~ in both cells exposed to 3 % and 20 % 0 2. As expected the detection of 
pGSK3~ in the different controls showed a much lower intensity. 
5.5 ILK Expression is Less Detectable in Explants Cultured at Low 
Oxygen Tensions 
A very useful model to study trophoblast differentiation is the explant culture 
of small samples of human placental chorionic vi lli. In this model, the chorionic villi 
are dissected from human placentas and cultured on Matrigel. On the Matrigel, the 
trophoblasts in the chorionic villi are able to differentiate into invasive cells, 
mimicking the in vivo situation, with the advantage that the architecture of the villi is 
conserved (Miller et al 2005). To further test if ILK expression was affected by 0 2 
tension, chorionic villi from week 7 and II of gestation were incubated on Matrigel 
for 6 days at 3 %, 8 % and 20 % 0 2 in the laboratory of Dr. Isabella Caniggia at the 
Samuel Lunenfeld Research Institute (Mt. Sinai Hospital, Toronto, Ontario). After 
fixation, tissue processing and paraffin embedding (see Chapter 2), explant tissue 
sections were studied for the expression of ILK by immunofluorescence. 
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Figure 5.6 ILK kinase activity in vitro is not affected by low 0 2 tension. HTR8-
SVneo cells were cultured at either 3 % or 20 % 0 2 for 24 h. After cells were lysed, 
ILK was immunoprecipitated with a specific antibody. ILK antibody-bead complexes 
were washed and incubated with GSK3P in the presence of ATP to study ILK kinase 
activity. The products of this reaction were studied by immunoblot analysis. As a 
control, beads were incubated with the cel l lysate in the absence of ILK antibody. 
Furthermore, an IgG control was utilized where non-specific mouse IgG, at the same 
concentration as the primary antiserum, was added to the cel l lysate in place of the 
primary antiserum. Blots shown are representative of three experiments (n=3). 
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The explants developed as expected: at 3 % 0 2 there was a lot of proliferation and no 
evidence of cell column formation as confirmed by the absence of ITGA5 (Fig 5.7). 
At 8 % and 20 % 0 2 the cells proliferated but there was already evidence of 
trophoblast cell column formation and a proportion of cells in this cell column 
expressed ITGA5 suggesting that the cells were able to differentiate into less 
proliferative but more invasive cells (Fig 5.8 and 5.9). ILK was expressed in the 
villous cytotrophoblasts of the chorionic villi at the three 0 2 tensions but it seemed, 
by the intensity of the signal, that ILK was markedly more detectable in the chorionic 
villous mesenchyme and in villous cytotrophoblast cells at 8 % and 20 % 0 2 
compared to detection at 3 % 0 2 (Fig 5.1 0). ILK expression was cytoplasmic with no 
detectable nuclear staining. In accordance with the results found in human placentas 
(Chapter 3), the syncytiotrophoblast showed practically no immunostaining with the 
anti-ILK antibody even at low 0 2 tensions. 
5.6 ILK Expression in Placentas from Preeclamptic Patients 
Although the molecular mechanisms causmg preeclampsia are not well 
understood there is general agreement that a deficient invasion of the trophoblast cells 
is present invariably in all preeclamptic placentas (Pijnenborg et a!. 1980; Pijnenborg 
1988; Pijnenborg et al. 199 1 ). Since ILK regulates trophoblast invasion (Chapter 4), it 
was hypothesized that ILK was reduced in preeclamptic patients who present 
impaired invasion of the matem al uterus by the trophoblasts. 
Placentas from preeclamptic patients (kindly provided by Dr. Isabella 
Caniggia from The Samuel Lunenfeld Institute, Toronto) (n=6) were analyzed for 
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Figure 5.7 ILK and ITGAS expression in chorionic villous explants exposed to a 
3 % 0 2 environment. Small terminal villi from human placenta were cultured on 
Matrigel in 3 % 0 2 environment for 6 days, then fixed in 4 % PF A, processed and 
paraffin embedded. The sections were then stained with anti-ILK (in red) and anti-
ITGA5 (in green) specific antibodies. ILK and ITGA5 were barely detected in the 
explants. In the bottom panel, nuclei were stained with DAPI. Scale bar, 50 f.lm. 
ITGA5, integrin a5; CT, villous cytotrophoblast, M, mesenchyme of the villous 
stroma; ST, syncytiotrophoblast. 
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Figure 5.8 ILK and ITGAS expression in chorionic villous explants exposed to 
an 8 % 0 2 environment .. Small terminal villi from human placenta were cultured on 
Matrigel in 8 % 0 2 environment for 6 days, then fixed in 4 % PF A, processed, and 
paraffin embedded. The sections were then stained the with anti -ILK (in red) and 
anti-JTGA5 antibodies (in green) specific antibodies. ln the bottom panel, nuclei were 
stained with DAPI (in blue). ITGA5, integrin a5; CT, villous cytotrophoblast; M, 
mesenchyme. Scale bar, 50 !liD. 
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Figure 5.9 ILK and ITGAS expression in chorionic villous explants exposed to a 
20 % 0 2 environment. Small terminal vi lli from human placenta were cultured on 
Matrigel in a 20 % 0 2 environment for 6 days, then fixed in 4 % PF A, processed, and 
paraffin embedded. The sections were then stained with anti-ILK (in red) and anti-
ITGA5 (in green) specific antibodies. In the bottom panel, nuclei were stained with 
DAPI. ITGA5, integrin a5; CT, vi llous cytotrophoblast; M, mesenchyme; ST, 
syncytiotrophoblast. Scale bar, 50 )lm 
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Figure 5.10 ILK detection is reduced in chorionic villous explants cultured in a 3 
% 0 2 environment. Small terminal villi from human placenta were cultured on 
Matrigel in a 3 %, 8 % and 20 % 0 2 environment for 6 days, then fixed in 4 % PF A, 
processed, and paraffin embedded. Sections of explants were incubated with mouse 
ILK-specific antibodies. ILK showed a pattem of expression similar to the pattem 
observed in normal human placenta throughout gestation, when the explant were 
exposed to 8 % and 20 % 0 2. CT, cytotrophoblast; M, mesenchyme; lgG control, 
non-specific lgG control. Scale bar, 50 j..ll11. 
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ILK expression by immunofluorescence and compared to age-matched controls. 
Placentas from patients with early preeclampsia onset (from week 20 to week 30, 
n=3; Fig 5.11) and placentas from patients with late onset of preeclampsia (from 
week 36 to term, n=3; Fig 5.12) were analysed. The placentas from early 
preeclampsia onset showed a much lower detection of ILK in endothelial cells of the 
blood vessels when compared to the aged-matched controls. The tissues from late 
onset showed a staining pattern in the villous cytotrophoblast and the mesenchyme 
that was similar to the age-matched controls, but ILK expression still seemed reduced 
in the endothelial cells offetal capillaries. ln all cases studied, the syncytiotrophoblast 
showed a stain ing pattern comparable to the non-specific isotype matched IgG 
controls suggesting that there was very little detectable ILK in this layer. 
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Figure 5.11 ILK expression in placentas from patients with early onset 
preeclampsia. Placentas from patients with early onset preeclampsia (early PE) and 
age-matched controls (AMC) were fixed, embedded and stained with ILK-specific 
antibodies. vCT, villous cytotrophoblast; FC, fetal capillaries; ST, 
syncytiotrophoblast, M, mesenchyme; lgG control, non-specific IgG control. ; w, 
week of gestation. Scale bar 100 !Jill. 
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Figure 5.12 ILK expression in placentas from patients with late onset 
preeclampsia. Placentas from patients with late onset preeclampsia (late PE) and 
age-matched controls (AMC) were fixed, embedded and stained with ILK-specific 
antibodies. vCT, villous cytotrophoblast; FC, fetal capi llaries; ST, 
syncytiotrophoblast, M, mesenchyme; IgG control, non-specific IgG control. ; w, 
week of gestation. Scale bar, 100 )...till. 
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CHAPTER6 
DISCUSSION 
6.1 ILK is Expressed in Chorionic Trophoblast Cells and 
Extra villous Trophoblasts of the Human Placenta 
Placental development is a complex process that involves the differentiation 
and invasion of fetal derived cells into the maternal uterus in a finely regulated 
manner. Trophoblast differentiation during early human placental development 
involves the two fundamental pathways of fus ion or invasion (Zhou et a!. 1997; 
Potgens et al. 2004; Bischof and Inninger-Finger 2005 ; Pollheimer and Knofler 
2005). Some trophoblasts fuse and form the syncytiotrophoblast, others divide and 
fonn more trophoblast cells or differentiate losing their proliferative characteristics to 
become invasive trophoblast cells (Zhou et al. 1997; Potgens et al. 2004; Bischof and 
lrminger-Finger 2005; Pollheimer and Knofler 2005; Baczyk et a!. 2006). 
Differentiation of trophoblasts into invasive cells is crucial for the proper 
development of the normal placenta. The trophoblasts must acquire the ability to 
migrate, reach and modify the maternal arteries to transf01m them into low resistance 
vessels. This ensures that enough blood, containing nutrients and oxygen, is supplied 
to the growing embryo. The trophoblastic cells also require an invasive nature to 
occupy the decidua and interact closely with uterine cells to coordinately secrete 
growth factors and horn1ones crucial for the maintenance of a healthy pregnancy. The 
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importance of this process becomes evident when the invasion is inadequate and 
mothers usually develop preeclampsia and the embryo shows signs of growth 
restriction (Kaufmam1 et a! 2003). 
The ubiquitous cytoplasmic serine/threonine kinase named ILK is a regulator 
of cell proliferation, cell-cell adhesion, migration, and invasion (Hannigan et al. 1996; 
Wu and Dedhar 2001), processes that are highly pertinent to vCT and EVT 
developmental pathways. Therefore, the central hypothesis for this thesis was that 
ILK would be expressed in trophoblast subtypes in human chorionic villi during early 
placental development and that ILK would regulate trophoblast migration and 
mvaswn. 
The results from immunofluorescence studies demonstrated that ILK was 
present in human placenta throughout gestation (see Chapter 3). Interestingly, ILK 
was detected in the villous cytotrophoblast layer of the chorionic villi and was barely 
detectable in the syncytiotrophoblast layer (Fig 3.2). Occasionally there was ILK 
staining on the apical surface of the syncytiotrophoblast. This result may be 
artifactual because of the presence of microvilli in this layer. It is possible that some 
residual non-specifically bound primary antisera remained trapped in proximity of 
these structures despite washes during the experiments, although the presence of ILK 
in this region cannot be rul ed out as many authors have described remainders of 
intercellular junctions within the syncytiotrophoblast (Carter 1964; Boyd and 
Hamilton 1966; Burgos and Rodriguez 1966; Metz et al. 1979; Reale et al. 1980; 
Wang and Schneider 1987). Some investigators have interpreted these junctions as 
vestiges of a former cellular state of the syncytium or as proof of recent 
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cytotrophoblastic contribution to the syncytiotrophoblast (Carter 1964; Boyd and 
Hamilton 1966). ln a systematic study of these junctions, Metz et al. (1979) as well as 
Reale et al. (1980) have described zonulae and maculae occludens that were mostly 
located in the apical membrane, as well as numerous isolated desmosomes, without 
contact to any surface membranes (Benirschke and Kaufmann 2000). Furthermore, 
the Dagnino lab (Vespa et al 2005) showed that ILK is an important modulator of 
Ca2+-dependent adherens and tight junction formation in epithelial cells so it is 
possible that ILK might be localized at these "former" cellular junctions but this 
remains to be directly examined. 
The immunostaining in the chorionic floating villi was discontinuous at times 
as ILK was not detected or detected at a low level in some vCT. These observations 
suggested that the regulation of ILK expression might be important for 
cytotrophoblast fusion. These results led to a new project conducted in our laboratory 
by Trina Butler that showed that ILK facilitates trophoblast fusion (Butler et al 2009). 
In the cell columns of anchoring villi, both vCT and the proximal tips of EVT cell 
columns showed ILK expression that colocalized with ITGA V (Fig 3.6). Cruet-
Hennequart et al. (2003) have described that 1TGA V regulates proliferation of 
ovarian cancer cells through ILK so, in the human placenta, ILK could be a mediator 
of proliferation in these specific trophoblast cell populations in response to ITGA V 
signalling and regulate outside: inside signalling. Distal to the villous tip of EVT cell 
columns from week 6 to term (Fig 3.7), ILK colocalized with ITGA5. This region of 
EVT cell columl1S, marked by detectable ITGA5Bl , is known to highly express FAK, 
paxillin, and MMP 2, and to possess detectable fibronectin, a ligand for ITGA5B I 
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(Damsky et al. 1992; MacPhee et al. 2001; Bauer et al. 2004) . As such, this region of 
the EVT cell column is characterized as possessing an intermediate, proliferative, 
migratory phenotype (Dam sky et al. 1994). The cytoplasmic tails of beta integrins are 
mediators of outside-inside signals that come from the ECM (Assoian and Schwartz 
2001; Hynes 2002) and interact with the carboxyl terminal end of ILK (Hmmigan et 
al. 1996; Zhang et al. 2004; Chiswell et al. 2008; McDonald et al. 2008). This 
suggests that integrin-ILK signalling could regulate the differentiation of trophoblasts 
into migratory cells during placental development. Thus, based on the ILK 
localization observed, ILK might promote cell cycle progression and trophoblast 
migration in vCT and EVT, respectively. The overexpression of ILK in mammary 
epithelial cells promotes anchorage-independent cell cycle progression through 
upregulation of cyclin Dl , and it also suppresses anoikis presumably through the 
phosphorylation and activation of AKT (Radeva et al. 1997; D 'Amico et al 2000). 
AKT 1 is a mediator of cell survival and is also a substrate for ILK, becoming 
phosphorylated on Ser-473, a critical residue for AKT1 activation (Persad et al. 
2001 ). Notably, pAKT 1 was also detectable in placental tissue lysates in all 
gestational timepoints examined and was immunolocalized to both vCT and EVT 
cells (Fig. 3.11) suggesting that, in human placenta, AKT might also be a substrate of 
ILK. 
6.2 ILK Regulates Migration of a Trophoblast-Derived Cell Line 
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To functionally address the role of ILK in the differentiation of EVTs 
exhibiting an intem1ediate, migratory phenotype, cell migration assays were 
conducted with HTR8-SVneo cells, an accepted cell line model of EVT (Graham et 
a!. 1993), transiently expressing different ILK-EGFP fusion proteins (see Chapter 3). 
The cells were less able to migrate when they were transiently transfected with a 
dominant negative lLK-E359K. The migration ability of the cells was significantly 
lower than those cells transiently transfected with ILK-WT and EGFP vector used as 
a control. Unexpectedly, the cells transfected with ILK-WT did not migrate more than 
the EGFP-control transfected cells. The lack of increase in number of migratory cells 
when they were transiently transfected with ILK-WT might reflect that the cells have 
a high amount of endogenous ILK. The high levels of ILK might be above the 
limiting rates so increasing the amount of ILK might fail to potentiate ILK-dependent 
processes. These novel results clearly demonstrated that ILK could indeed mediate 
trophoblast cell motility. Furthem1ore, they support a role for ILK in cell migration as 
shown by studies that reported that SCp2 mouse mammary epithelial cells stably 
transfected with the wild type fonn of ILK migrated more than cells stably 
transfected with antisense ILK (Filipenko et a!. 2005). The migration of the SCp2 
cells was dependent on the presence of Rae and Cdc42, which would be very 
interesting to study in the future to elucidate the signaling pathways used by ILK to 
regulate trophoblast migration. In another study, Vouret-Craviari eta!. (2004) showed 
that in bovine aortic endothelial cells, migration was inhibited when ILK expression 
was silenced with ILK specific siRNA. They also showed that cell-matrix adhesion 
was increased in cells lacking ILK and as a consequence migration was significantly 
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decreased (Youret-Craviari et al. 2004) demonstrating once more the importance of 
ILK for cell migration. Fukuda et al. (2003) also showed impaired migration when 
ILK expression was inhibited in HeLa cells with siRNA specific for ILK. 
In an attempt to study the mechanisms underlying the regulation of HTR8-
SVneo trophoblast migration by ILK, and considering that the organization of the 
cytoskeleton can be regulated indirectly by ILK (Zhang et al. 2007), HTR8-SVneo 
cells transiently expressing pEGFP-ILK fusion proteins were immunostained with 
EGFP and ILK specific antibodies. The results from these experiments (Fig 3.23) 
showed that exogenous ILK localized to FAs in cells transiently transfected with 
pEGFP-lLK-WT but when the cells were transfected with pEGFP-lLK-E359K the 
ILK immunostaining was primarily cytoplasmic and similar to the cells transiently 
transfected with pEGFP empty vector. This suggested that ILK-E359K protein was 
unable to localize to F As. This might partially explain the lack of migration of the 
cells into the wound when they are transiently transfected with the dominant negative 
pEGFP-lLK-E359K since it could sequester key proteins involved in migration away 
from FA sites. To migrate, a cell needs to be polarized, which means that the 
molecular processes at the front and at the back of moving cells are different (Ridley 
et al. 2003; Parsons et al. 20 1 0). It might be that the inability of ILK-E359K to bind 
to a -parvin (Nikolopoulos and Turner 2002; Stanchi et al. 2009) alters tbe ability of 
the cells to form elongated actin bundles at the leading edge of the cell inhibiting the 
polarization of the cell and in this way impairing cell migration. Although not much 
is known about the role of a-parvin in actin elongation there are studies that showed 
that when ILK is unable to bind to parvin, it cannot be recruited to focal adhesions, 
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which are the specializations that form before the actin bundles are elongated (Zhang 
et al 2004; Dubash et al 2009). These results are in accordance with Vouret-Craviari 
et al. (2004), Grashoff et al. (2004) and Sakai et al. (2003) who also found that the 
absence of normal ILK altered the migration and assembly of fibrillar adhesions in 
endothelial cells, keratinocytes and mouse embryonic fibroblasts, respectively. 
To further study if the cells were able to form fibrillar adhesions when they 
were expressing the different EGFP-lLK fusion proteins, HTR8-SVneo cells were 
plated on fibronectin under low serum conditions to induce the invasive phenotype 
and rhodamine red tagged-phalloidin was added to visualize actin fi lament bundles . 
Anti-EGFP antibodies were used to determine if EGFP-fused ILK was localized to 
those fibrilar adhesions. The cells transfected with the dominant negative pEGFP-
lLK-E359K were not able to form fibrillar adhesions in contrast with the control and 
the pEGFP-ILK-WT transfected cells. This was evident in the latter cells by the 
presence of elongated structures stained with phalloidin along the side of the cells 
(Fig 3.24). ln the cells transiently transfected with pEGFP-ILK-E359K, the actin 
bundles were short and were present equally in the cytoplasm and in the plasma 
membrane where they appeared as non-continuous short lines similar to what Vouret-
Craviari et al. (2004) described in endothelial cells transfected wi th ILK specific 
siRNA. lJ1 cells transiently transfected with pEGFP-lLK-WT, or the pEGFP control, 
the actin bundles were long and continuous along the plasma membrane. ILK-WT 
showed a stronger detection than the ILK-E359K in those actin bundles suggesting 
that ILK localizes to those adhesions. This implicates ILK as an important member of 
these adhesion specializations in HTR8-SVneo trophoblast cells. Altogether the 
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results suggested that trophoblasts need functional ILK to form focal and fibrillar 
adhesions. 
Experiments to study the phosphorylation status of AKT fo llowing the 
transient transfection of HTR8-SYneo cells with the different pEGFP-ILK containing 
plasmids showed that regardless of expression of 1LK-E359K, ILK-WT or EGFP 
alone, AKT was comparably phosphorylated (Fig 3.22 and 5.4). This could mean that 
ILK does not regulate trophoblast migration through this signalling pathway. Due to 
the nature of the transient transfection it could also be possible that the endogenous 
levels of ILK are sufficient enough to phosphorylate the substrates regard less of the 
exogenous levels of ILK-E359K. Another possible explanation is that the sensitivity 
of the immunoblot method was not high enough to see a difference in 
phosphorylation of AKT or GSK3~ in response to the expression of the dominant 
negative ILK-E359K. 
The effect of knocking down ILK with siRNA on the migration of the HTR8-
SVneo trophoblast cells was also tested (data not shown); however, several attempts 
to knockdown ILK with siRNA failed, suggesting that ILK was not effectively 
targeted by the chosen siRNA or that ILK protein levels in the cell were very stable 
with a long half-life. Due to lack of funding different sequences were not tested. It 
would be very interesting to develop a future project using ILK knockdown 
approaches such as siRNA to identify the signalling pathways controlled by ILK 
during migration. With this approach the endogenous levels of ILK would be minimal 
and the interpretation might be less compl icated. 
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Hannigan et al. (1996) demonstrated that overexpression of ILK in epithelial 
cells results in disrupted cell-cell adhesion. ILK can also downregulate ~-catenin 
expression through activation of the transcriptional repressor Snail, independently of 
~-catenin/T cell factor regulation (Tan et al. 200 1). Furthermore, ILK can induce 
EMT in a variety of epithelial cell types (reviewed in Hannigan et al. 2005). EMT is a 
critical event in EVT differentiation because these trophoblast cells must undergo 
EMT in the cell column to facilitate their change in phenotype to less cohesive, single 
pleomorphic trophoblast cells that will migrate and invade the decidua and maternal 
spiral arteries (Vicovac and Aplin 1996) . Thus, ILK may mediate trophoblast cell 
differentiation by initiating downregulation of ~-catenin expression in vCT and EVT 
to facilitate the formation of syncytiotrophoblast and induction of EMT. Interestingly, 
ongoing research in the MacPhee Laboratory has found that Snail and poly (ADP-
ribose) polymerase-! (PARP-1) are expressed in vCT and EVT of human placenta 
throughout development (Butler et al. , manuscript in preparation). It would be very 
fascinating to study what happens with the expression of these proteins, ~-catenin and 
Snail, if ILK was depleted in trophoblasts with specific targeted siRNAs and 
migration was inhibited. Since in cancer derived cell lines the overexpression of ILK 
induced down regulation of E-cadherin by upregulating Snail through PARP-1 
(McPhee et al. 2008), it is possible that ILK might be regulating the expression of 
those proteins to control migration in trophoblast cell s. 
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6.3 ILK Regulates the Invasion of Matrigel in a Trophoblast Derived 
Cell Line 
Differentiation of trophoblasts into invasive cells is crucial for the proper 
development of the normal placenta. Trophoblasts must acquire the ability to migrate, 
reach and modify the maternal arteries to transform them into low resistance vessels 
so enough blood supplies the growing embryo with nutrients and 0 2 (Benirschke and 
Kaufmann 2000). The importance of this process becomes evident when the invasion 
is inadequate and mothers develop preeclampsia, a syndrome that puts at risk the 
health of the mother and increases the probabilities of a preterm birth (Goldenberg et 
al 2008). It is also thought that problems in placentation could be the origins of many 
future complications for the fetus like cardiac and kidney disease and diabetes 
mellitus (Barker 1990; Barker 2004). Little is known about what fails during 
preeclampsia that renders a trophoblast cell unable to invade deeply into the maternal 
uterus. The finding of which proteins are essential in the process of transforming from 
one type of cell to another, for example from proliferative epithelial-l ike trophoblasts 
to invasive mesenchymal- type trophoblasts, will perhaps provide answers to 
unsolved problems such as the cause of preeclampsia or the etiology of many 
miscarriages. It could also lead to the di scovery of novel markers for early detection 
of preeclampsia. 
It was hypothesized that ILK regulates invasion in trophoblasts. The results 
from the invasion assays (Fig 4.8) demonstrated clearly that normal function of ILK 
was needed in a human derived trophoblast cell line to invade the Matrigel. The 
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importance of ILK for trophoblast invasion was highlighted by the reduction of 
mvaston when HTR8-SVneo cells were transiently transfected with dominant 
negative pEGFP-ILK-E359K. This mutant has a point mutation in a conserved 
glutamic acid residue located in the kinase domain, E359K (Nikolopoulos and Tumer 
2002) and is unable to interact with paxillin and a-parvin. In contrast to ILK-WT, 
which co-precipitated both a-parvin and paxillin, no binding of these proteins to the 
ILK-E359K mutant was observed (Nikolopoulos and Tumer 2001). Furthermore, 
immunofluorescence staining of ILK-E359K expressing cells showed that this mutant 
cannot target to F As but remains in the cytosol (Nikolopoulos and Tumer 2002). The 
interaction between ILK and a-parvin is essential for ILK-PINCH and parvin (tiPP) 
complex fom1ation, recruitment to FAs and stabi lization of integrin-actin connection 
as shown in studies where ILK or PINCH expression were inhibited and F As did not 
fonn (Stanchi et al. 2009). There is evidence that the recruitment of the tiPP complex 
to integrins is subject to tight regulation that occurs at multiple levels. A first step 
involves the regulation of tlPP complex fonnation . A second regulatory mechanism 
relies on proteasome-mediated degradation of the tiPP components (Fukuda et al. 
2003) . In this latter study they showed that when ILK or PINCH expression was 
inhibited the rest of the complex members were degraded by the proteasome system. 
When ILK is mutated to ILK-E359K, it does not bind to a-parvin (Stanchi et al. 
2009), but is still able to bind to PINCH, as the binding site is through the ANK 
domains in the N-tetminal region of the protein (Tu et al. 1999; Chiswell et al. 2008; 
Maydan et al. 201 0). This ILK-E359K might compete with the endogenous ILK, 
leaving many ' incomplete" complexes in the cytoplasm that are unable to locate to 
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F As (Stanchi et al. 2009). Therefore, the mutation might alter the formation of an 
important signalling node that ultimately drives invasion in the trophoblast cells. 
Interestingly, the introduction of ILK-S343D into HTR8-SVneo cells significantly 
increased the number of cells invading the Matrigel (Fig 4.8) while the introduction 
of ILK-WT resulted in similar invasion to those cells transiently transfected with the 
pEGFP control vector. These results suggest that ILK kinase activity may be an 
important factor regulating the invasion of this cell line. Although ILK function has 
not been explored in trophoblast cells before, these results are in accordance with 
studies done with cancer-derived cell lines. Inhibition of ILK activity usmg 
QLT0267, an ATP-competitive small-molecule inhibitor (Maydan et al. 2010) 
suppressed the invasive properties of ErbB2-expressing mammary epithelial cells in 
vitro (Pontier et al. 201 0). Furthermore, overexpression of ILK in intestinal and 
mammary epithelial cells resulted in a highly invasive phenotype, which was 
inhibited by QLT0267 and was associated with increased levels of expression of the 
matrix metalloproteinase MMP-9 (Troussard et al. 2000). The in vitro studies in this 
thesis confim1ed that ILK can regulate trophoblast invasion in the human EVT-
derived HTR8-SVneo cell line. 
6.4 ILK Expression in Blood Vessels of Chorionic Villi 
During the first trimester of placental development, ILK protein was highly 
detectable in villous stromal cells and was also detectable in developing blood vessels 
of first trimester and tem1 chorionic villi, where ILK colocalized with vWF, a marker 
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for endothelial cells (Fig 3.8). It has been shown previously that in both tumors (Tan 
et al. 2004) and in endothelial cells (Kaneko et al 2004) ILK regulates endothelial 
morphogenesis induced by VEGF. VEGF is a potent vasculogenic factor. VEGF and 
its receptor sFltl, have been detected in villous stromal cells, particularly in the 
decidual macrophages and in the vCT (Clark eta!. 1996; Demir eta! 2004). Thus, it is 
possible that the VEGF response in fetal endothelial cells is mediated through ILK 
signalling pathways. The transcription factor HIF 1 a is also detectable at the mRNA 
and protein levels in villous mesenchyme and trophoblast layers during the early first 
trimester (Caniggia et a!, 2000b; Rajakumar and Conrad 2000) coincident with a low 
0 2 environment at this time, and is also reportedly detectable in second and third 
trimester placentas (Rajakumar and Conrad 2000). Expression of VEGF is mediated 
by HIF l a independently of hypoxia, through a mechanism involving PI3K, ILK, and 
AKT (Jiang eta!. 2001; Fukuda eta!. 2002; Tan et al. 2004), and knockout of H!fl a, 
Epasl or Arnt in mice resulted in defective placental vascularization in addition to 
abenant trophoblast cell fates (Cowden Dahl et a! 2005). Gene microanay analysis 
has shown that ILK expression can be highly upregulated by hypoxic conditions 
(Scanduno et a!. 2001) adding another layer of complexity to the regulation of ILK 
expression. Finally, endothelial cell-targeted knockout of ILK in mice results in 
embryonic lethality as a result of defective placental vascularization (Friedrich et a!. 
2004). Therefore, these reports and our experimental data together strongly suggest 
that ILK could be involved in placental vascularization during early human gestation. 
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6.5 ILK is Expressed in the Mouse Placenta 
The results from immunofluorescence experiments in the human placenta and 
migration and invasion assays with HTR8-SVneo cells (Chapters 3 and 4) suggest 
that ILK plays a major role in migration and invasion of human EVT. To further 
explore the role of ILK in invasion, and considering the obvious limitations for 
genetic manipulation that the human placenta presents, the expression of ILK was 
studied in mouse placenta. The main objective was to examine the expression of ILK 
in the mouse placenta during development using immunohistochemistry. This 
information would then become a foundation of knowledge for future exploration of a 
conditional knockout of ILK in the trophoblast cells that become invasive during 
mouse placental formation and are likely analogous to populations of invasive 
trophoblasts in humans. The mouse placenta is a good model because trophoblast 
cells that form the placenta in the human and the mouse are highly homologous 
(Georgiades et a l. 2002) and the genome of the mouse is well characterized making it 
possible to manipulate the genetic information. For example, Mash 2 is expressed in 
the spongiotrophoblasts and its human orthologue HASH 2 is detected in 
cytotrophoblasts cell columns (Alders et al. 1997; Janatpour et al. 1999; Hemberger 
and Cross 2001 ). In both organisms this gene is also downregulated during 
trophoblast differentiation into invasive trophoblasts, i.e. the GlyC in mouse placenta 
and interstitial EVT in humans (Janatpour et al. 1999). Gcml is also expressed in both 
the mouse placental labyrinth and the human CT in floating villi and has been 
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implicated in the fom1ation of the syncytiotrophoblast (Cross et al. 2003b; Baczyk et 
al. 2004). 
Studies m early mouse embryo development (Sakai et al. 2003) showed 
expression of ILK in both the trophectoderm and inner cell mass but until now there 
was no infom1ation available about the expression of ILK in the mouse placenta. 
Jnterestingly, this study showed that ILK has a particular temporal and spatial pattern 
of expression in the placenta during gestation and was expressed in three regions of 
the mouse placenta (Fig 4.3, 4.4), the labyrinth, the junctional zone and in the TGCs. 
The expression of ILK in early stages in the ectoplacental cone (Fig 4.1) 
suggested that ILK might be present in the cell precursors of the spongiotrophoblasts. 
By E9.5 it was evident that ILK is highly expressed in the TGCs and to a much lesser 
extent in the early spongiotrophoblast (Fig 4 .2). These differences in level of 
detection could reflect the different characteristics of the cells: spongiotrophoblast 
have no invasive characteristics and are supposed to be precursors of other cell types 
while TGC are fully differentiated cells able to invade the maternal uterus 
(Georgiades et al. 2002; Simmons and Cross 2005; Simmons et al. 2007). 
From El 0.5 to E l 7.5, ILK was expressed in the labyrinth, spongiotrophoblast 
layer, GlyC, and TGC. In the labyrinth ILK was found in the cytoplasm of cells 
adjacent to endothelia l cells immunostained for laminin (Fig 4.5) which is a marker of 
fetal capillaries (Natale 2006) and co-localized with Cx26 (Fig 4.6), which suggested 
that ILK was expressed in the syncytiotrophoblast layer that is adjacent to the fetal 
capi llaries of the mouse placenta (Coan et al. 2005). In contrast to what was observed 
in human placenta where ILK was highly expressed in the vCT (see Chapter 3), ILK 
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was expressed in the syncytiotrophoblast layer of the mouse placenta. This is an 
interesting finding since in the mouse the syncytiotrophoblast is the layer in direct 
contact with fetal tissues, in contrast to what happens in human placenta where the 
vCT is lining the fetal mesenchyme, separated by a basement membrane. This could 
suggest that regulation of ILK expression in polarized epithelia depends on the 
interaction with the basement membrane or that the expression of ILK might be 
necessary for the attachment and/or integrity of the basement membrane. There are 
studies in which keratinocyte-specific deletion of ILK in mice led to reduced integrin-
mediated adhesion and impaired basement-membrane integrity (Lorenz et al. 2007). 
There are other studies that showed that developing mice lacking ILK expression died 
at peri-implantation stage due to impaired epiblast polarization associated with 
abnormal F-actin accumulation at sites of integrin attachments to the BM zone (Sakai 
et al 2003). Recently, it was demonstrated that ILK can facilitate syncytialization and 
differentiation of human BeWo trophoblast cells (Butler et al. 2009), but the specific 
role of ILK in the syncytiotrophoblast of the mouse placenta is still unknown. This 
study now allows a consideration for a syncytiotrophoblast-specific knockout of ILK 
to specifically detennine the necessity and possible function of ILK in this region. 
In the junctional zone, ILK was highly expressed in some of the nuclei of the 
spongiotrophoblasts and in the GlyC (Fig 4.6 and 4. 7). Recently it has been shown 
with double in situ hybridization (Tpbpa and Asc/2, previously named Mash2) that 
there are at least two populations of spongiotrophoblasts: one group exhibiting Tpbpa 
expression while the other does not (Hu and Cross 2011). It could be that the 
heterogenous expression of ILK is related to the different origin of the 
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spongiotrophoblasts or it might be reflecting a different function of ILK in certain 
spongiotrophoblast cells. 
The GlyC are analogous to human EVT cells, particularly the distal cells of 
the column, which are also rich in cytoplasmic glycogen (Georgiades et al. 2002). In 
the mouse placenta, GlyC are the only zygote-derived trophoblasts that invade the 
decidua basalis similar to interstitial EVT in human placenta. They both express 
urokinase-type plasminogen activator (Teesalu et al. 1998), Asc/2 (Alders et al. 1997; 
Tanaka et al. 1997) and IGF-11 (Coan et al 2006). Now the results in this thesis show 
that both also highly express ILK indicating that ILK could be performing similar 
functions in those cells. 
ILK was found in the parietal TGCs that were identified by their large nuclear 
size and their location, in the region between the spongiotrophoblast layer and the 
decidua (Fig 4.4). The expression of ILK in the TGC was not homogeneous; some 
TGC showed higher expression of ILK in the cytoplasm and some showed expression 
ofiLK only in the nucleus. These findings might reflect the different origins ofTGCs 
(Simmons et al. 2007) found in the mouse placenta. Some of the TGCs arise directly 
from the mural trophectoderm cells in the blastocyst in a process called primary TGC 
differentiation. However, most of the parietal TGCs arise from the polar 
trophectoderm and these are known as secondary TGCs (Simmons and Cross 2005). 
Historically, it has been hypothesized that secondary TGCs are derived from 
progenitor cells within the ectoplacental cone and the spongiotrophoblast layers that 
are Ascl2 and Tpbpa/4311 positive (Simmons and Cross 2005). However, lineage-
tracing studies have shown that only some TGC subtypes arise from Tpbpa-positive 
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precursor cells (Simmons et al. 2007) which are located in the outer ectoplacental 
cone starting at ~E8.5 and later in the spongiotrophoblast. The source of the Tpbpa-
negative precursors is unknown but could be the extra-embryonic ectoderm/chorion 
trophoblast cells, inner ectoplacental cone cells, or both (Simmons et al. 2007). 
Another possible explanation for the heterogeneous staining could be that ILK might 
play different roles in TGC and is only translocating to the nucleus in certain stages 
of the cell cycle. The work in our laboratory, carried out by Trina Butler, 
demonstrated that nuclear localization of ILK increases in BeWo cells as 
syncytialization occurs (Butler et al. 2009). By transfecting the cel ls with a dominant 
negative pEGFP-ILK-E359K, syncytialization was inhibited suggesting that ILK is 
necessary for this differentiation process in trophoblasts. It is important to note that, 
in contrast with human "giant cells", mouse parietal TGCs do not originate from 
fusion of precursors cells but undergo endoreduplication, a process in which the DNA 
duplicates repeatedly without division of the cytoplasm (Vannuza et al 1988). Those 
cell s undergo endocycles, instead of leaving the cell cycle, generating a polytenic 
genome in which many sister chromatids are synapsed together. For cells to switch 
from a mitotic cell cycle to an endocycle the level of several proteins fluctuate in 
order to keep the cell in the endocycle without division of the cytoplasm (Follette et 
al 1998; Zybina and Zybina 1996). For example, mSna, a zinc finger transcription 
factor homologous to Snail in Drosophila, regulates the G2 decision point of whether 
trophoblast cells go through mitosis or enter the endocycle (Sigrist and Lehner 1997). 
It has been shown that mSna is present in the TGC precursors but not in the TGC 
demonstrating that mSna is a repressor of endoreduplication (Nakayama et al. 1998). 
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Butler et al. (2009) also showed that the expressiOn of ILK was related to the 
expression of Snail as increased ILK and Snail expression coincided with repressed 
expression of E-cadherin during syncytialization. Another difference with the classic 
cell cycle is that during the transition from the mitotic cell to the endocycle, the cyclin 
D isoform switches from D3 to D l (Hu and Cross 201 0). It has been shown that ILK 
regulates the phosphorylation and inactivation of GSK3p, which in turns allows for P-
catenin translocation to the nucleus and the increased expression of cyclin D 1 
(Troussard et al. 1999). So the difference in ILK expression in TGC might be 
reflecting the presence of cells in different stages of the cell cycle where cells that do 
not express ILK might have already completed the endocycles. This could be 
considered analogous to what happens in human placenta where ILK is present in the 
vCT that are precursors of the syncytiotrophoblast but is barely detected in the 
syncytiotrophoblast layer. 
Overall, the immunolocalization and temporal pattern of ILK expression in 
the developing mouse placenta confinns the feasibility of undertaking a conditional 
knockout of ILK in the mouse spongiotrophoblast layer to specifically detern1ine the 
necessity of ILK for spongiotrophoblast to differentiate into glycogen trophoblast and 
to regulate glycogen trophoblast invasion. 
6.6 ILK Expression at Low Oxygen Tension 
ILK gene expression showed a transient rise in expression in HTR8-SVneo cells 
exposed to low 0 2 tension (Fig 5.2). In contrast, HTR8-SVneo cells showed no 
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detectable differences in ILK protein expression either when cultured under hypoxia 
mimic conditions created with CoCb or DFX (Fig 5.3) or at 3 % 0 2 (Fig 5.4). With 
respect to the different responses observed to a low 0 2 environment between mRNA 
and protein expression, it is possible that post-transcriptional mechanisms could be 
controlling the expression of ILK. MicroRNAs (miRNAs or miR) are endogenous 
noncoding RNAs of approximately 22 nucleotides that bind to complementary 
sequences within mRNAs, thereby either inhibiting translation or causing mRNAs to 
become degraded (Ambros 2004; Bartel et al. 2004; Ventura and Jacks 2009). 
Recently a study on c-Src overexpressing tumor cells showed that the down-
regulation of microRNA miR-542-3p led to upregulation of ILK which controlled the 
adhesion and invasion of cells in vitro (Oneyama et al. 20 12). These results suggested 
that ILK expression can also be regulated by microRNA expression. miRNA are 
expressed in a tissue-specific manner (Morales-Prieto and Markert 2011). Recently, a 
study revealed a group of miRNAs that is expressed by placenta and brain (Miura et 
al. 2010). miR-542-3p was not included in this list but it would be really interesting to 
study the presence of ILK regulatory miRNA in the placenta. Regarding the 
discrepancies observed in the response to the 0 2 environment between ILK mRNA 
and protein expression, it could also be possible that ILK protein tumover could be 
rapid under these conditions masking any detectable increases following low 0 2 
exposure. As soon as the cells are exposed to low 0 2 there was a significant decrease 
in the level of mRNA prior to the transient increase observed. A recent study on the 
stability of ILK estimated that the half life of the ILK protein is approximately 8.4 h 
in the presence of cycloheximide (Aoyagi et al. 2005), so it could be that under low 
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0 2 conditions there is a positive feedback (as soon as 6 h upon exposure to low 0 2) 
inducing a transient increase in mRNA to maintain the levels of ILK. 
With respect to the difference in ILK protein expression observed between the 
explant experiments and the HTR8-SVneo cell experiments, where ILK seemed to be 
downregulated in explants at 3 %and not affected in cell cultures, it could be possible 
that there are signalling pathways which control the expression of ILK that respond to 
extracellular matrix signals lacking in cell culture but partially represented in the 
explant system. For example, growth factors secreted by the mesenchymal cells or the 
syncytiotrophoblast and/or neighbouring cells in the cell column could be present in 
explants compared to immortalized cell lines. The differing results could also be a 
reflection of the different origins in cell types i.e ex plants that are likely from floating 
villi (Genbacev et al. 1993a; Miller et al. 2005) versus the cell line HTR8-SVneo, 
which was derived from EVT (Graham et al. 1993). 
It was possible that there was a change in ILK activity instead of a change in level 
of protein expression in response to low 0 2 . To test this hypothesis, the expression of 
pAKT or pGSK3~ was first studied by immunoblot analysis as a means of inferring 
ILK activity. This was evaluated in HTR8-SVneo cells exposed to low 0 2 and 
simultaneously expressing a dominant negative ILK-E359K, ILK-WT, constitutively 
active ILK-S343D or EGFP alone and compared to cells expressing the same 
exogenous proteins, but exposed to 20 % 0 2. As shown in Fig 5.5, pAKT levels 
increased in HTR8-SVneo cells exposed to low 0 2 tensions suggesting ILK activity 
could be responsible for this effect, but this increase could not be inhibited by the 
presence of the dominant negative ILK-E359K. Conversely, there was no increase in 
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pAKT detection when the cells were transiently transfected with the constitutively 
active pEGFP-ILK-S343D and exposed to a 20% or 3 % 0 2 environment. It may be 
that the expression of the fusion proteins was not high enough to compete with the 
endogenous ILK that still exhibited a high level of detection in transfected cells (Fig 
5.5). An altemative way to study if ILK kinase activity was responsible for increased 
pAKT detection under low 0 2 conditions would be to reduce ILK expression by 
siRNA targetting in a trophoblast-derived cell line such as HTR8-SVneo, expose the 
cells to a low 0 2 environment, and determine pAKT and pGSK3~ levels by 
immunoblot analysis. 
When the activity of ILK was studied in HTR8-SVneo cells in vitro using GSK3~ 
as a substrate there was no significant change in detection of pGSK3~ at 3 % 0 2 
compared to 20 % 0 2 relative to the amount of total GSK3~ (Fig 5.6), suggesting that 
0 2 is not playing a major role in the regulation of ILK activity in vitro in HTR8-
SVneo cells. These results do not agree with Scandurro et al. (2001) who found that 
the exposure of the hepatoma derived cell line, Hep3B to 1% 0 2 significantly 
increased the kinase activity of ILK after 1 h of exposure to low 0 2 and this increase 
was even greater in magnitude at 48 h. The difference in results might be due to 
differences in the origin of the cell lines studied as Hep3B is a malignant type of 
cancer-derived cell line and the HTR8-SVneo is immortal but not malignant (Graham 
et al. 1993). Another crucial difference in the experiments was the percentage of 0 2 
that the cells were exposed to. In the study of Scandurro et al. (200 1) the 0 2 tension 
was 1% and the HTR8-SVneo cells were exposed to 3 % 0 2 which is more 
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representative of the physiological levels of 0 2 present in the placenta before week 10 
of gestation (J auniaux et al 1999). 
6. 7 Preeclampsia 
Preeclampsia is associated with failure of cytotrophoblasts to invade the spiral 
arterioles (Zhou et al. 1993). In this study, a small group of preeclamptic and age-
matched control placentas were examined. The placentas from early onset 
preeclampsia showed a reduced detection of ILK in fetal blood vessels and 
cytotrophoblasts while the placentas from late onset preeclampsia showed a staining 
similar to the age matched controls. The lower ILK detection in early onset 
preeclampsia could be a real reduction in ILK expression that require further study by 
immunoblot analysis and other techniques like qRT-PCR to study ILK gene 
expression in this tissue. The structure of the preeclamptic tissues looked more 
similar to a term placenta so it could also be that, as an adaptation to the lower blood 
supply, the cytotrophoblast cytoplasm becomes thinner to improve the gas and 
nutrient exchange making ILK detection more difficult by immunofluorescence. Even 
if that is the case, the expression of ILK in the fetal capillaries also seemed reduced 
which cou ld suggest that the fetal blood vessels are affected in preeclamptic patients. 
The villous capi llary bed is different from that in systemic organs (Kingdom et al. 
2000; Kaufman et al. 2004). From 25 weeks post conception until tem1, patterns of 
villous vascu lar growth switch from prevailing branching angiogenesis to prevalence 
of non-branching angiogenesis (Kingdom et al. 2000; Kaufman et al. 2004). As a 
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consequence, the villous capillaries are longer but much less branched, while villous 
arteries and arterioles are rather short and lack innervation. Thus the villous 
capillaries contribute more significantly to feto-placental impedance than capillaries 
do in systemic organs (Kingdom et al. 2000; Kaufman et al. 2004). These 
characteristics suggest that an alteration in the morphology of fetal capillaries could 
indirectly affect the maternal blood pressure. The switch in the type of angiogenesis 
correlates with a decrease in local VEGF and an increase in PlGF (Kingdom and 
Kaufmam1 1999). Studies comparing nonnal and preeclamptic tissue have shown that 
levels of PIGF and VEGF are significantly lower than 111 normal patients. 
Interestingly, it has been described before that ILK might be regulating VEGF 
expression in response to 0 2 levels (Tan et al. 2004). Since that original report in 
cancer cells many laboratories have shown that VEGF expression is reduced if ILK is 
silenced (Edwards et al. 2008; Wang et al. 2011; Wani et al. 20 11 ). Although these 
studies have been conducted in cancer cells they still suggest that there might be a 
link between preeclampsia and a lower expression of ILK. What is not possible to 
know is if the lower detection of ILK in the preeclamptic tissues is a consequence of 
an unknown alteration that could be impacting ILK levels or if this reduced detection 
of ILK expression is also playing a major role in the reduction of trophoblast invasion 
present in preeclamptic women. It would be very interesting to study a larger number 
of samples of placentas from addi tional patients and try to detect ILK in plasma and 
see if the levels of ILK could predict the occurrence of preeclampsia. ILK has already 
been detected in plasma of patients with invasive ovarian cancer with levels 
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significantly higher than in normal patients (Ahmed et al. 2004), so a decrease in 
nom1al ILK levels would be expected in preeclamptic patients. 
6.8 Conclusions and Future Directions 
This study showed for the first time that ILK is present in human placenta in 
the cells that differen tiate into syncytiotrophoblast and in cells that differentiate into 
EVT suggesting an important role in their differentiation. The results from the 
migration and the invasion assays suggest that ILK directly or indirectly regulates 
these fundamental processes thought to be responsible for the remodeling of the 
matemal arteries and the interaction with cells in the decidua. This contributes to the 
general understanding of normal placental development, a process regulated by a vast 
number of factors but still poorly understood. Unfortunately, it was not possible to 
identify the exact pathways that were directly regulated by ILK. The results are sti ll 
significant as they clearly showed that ILK is important. 
To further study the signalling pathways regulated by ILK in trophoblast-
derived cell lines, an siRNA approach might prove more useful as, with the right 
siRNA sequences, very low or no detectable levels of endogenous ILK should be 
present and therefore the results should be more conclusive than the ones shown here 
with transient transfection of dominant negative, constitutively active or wild type 
forms of ILK. The signalling pathway studies should be expanded because it is 
probable that the regulation of invasion in trophoblast cells is via the regulation of 
actin cytoskeleton organization or the activation of c-SRC that leads to the activation 
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of the Ras/MEK pathways instead of the regulation of AKT or GSK3~ that regulate 
survival and proliferation. An array or proteomic approach should render a 
comprehensive set of data that could be very useful to identify new signalling 
partners of ILK in the trophoblast. 
The fact that ILK was present in the cells that invaded the decidua in mouse 
placenta, the GlyC, suggested that it was feasible to continue the studies of the role of 
ILK during gestation with a conditional mouse knockout in the placenta. Thus, a key 
future step should be to develop mice exhibiting ILK knockdown specifically in the 
spongiotrophoblast layer that gives origin to the invasive cells in the mouse placenta. 
The MacPhee laboratory obtained "floxed" ILK mice from the laboratory of Dr. R. 
Fassler (Max Planck Institute, Martinsreid, Germany) (Sakai et al 2003) and they 
were crossed with mice that carry the Cre recombinase gene under the control of a 
spongiotrophoblast specific promoter for the Tpbpa gene (Calzonetti et al 1995), 
obtained from the laboratory of Dr J. Cross (University of Calgary). In this case 
Tpbpa was used because it is expressed in the spongiotrophoblast layer of the mouse 
placenta and these are the cells that give origin to the GlyC cells (S immons and Cross 
2005). For the establishment of a C57BL/6J mouse line expressing ere recombinase 
under the control of the mouse Tpbpa promoter (Tpbpa-Cre+ ), CD-I tpbpa-Cre+ 
mice, provided by Dr. J Cross (University of Calgary, Canada) were crossed with 
C57BL/6J because this was the strain that carried the floxed ILK gene. Eight 
backcross generations resulted in at least a 99% donor inbred genome. The 
conditional knockout of ILK in the spongiotrophoblast layer can now proceed and 
should show if ILK is necessary for the differentiation of spongiotrophoblasts into 
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GlyC. A TGC specific knockout of ILK could also be conducted due to high levels of 
ILK in these cells which have an invasive phenotype. These future experiments could 
have a huge impact on our knowledge of placental development and provide new 
clues on proteins that could, in the near future, become targets of novel therapies. 
ILK detection was reduced in explants exposed to 3 % 0 2 and in the fetal 
capillaries of preeclamptic placentas in contrast with the cell culture system where 
ILK protein was not affected by a low 0 2 environment. This might suggest that, in 
vivo and over time, a down regulation of ILK might render the cells less migratory 
and invasive leading to failure in placental development. This suggests that the mouse 
model might prove to be a better model than the trophoblast derived cells for the 
study of the regulation of these type of proteins that are regulated by the extracellular 
matrix, growth factors and 0 2 in a cooperative manner. 
Ideally a higher number of placentas from preeclamptic patients should be 
compared with age-matched controls to confirm the results obtained in this study. 
Lastly, another interesting project would be to compare the plasma levels of ILK in 
normal pregnant women, gestational hypertensive pregnant women and non-pregnant 
women to test if ILK could be a good marker for the prediction of preeclampsia. 
In summary, this is the first study to establish that during early placental 
development and at term, ILK protein is highly expressed in vCT that will enter the 
fusion pathway and also in the EVT that has entered the invasive pathway of 
trophoblast differentiation, and that ILK regulates trophoblast migration and invasion. 
The results also suggested that the migration might be regulated by the adaptor 
function of ILK as a dominant negative fonn of ILK was able to inhibit migration but 
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was unable to reduce the activation of AKT or GSK3~, two well-known substrates of 
ILK. During this project, it was also shown for the first time that ILK is expressed in 
the mouse placenta indicating that it is feasible to conditionally knockout ILK in the 
different layers of the placenta to test if ILK is necessary for trophoblast 
differentiation in vivo. 
These research findings now serve as a foundation for future studies to 
elucidate the role of ILK in placental vasculogenesis, syncytiotrophoblast 
differentiation, and the differentiation of invasive EVT. Hopefully it will also 
contribute to inspire others to continue the quest for markers and potential treatments 
for preeclampsia, a syndrome that sti ll has no cure other than a pretem1 delivery. 
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